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ABSTRACT 
Using an in vitro model of HIV-1 male-to-female transmission to identify key 
aspects of the bottleneck hypothesis 
Karl Siegert 
Fred C. Krebs, PhD  
 
When semen comes in contact with the female reproductive tract (FRT), it 
elicits a polarized- and time-dependent release of cytokines and other soluble 
factors from the epithelial barrier. These factors are involved in tissue remodeling, 
as well as immune cell activation and recruitment. This influx of immune cells 
potentially susceptible to human immunodeficiency virus type (HIV-1) infection 
leads us to hypothesize that (i) semen alters the subepithelial environment of the 
FRT to be more pro-inflammatory, (ii) the pro-inflammatory environment induced 
by semen will modulate surface expression of antigens on immune cells, 
specifically the HIV-1 co-receptors on T cells, and (iii) that the combined effect of 
semen-induced inflammation and immune cell alterations will increase the risk of 
male-to-female R5-tropic HIV-1 transmission. To test these hypotheses in vitro, 
three different cell lines derived from the vagina, ectocervix, and endocervix were 
used to establish a polarized, transwell-based polarized epithelial model. After 
introduction of activated PBMCs into the basolateral chamber and apical exposure 
of the epithelial cells to semen (from healthy donors), the basolateral medium was 
collected and assessed for cytokine production using an ELISArray of twelve pro-
inflammatory cytokines, while the PBMCs were harvested and assayed by flow 
cytometry for cell surface markers indicative of cell status and susceptibility to HIV-
	 xiii 
1 infection. To model HIV-1 transmission, a pseudovirus containing a GFP reporter 
was constructed in conjunction with either an X4-tropic envelope (HXB2) or an R5-
tropic envelope (a known transmitted/founder virus). Immediately after apical 
semen exposure to the epithelium, PBMCs were collected and infected with a 
pseudovirus, and then assayed for infection (as indicated by GFP expression). In 
co-cultures of epithelial cells and PBMCs in the absence of infection, conditioned 
media in the subepithelial chamber was pro-inflammatory in nature, a condition 
which was exacerbated in the presence of semen. In three separate co-cultures 
incorporating each of the three epithelial cell lines, the innate immune response in 
the absence or presence of semen was dominated by IL-8. Flow cytometric 
analyses of the PBMCs showed that CCR5+ T lymphocytes decreased in numbers 
in the absence of semen only in the ectocervical model. However, CXCR4+ T 
lymphocyte numbers did not change appreciably in any epithelial model system. 
When PBMCs were pre-conditioned and then infected with an R5 or X4 
pseudovirus, only those conditioned by the ectocervical cells displayed increased 
levels of infection by the R5 virus, but with no change in X4 virus infection. Ongoing 
studies are investigating the mechanism by which semen preferentially selects for 
R5 viruses over X4 viruses
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Chapter 1 
 
 
Immunomodulation by seminal factors 
and implications for male-to-female HIV-1 transmission 
 
Shawn Keogan, Karl Siegert, Brian Wigdahl, and Fred C. Krebs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1 Abstract 
The role of semen in heterosexual transmission of the human 
immunodeficiency virus type 1 (HIV-1) has been marginally viewed as an inert 
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vehicle for the delivery of virus. However, studies from the field of reproductive 
biology have made it clear that seminal fluid is a complex and dynamic medium 
containing high concentrations of factors that play key roles in modulating the local 
immune response in the female reproductive tract during fertilization and 
embryogenesis. It is therefore strongly implied that the same seminal factors 
responsible for guiding the immune response in reproduction also play a role in 
male-to-female transmission of HIV-1. To begin to understand how these factors 
affect male-to-female HIV-1 transmission, multiple studies have comparatively 
profiled the contents of seminal fluid collected from uninfected and HIV-1-infected 
men. This review provides an overview of these studies, as well as a discussion of 
the potential impact of semen on HIV-1 transmission. 
 
 
 
 
 
 
 
 
 
1.2 Introduction 
A growing body of contemporary studies indicates that semen, which in its 
simplest form is a vehicle for sperm cells, is also an active partner in conception 
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and an influential and dynamic fluid capable of shaping the ensuing maternal 
immune response. Studies from the fields of fertility and conception have 
demonstrated that seminal fluid plays a key role in modulating the immune system 
of the female reproductive tract (FRT) during conception. Because FRT immune 
responses (particularly the innate immune response) also play important roles in 
the defense against sexually transmitted disease (STD) pathogens, it stands to 
reason that these semen-mediated effects may also influence the transmission of 
STD pathogens, including the human immunodeficiency virus type 1 (HIV-1). 
The effects of semen and its components is an area of study that is of 
increasing interest to those investigating sexual transmission of HIV-1. In the 
current acquired immune deficiency syndrome (AIDS) epidemic, 75%-85% of the 
34.2 million people living with HIV-1 were infected through sexual contact.[1] 
Furthermore, it is estimated that 30-40% of those sexually acquired infections were 
the result of male-to-female transmission,[2] which underscores the importance of 
understanding all aspects of sexual HIV-1 transmission, including the roles that 
semen may play in influencing the acquisition of HIV-1 among women at risk for 
infection. 
Studies of HIV-1 transmission have often disregarded the effect of semen 
during viral infection, assuming that semen was simply an inert vehicle for 
protecting and transporting sperm cells in the FRT. In vitro and in vivo experiments 
focused on HIV-1 transmission are often performed in the absence of semen and, 
instead, rely on the use of either cell-free virus or infected cells as the source of 
HIV-1. Experiments that do involve semen are usually focused strictly on its direct 
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effects on the antiviral efficacies of candidate microbicides. Although experiments 
such as these are valued for their simplicity and consistency, they fail to account 
for the biological effects of semen on events that take place during the process of 
HIV-1 transmission. 
Recent studies suggest that semen is a more active participant in the 
process of HIV-1 infection during sexual intercourse. In a review published in 2011 
centered semen and female genital tract secretions, unpublished experiments 
were cited in which the innate antiviral activity of cervicovaginal lavage fluid 
decreased in the presence of seminal fluid, indicating that seminal fluid contained 
factors that were likely modulating responses in the FRT involved in innate immune 
responses.[3] More recent studies have provided new insights into the effects of 
semen on the immunological environment within the FRT. Experiments involving 
FRT-derived epithelial cells exposed to semen suggested that transforming growth 
factor beta (TGF-β), contained in very high concentrations within the semen, may 
be responsible for directing a local immune response within the FRT that favors 
embryo implantation.[4] It was concluded that TGF-β, which is present in all three 
isoforms in semen, was a major factor responsible for initiating the early local 
inflammatory response through the induction of granulocyte-macrophage colony-
stimulating factor (GM-CSF) and interleukin 6 (IL-6) expression from cervical 
epithelial cells.[4] In addition, previous studies performed in the field of 
reproductive biology demonstrated that seminal TGF-β was also responsible for 
inducing a local anti-inflammatory response that favored tolerance of the paternal 
antigens and embryo implantation during the resolution phase of inflammation.[5] 
  
  
	
5 
While these studies strongly suggested that the introduction of semen had a 
profound effect on the immunological environment within the FRT, they did not 
reveal the specific effects of semen on HIV-1 transmission. 
Investigators who strive to better understand the effects of semen on HIV-1 
transmission within the FRT will face at least two challenges. First, semen is a 
complex mixture of cytokines, chemokines, growth factors, and other biologically 
active molecules. Some of these factors may serve to promote HIV-1 transmission 
and infection, while others may have roles as antiviral factors. Other factors may 
instead be pleiotropic with respect to the risk of HIV-1 transmission, dependent on 
time following the initiation of coitus and the introduction of semen, regional 
differences within the FRT, the target cell type, conditions within the FRT 
associated with concurrent infections, or other physiological conditions. Studies of 
semen-mediated effects will need to consider this spectrum of activities and strive 
to assign specific functions in the FRT to individual factors contained within the 
seminal plasma. 
The second challenge will be posed by natural variations in semen content 
among men. Like studies involving primary tissues or peripheral blood samples, 
experiments involving semen samples will need to account for natural variations in 
semen content among men, including changes associated with aging, nutritional 
status, immunological status, or other pathological conditions in the male 
reproductive tract (MRT) that may alter the multi-factorial nature of seminal fluid. 
Adding another layer of complexity to donor-to-donor variability are changes in 
semen content as a consequence of HIV-1 infection. Several recent studies have 
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demonstrated significant differences in seminal cytokine and chemokine content 
between HIV-1-infected and uninfected men.[6, 7] It is also likely that seminal 
content varies with HIV-1-associated disease progression, administration of 
antiretroviral therapy, and substance abuse. Therefore, experiments involving 
semen samples from HIV-1-infected donors will be particularly challenging, 
requiring multiple donors with detailed clinical histories. 
The goal of this review is to provide a starting point for addressing these 
challenges by summarizing recent investigations that have revealed associations 
between seminal factor content and HIV-1 infection. 
 
1.3 Semen has a complex composition 
 1.3.1 Semen composition 
Studies of male infertility have provided numerous opportunities to assess 
the concentrations of biologically active factors contained in semen from both 
healthy and diseased donors. These studies have clearly shown that semen 
contains a diverse range of immunomodulatory factors, including cytokines, 
chemokines, growth factors, hormones, minerals, and ions, that can vary greatly 
with changes in reproductive health or infection. Changes in the concentrations of 
these factors can alter the semen profile, resulting in dysregulation, as evidenced 
by the many types of male infertility that have been identified. These studies have 
measured various aspects of semen in order to determine correlations between 
changes in semen content and fertility. However, as mentioned previously, there 
is a high level of variability across studies due to differences in methodology and 
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donor diversity, as well as differences in the range of factors measured between 
studies. Recently, investigations using multiplex technology have provided more 
comprehensive measures of cytokine levels in semen from uninfected 
individuals[6-8] [9]. These studies have demonstrated that, in general, seminal fluid 
has a slightly pro-inflammatory profile, as well as an abundance of hormones and 
growth factors[8, 9]. Additionally, when compared to the peripheral blood 
compartment, seminal fluid was found to be more concentrated in most measured 
factors, highlighting the contribution of compartmentalization to the independent 
development of semen content in the MRT.[6, 10] 
In addition to soluble factors and sperm cells, semen also contains cells 
derived from the male immune system. The average, uninfected male has 
approximately 5,000 CD4+ T-lymphocytes/ml present in seminal fluid.[11] 
Macrophages and CD8+ T cells can also be found distributed throughout the MRT, 
specifically within the epithelium lining the vas deferens and epididymis, and in the 
interstitial spaces between seminiferous tubules.[12] The CD4+ T-cell population 
is often elevated in the MRT as a consequence of autoimmunity or STD pathogen 
infection, and may contribute to the levels of pro-inflammatory factors found in 
seminal fluid. These changes in content could subsequently lead to an altered 
immune response once in the FRT.[12] 
 
1.4 Changes in semen content associated with HIV-1 infection 
A complete understanding of the effects of semen on male-to-female 
transmission will require knowledge about the factors that participate in the events 
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leading to transmission and how those factors vary with HIV-1 infection and 
relevant clinical variables, such as HIV-1-associated disease progression, current 
antiretroviral therapy (ART) regimen, substance abuse, and aging. Cytokines, 
chemokines, and other factors have been shown in several studies to vary 
significantly in semen from HIV-1-infected men.[6, 8] Additionally, there is also 
considerable variability in the HIV-1 viral load in semen among infected men.[8, 
10] 
 1.4.1 Changes in biological factor content 
Most of the information on the physiological concentrations of factors such 
as cytokines, chemokines, and growth factors present in seminal fluid has come 
to light through investigations focused on reproductive biology. These studies 
typically analyze semen from a group of donors considered to be “normal” relative 
to other groups subcategorized by infertility diagnoses [9]. Several recent studies, 
however, have endeavored to build profiles of the contents of semen from HIV-1-
positive men as compared to uninfected males (summarized in Table 1.1). 
The first major study of this type compared the concentrations of cytokines 
in semen to the concentrations found in serum.[6] Analyses indicated that semen, 
independent of HIV-1 infection, had consistently higher concentrations of 
inflammatory cytokines relative to blood. Additionally, several semen cytokines 
were further elevated relative to corresponding concentrations in blood from HIV-
1-infected men, including IL-1β, IL-4, IL-7, IL-8, GM-CSF, and MCP-1.[6] Elevated 
concentrations of such factors in the seminal fluid over serum are likely a 
consequence of MRT compartmentalization.[6] These findings were confirmed in 
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similar studies comparing semen-to-blood cytokine ratios in HIV-1-infected and 
uninfected samples; in particular, there was a noted increase in a number of 
seminal cytokines during HIV-1 infection, including IL-1α, IL-1β, IL-6, IL-7, IL-8, 
MIP-3α, RANTES, and TGF-β [10, 13, 14]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1. Concentrations of factors in human semen change as a result of 
HIV-1 infection. The table summarizes the results of studies that documented 
factor concentrations in semen from HIV-1-infected patients or healthy donors. 
Each entry includes the identity of the factor, changes that occur with HIV-1 
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infection, and the source references. GM-CSF, granulocyte-macrophage colony-
stimulating factor; IFN-γ, interferon gamma; IL-1α, interleukin 1 alpha; IL-1β, 
interleukin 1 beta; IL-2, interleukin 2; IL-4, interleukin 4; IL-5, interleukin 5; IL-6, 
interleukin 6; IL-7, interleukin 7; IL-8, interleukin 8; IL-10, interleukin 10; IL-16, 
interleukin 16; IP10, interferon gamma-induced protein 10; MCP-1, monocyte 
chemotactic protein 1; MIG, monokine induced by interferon gamma; MIP-1α, 
macrophage inflammatory protein 1 alpha; MIP-1β, macrophage inflammatory 
protein 1 beta; MIP-3α, macrophage inflammatory protein 3 alpha; PGE2, 
prostaglandin E2; RANTES, regulated on activation, normal T-cell expressed and 
secreted; TGF-β, transforming growth factor beta; TNF-α, tumor necrosis factor 
alpha. 
 
 
 
 
 
 
 
 
Table 1.1 
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Semen 
component 
Changes with HIV-1 infection Reference 
GM-CSF Studies of GM-CSF in SF were variable; some reported no changes 
while others observed significant increases. One study observed 
significant increases specifically during the acute phase of infection  
[6, 8, 10]  
IFN-γ Not detected in infected or uninfected SF samples studied [10, 15] 
IL-1α Increased significantly  [8, 10] 
IL-1β Significantly increased during HIV-1 infection, but decreased 
significantly after HAART 
[6, 10, 15] 
IL-2 Not detected in infected or uninfected SF samples studied [10] 
IL-4 Significantly increased  [6] 
IL-5 Increased, but not significantly [6] 
IL-6 Significantly increased during HIV-1 infection. Levels were also 
significantly correlated with changes in semen viral load and stage of 
infection, with higher concentrations of IL-6 detected during acute phases 
[6, 8, 10, 
14, 15] 
IL-7 Significantly increased  [6, 10] 
IL-8 Significantly increased and correlated with elevated semen viral load [6, 8, 10, 
14] 
IL-10 No change [6] 
IL-16 Significantly increased  [10] 
IP-10 No change [8] 
MCP-1 Significantly increased during HIV-1 infection, but decreased back to 
uninfected levels during chronic stages of infection 
[6, 8, 10] 
MIG Variable findings, ranging from significantly increased to significantly 
decreased during infection 
[6, 10] 
MIP-1α Significantly increased [8, 10] 
MIP-1β Significantly increased [8, 10] 
MIP-3α Significantly increased [10] 
PGE2 No change  [8] 
RANTES Significantly increased in HIV-1 positive males. However, significant 
decreases in RANTES were correlated with elevated semen viral load. 
[8, 10, 13]  
TGF-β1 Significantly increased in HIV-1 positive males. However, significant 
decreases in TGF-β were correlated with elevated semen viral load 
[8, 10, 15] 
TNF-α Studies on the presence of TNF-α in SF were variable, ranging from 
undetectable to very low levels in uninfected and infected 
[8, 10, 15] 
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Seminal factor content is also dependent on the stage of HIV-1 infection. A 
recent study comparing therapy-naïve acute and chronically HIV-1-infected men 
determined that levels of pro-inflammatory cytokines IL-6, IL-8, and MCP-1 in 
chronically infected subjects were present at concentrations in semen comparable 
to those of the uninfected controls. These same factors, however, were 
significantly increased in the acute phase group.[8] Interestingly, TGF-β was a 
prominent exception, as there was a three-fold higher concentration in semen from 
the chronic phase group relative to semen from the acutely infected population.[8] 
Increases in pro-inflammatory semen cytokines combined with decreases in TGF-
β during acute HIV-1 infection suggest that semen from these men might promote 
a greater risk of infection in the FRT.[8] 
 
 1.4.2 Changes in cellular content subsequent to HIV-1 infection and 
ART 
Seminal immune cells, which can contribute to the pool of 
immunomodulatory factors contained in semen, also vary with HIV-1 infection and 
antiretroviral therapy. Comparisons of white blood cell (WBC) content in semen 
revealed that HIV-1-infected men prior to the initiation of ART had fewer WBCs in 
their semen (1.0 x 105 cells/ml) relative to uninfected men (2.4 x 105 cells/ml).[16] 
Upon closer inspection of the WBC subpopulations, it was evident that while most 
HIV-1-infected untreated men maintained a population of macrophages in their 
semen, CD4+ and CD8+ T cells were not detectable in their semen. In contrast, 
semen from the average uninfected male contained 5.7 x 103 CD4+ T cells and 
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1.9 x 103 CD8+ T cells per milliliter of semen.[16] Interestingly, upon treatment 
intervention, all subpopulations of WBCs in infected samples were restored to 
levels comparable to those of HIV-1-negative subjects.[16] Additional analyses 
indicated that changes in cell populations were also dependent on the types of 
antiretroviral drugs included in the patient’s regimen. When WBCs were quantified 
in patients before and after the addition of indinavir (a protease inhibitor capable 
of penetrating the blood-testes-barrier) to a dual nucleoside ART regimen, the 
CD4+ T-cell population was further increased in both the peripheral blood and 
seminal fluid, and increases in CD8+ T cells in the semen were also noted.[16] 
Of course, it is important to note that immune cells in HIV-1-infected semen 
also serve as carriers of the virus in addition to a potential source of 
immunomodulatory factors. HIV-1 provirus can be isolated from semen-derived 
macrophages and T cells of HIV-1-positive men, suggesting that both cell types 
may act as vehicles of cell-associated virus and agents of HIV-1 transmission.[17] 
Therefore, variations in seminal immune cell content as a consequence of ART will 
result in changes in the levels of transmissible HIV-1 as well as changes in the 
contributions that these cells make to the pool of soluble immunomodulatory 
factors in semen that may impact the risk of HIV-1 transmission. 
 
1.5 Role of changes in biological factor content on HIV-1 transmission and 
pathogenesis  
Factors contained in semen (and changes in their concentration associated 
with HIV-1 infection and other conditions) have the potential to influence the chain 
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of events that result in HIV-1 transmission. MCP-1 provides a particularly 
illustrative example of a biological factor contained in semen that may impact STD 
pathogen transmission as well as reproductive fitness through variations in 
concentration. Increased levels of MCP-1 (monocyte chemotactic activating factor, 
also known as MCAF) may be produced by monocytes, endothelial cells, or 
fibroblasts present in the MRT and may be involved in protecting the reproductive 
tract against bacterial pathogens.[18] The role of MCP-1 in reproductive biology, 
however, is not limited to the male. It has been speculated that once semen has 
been deposited into the FRT, MCP-1 present in the seminal fluid may be 
responsible for the local recruitment and activation of monocytes, which may be 
important in clearing excess sperm.[18] Upon recruitment, these monocytes 
release IL-6 as a response to MCP-1, resulting in further activation and 
differentiation into macrophages.[18] The changes in factors initiated by MCP-1 
are an example of an intricate cytokine network in which one semen-associated 
factor is correlated with the expression of other cytokines. In this case, MCP-1-
induced IL-6 results in the activation and proliferation of T-lymphocytes, which 
could play a key role in maintaining or expanding the HIV-1-infected T-lymphocyte 
founder populations shortly after virus transmission.[19, 20] At the same time, 
semen IL-8, which is increased in conjunction with MCP-1, may also enhance the 
role of IL-6 by recruiting additional immune cell populations, including neutrophils 
and T-lymphocytes that traffic to the FRT.[18, 21] 
Controlling this cascade of events as a means of decreasing transmission 
is an important area of study. A recent study of the sphingosine-1-phosphate (S1P) 
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receptor modulator FTY720 (Fingolimod), which is being considered for use as a 
topical vaginal microbicide, demonstrated inhibition of infection in the genital tract 
of macaques by decreasing the levels of pro-inflammatory mediators IL-8 and IL-
1Rα and reducing the number of CD4+ T cells in the genital tract.[21] These 
findings highlight the potential contribution of elevated semen-derived IL-8 on HIV-
1 infection in the FRT, which may cause increased peripheral CD4+ T-cell 
trafficking and activation of subepithelial T cells in the local environment, leading 
to an increased presence of immune target cell populations and greater likelihood 
of local HIV-1 infection. This study also provides an excellent example of 
preventative approaches that indirectly target events within the FRT that impact 
HIV-1 transmission instead of directly targeting HIV-1 infection. 
HIV-1-infected seminal fluid is also enriched in other factors that may 
enhance target cell recruitment. For example, increases in macrophage 
inflammatory protein (MIP)-1α and -1β, as well as regulated and normal T-cell 
expressed and secreted protein (RANTES), could induce the local recruitment and 
activation of macrophages, dendritic cells, and T cells within the subepithelium of 
the FRT. Similarly, the growth factor granulocyte macrophage colony stimulating 
factor (GM-CSF) induces the maturation of dendritic cells and macrophages at the 
site of deposition.[6, 8, 22] Once local cells are infected, GM-CSF may boost viral 
replication in target cells through upregulation of HIV-1 long terminal repeat (LTR) 
activation and viral transcription.[22, 23] 
Seminal fluid from HIV-1 infected males also contains increased 
concentrations of pro-inflammatory cytokines,[24] which may play a large role in 
  
  
	
16 
increasing the likelihood of transmission in the FRT. Studies of FRT tissue indicate 
that the majority of T cells in the cervicovaginal tract have an effector memory 
phenotype, a population that upon activation was more susceptible to infection by 
R5 HIV-1 (a virus that uses CCR5 as its co-receptor) relative to X4 HIV-1, making 
this cell population a prime target for transmitted HIV-1.[25] Activation of the 
susceptible resident immune cells may be induced by the inflammatory cytokines 
present in seminal fluid. However, in addition to the direct effects on T-cell infection 
kinetics, inflammatory cytokines in semen may also be responsible for inducing 
increases in permeability of the epithelial barrier lining the FRT. For example, IFN-
γ has been shown to enhance permeability by inducing the internalization of tight 
junction proteins.[26] Similarly, intestinal epithelial monolayers become more 
permeable with IL-1β exposure via NF-κB activation.[27] The resulting increases 
in permeability may be key to enhancing the ability of HIV-1 to cross the epithelial 
barrier, providing direct access to resident subepithelial target immune cells.[28] 
Increases in epithelial permeability may also facilitate the diffusion of seminal 
immunomodulatory factors through the epithelial barrier to subepithelial immune 
cell populations. Cervicovaginal epithelial cells can also serve as intermediaries, 
releasing immunomodulatory factors in a basolateral direction in response to apical 
exposure to soluble factors in semen. Subsequent to the introduction of HIV-1-
infected semen into the FRT, both mechanisms may contribute to changes in the 
subepithelial microenvironment and effects on local immune cell populations. 
Of particular relevance to HIV-1 transmission are the effects of TGF-β. TGF-
β, as described previously, is found in very high concentrations within seminal fluid, 
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but its concentration varies depending on the state of HIV-1 disease.[8] In acutely 
infected males, there is a lower concentration of TGF-β and higher levels of pro-
inflammatory factors as compared to chronically infected and uninfected 
individuals. This cytokine profile may favor viral replication via LTR activation, 
since higher TGF-β levels in seminal fluid of chronically infected males were 
associated with HIV-1 suppression.[8] Of the three isoforms of TGF-β present in 
seminal fluid, TGF-β3 was detected in the highest concentrations and has been 
shown to induce the release of GM-CSF and IL-6 in the FRT.[4] Combined with 
the findings already discussed on GM-CSF and IL-6, it is likely that the effects of 
TGF-β on cytokine release are important to HIV-1 transmission. During exposure 
to the seminal fluid of an acutely infected male, TGF-β will induce the release of 
GM-CSF within the FRT, leading to the recruitment of target cell populations. 
These cells may become activated in the pro-inflammatory environment and 
become more susceptible to infection. After infection, the low ratio of TGF-β to pro-
inflammatory cytokines (such as IL-6) in the semen may result in increased viral 
replication within infected immune cells. 
It is clear that the factors in seminal fluid are part of a complex network of 
interactions. A recent study of 21 analytes in seminal fluid identified 72 statistical 
correlations that exist between cytokines, chemokines, and growth factors in 
connection with either HIV-1 load or CD4+ T-cell count. Furthermore, changes in 
individual factors were also interrelated to changes in other seminal cytokines[24] 
The findings in this study illustrate the complexity of the semen cytokine network. 
For example, HIV-1 infection was correlated with increased levels of pro-
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inflammatory cytokines, including IL-1α, IL-1β, IL-6R, and RANTES in seminal 
fluid.[24] RANTES was positively correlated with increases in MIP-3α, which in turn 
corresponded to increases in IL-8 in semen. Furthermore, levels of IL-8 were 
associated with increased expression of IL-6, MIP-1β, and MCP-1, which together 
provide pro-inflammatory feedback. Establishing a concrete relationship between 
changes in the factors that originate in the MRT and the presence of HIV-1 in 
semen will be important to developing an understanding of their influence on virus 
transmission within the FRT. 
 
1.6 Summary 
Semen is a dynamic fluid capable of orchestrating and influencing immune 
responses within the FRT. The numerous agents in semen that profoundly affect 
the immunological environment of the FRT include cytokines, chemokines, growth 
factors, and other biologically active molecules. Changes in these factors brought 
about by HIV-1 infection or other influences may affect key events that take place 
during male-to-female HIV-1 transmission, resulting in an increased or decreased 
risk of transmission. While studies have provided useful glimpses into factors in 
semen that change in concentration subsequent to HIV-1 infection, many 
questions remain to be answered about changes that occur in the semen as a 
consequence of HIV-1 infection and related variables (Fig. 1.1A). Once answers 
to these questions have been obtained, subsequent queries will explore 
mechanisms of HIV-1 transmission within the FRT that are affected by changes in 
the content of immunomodulatory factors in semen (Fig. 1.1B). Having greater 
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knowledge about the dynamics of biological factors in semen will increase our 
understanding of HIV-1 transmission and provide insights into new opportunities 
for preventing HIV-1 transmission in women at risk for infection in the current 
epidemic. 
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FIGURE 1.1 
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FIG. 1.1. Factors in the male reproductive tract (MRT) that can affect semen 
content and the effects of those changes on epithelial and immune cells in 
the female reproductive tract (FRT). (A) Clinical variables (substance abuse, 
age, HIV-1-associated disease, and ART) may influence the content of semen 
through the BTB. MRT pathological conditions (infertility, concurrent STI) will 
directly affect the semen content. The result will be the production of semen with 
altered content of immunomodulatory factors. (B) Semen with altered 
immunomodulator content will directly affect CV epithelial cells and indirectly 
impact subepithelial immune cells through the stimulated, polarized release of 
secondary factors from semen-exposed epithelial cells. ART, antiretroviral 
therapy; BTB, blood-testes barrier; CV, cervicovaginal; PB, peripheral blood; STI, 
sexually transmitted infection. 
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2.1 Abstract 
Human semen is a complex medium containing high concentrations of 
cytokines, chemokines, and growth factors that play key roles in orchestrating 
immune responses during reproduction. These factors are essential to establishing 
conditions that facilitate fertilization and embryogenesis through modulation of 
local immune responses in the female reproductive tract. Typically, semen initiates 
a biphasic process of inflammation that is gradually resolved, leading to immune 
cell recruitment pivotal to clearing excess sperm and establishing tolerance of the 
fetal allograft. However, the identity and concentration of factors found in semen 
may be altered in the male reproductive tract as a consequence of sexually 
transmitted infections and infertility conditions. As a result, imbalances in semen 
content can skew the secretory response of the cervicovaginal epithelium after 
deposition during heterosexual intercourse, which may distort local immune 
activity and lead to embryo rejection or enhanced pathogen transmission. 
Recognizing the array of factors contained in semen and the degree to which they 
vary is an essential part of understanding the impact of variations in semen content 
on reproductive biology and the transmission of sexually transmitted disease 
pathogens. 
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2.2 Introduction 
There is a growing body of reproductive biology information that indicates a 
more active role for semen in the female reproductive tract (FRT) than initially 
suspected. A review of semen and female genital tract secretions in the context of 
microbicide development cited unpublished experiments that suggested the 
presence of factors in seminal fluid that were likely modulating innate immune 
responses in the FRT [3]. More recent studies involving FRT-derived epithelial 
cells exposed to semen suggested that transforming growth factor beta (TGF-β), 
present in very high concentrations within semen, may be responsible for directing 
a local immune response within the FRT that favors embryo implantation [4]. It was 
concluded that TGF-β was a major factor responsible for initiating the early, local 
inflammatory response through the induction of granulocyte-macrophage colony-
stimulating factor (GM-CSF) and interleukin 6 (IL-6) expression from cervical 
epithelial cells [4] [29]. Additional studies demonstrated that seminal TGF-β was 
also responsible for inducing a local anti-inflammatory response that favored 
tolerance of the paternal antigens and embryo implantation during the resolution 
phase of inflammation [5]. These studies strongly suggest that the introduction of 
semen has a profound effect on the immunological environment within the FRT, 
which may influence both reproduction and heterosexual disease transmission. 
Gaining an understanding of the effects of semen within the FRT is 
confounded by multiple factors, not the least of which is the complexity presented 
by the involvement of two separate systems – the male reproductive tract (MRT) 
and the FRT – each with their own anatomical and immunological aspects to 
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consider. Semen is a complex mixture of cytokines, chemokines, and biologically 
active molecules. The concentration of these factors is influenced by donor-
specific variables at multiple levels (health, diet, age, infection, and substance 
abuse) and can be further altered as a consequence of infertility. Studies have 
demonstrated significant differences in seminal cytokine and chemokine content 
between infertile and fertile men, which can vary depending on the type of infertility 
condition and disease progression. The activities of these factors once deposited 
in the FRT add another level of variability. The FRT, in turn, is subject to its own 
unique set of variables, including hormones, age, and conditions associated with 
concurrent infections or other physiological conditions [29]. Studies of semen-
mediated effects will need to identify which responses are separately controlled by 
female or male factors, and which outcomes result from combined interactions. 
The goal of this review is to document the variability of semen and semen-
derived factors and explore their roles in initiating the local immune responses 
within the FRT that are key to successful reproduction and prevention of infection. 
 
2.3 Semen has a complex and variable composition 
Mature sperm cells in the testes that are ready for ejaculation pass through 
the epididymis where prostate fluid, which is rich in proteins and other factors such 
as citric acid and zinc [30], is added (Fig. 2.1). Prior to release, semen is further 
augmented by fluid from the seminal vesicles, which are responsible for 
establishing the alkaline pH of semen [30]. The average volume of seminal fluid 
ejaculated is 3.5 ml, but can range anywhere from 100 μl to 11 ml [31]. Just as the 
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total volume varies, the concentrations of biologically active factors, including 
hormones, mucin, cadaverine, putrescine, spermine, enzymes, 
cytokines/chemokines, fructose, and vitamin D, and other soluble factors present 
in seminal fluid [32], can also vary significantly not only between donors but also 
within one individual over time. Semen content can also be affected by other 
factors, such as changes in fertility, age, frequency of ejaculation, infection by 
sexually transmitted disease (STD) pathogens, substance abuse, prescription 
medications, and other factors that reflect an individual’s lifestyle [33, 34]. To 
address the elements of intra- and inter-donor variability, experiments requiring 
semen have either used large cohorts or often incorporated combined seminal fluid 
samples from five or more donors, creating working samples with greater volume 
and content more representative of the “average” male semen content. 
Studies of male infertility have provided numerous opportunities to assess 
the concentrations of biologically active factors contained in semen. These studies 
have clearly shown that (i) semen contains a diverse and wide range of 
immunomodulatory factors that likely participate in reproduction as well as 
pathogen defense, and (ii) the concentrations of these factors can vary greatly with 
changes in reproductive health or infection. Table 2.1 is a compilation of biological 
factors detected in semen across numerous studies along with their 
concentrations, clinical conditions under which they were collected, and the degree 
to which their concentrations varied with MRT pathology. Some of these factors 
are highlighted in this review. 
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Figure 2.1 
 
 
 
Fig. 2.1. Flow diagram of semen production within the human male 
reproductive tract (MRT). This schematic representation of the MRT illustrates 
the tissues involved in semen production within the MRT, the timing of semen 
production, and the points at which seminal fluid volume and content are altered. 
BTB, blood-testes barrier; PSA, prostate-specific antigen; PAP, prostatic acid 
phosphatase; TGF-β, transforming growth factor beta. 
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Table 2.1 Human semen contains numerous biologically active factors 
that change with MRT pathology. The table summarizes the results of studies 
focused on semen content. (A) Physical factors and proteins. (B) Pro-inflammatory 
cytokines. (C) Anti-inflammatory cytokines. (D) Chemokines. (E) Growth and 
signaling factors. Each entry includes the identity of the factor, donor health or 
associated condition, demonstrated concentration (or concentration range), and 
the reference cited. Concentration ranges for factors from men who were healthy 
or diagnosed with a clinical abnormality (“abnormal”) were compiled (shown in 
bold) if multiple studies of a particular factor were available. Abbreviations: ND, not 
detectable; E2, estradiol; FSH, follicular stimulating hormone; PAP, prostatic acid 
phosphatase; LH, luteinizing hormone; GM-CSF, granulocyte-macrophage colony-
stimulating factor; PRL, prolactin; IFN-γ, interferon gamma; IL-1α, interleukin 1 alpha; IL-
1β, interleukin 1 beta; IL-2, interleukin 2; IL-4, interleukin 4; IL-5, interleukin 5; IL-6, 
interleukin 6; IL-7, interleukin 7; IL-8, interleukin 8; IL-10, interleukin 10; IL-12, Interleukin 
12; IL-16, interleukin 16; IL-17, Interleukin 17; IL-18, Interleukin 18; IL-23, interleukin 23; 
IP10, interferon gamma-induced protein 10; I-TAC, inducible T-cell alpha chemoattractant; 
MCP-1, monocyte chemotactic protein 1; MIF, macrophage migration inhibitory factor; 
MIG, monokine induced by interferon gamma; MIP-1α, macrophage inflammatory protein 
1 alpha; MIP-1β, macrophage inflammatory protein 1 beta; MIP-3α, macrophage 
inflammatory protein 3 alpha; PGE2, prostaglandin E2; RANTES, regulated on activation, 
normal T-cell expressed and secreted; SDF-1α, stromal derived factor 1; TGF-β, 
transforming growth factor beta; TNF-α, tumor necrosis factor alpha. 
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Table 2.1A 
Cytokine/ 
Chemokine/ 
Factor 
State of 
fertility/ 
disease 
Concentration Reference 
Sperm Count   
 Healthy 27.1 x 106/ml – 110 x 106/ml 
Abnormal 0 – 98.9 x 106/ml 
Healthy Healthy 42.4 x 106/ml 
110.4 x 
106/ml 
84 x 106/ml 
49.3 x 106/ml 
72.98 x 
106/ml 
27.1 x 106/ml 
79 x 106/ml 
58.07 x 
106/ml 
64.4 x 10 6/ml 
87.6 x 106/ml 
76.7 x 106/ml 
77.5 x 106/ml 
90 x 106/ml 
[1, 35-46] 
Fertile (smoker) 77.6 x 106/ml [43] 
Fertile + infection 32.9 x 106/ml [35] 
20 – 25 y old males 76.3 x 106/ml [47] 
50 – 55 y old males 73.1 x 106/ml [47] 
Infertile  Infertile (no pathogen infection) 37 x 106/ml, 
38.3 x 106/ml 
3.7 x 106/ml 
[43, 44]	
[37]	 
Infertile + pathogen infection 25 x 106/ml [37] 
Infertile (smoker) 31.5 x 106/ml [43] 
Normospermia 98.9 x 106/ml 
54.04 x 
106/ml 
56.10 x 
106/ml 
[40, 41, 
48]	 
Leukospermia 26.3 x 106/ml [35] 
Leukospermia + infection 20.5 x 106/ml [35] 
Oligozoospermia 7.1 x 106/ml 
6.8 x 106/ml 
9.78 x 106/ml 
8.31 x 106/ml 
[38, 41, 
48] 
Azoospermia 0 [36] 
Asthenozoospermia 44.3 x 106/ml 
43.49 x 
106/ml 
54.55 x 
106/ml, 
45.3 x 106/ml 
[38, 40, 
41, 46] 
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Oligoasthenozoospermia 8.3 x 106/ml [46] 
Oligo-terato-asthenozoospermia 4.5 x 106/ml [38] 
Oligo-terato-asthenozoospermia + 
varicocele 
16.5 x 106/ml [36] 
Oligo-terato-asthenozoospermia + 
genital tract infection 
14.2 x 106/ml [36] 
Oligo-terato-asthenozoospermia + 
testicular lesion 
12.8 x 106/ml [36] 
Adrenaline  
 Healthy  7.60 ng/ml [41] 
Infertile Normozoospermia 3.12 ng/ml [41] 
 Oligozoospermia 2.85 ng/ml [41] 
Asthenozoospermia 2.71 ng/ml [41] 
Chloride  
 Healthy  1.42 mg/ml [32] 
Citrate  
 Healthy  528 
mg/100ml 
[32] 
Dopamine  
 Healthy  4.34 ng/ml [41] 
Infertile Normozoospermia 2.36 ng/ml [41] 
 Oligozoospermia 2.36 ng/ml [41] 
Asthenozoospermia 1.82 ng/ml [41] 
E2  
 Infertile Normospermia 25.1 ng/ml [48] 
Oligozoospermia 24.8 ng/ml [48] 
Azoospermia 22.5 ng/ml [48] 
FSH  
 Healthy 2.4 – 7.2 mIU/ml 
Abnormal 2.4 – 10.2 mIU/ml; 4.1 – 19.9 ng/ml 
Healthy  2.4 mIU/ml 
5.67 mIU/ml 
6.9 mIU/ml 
7.2 mIU/ml 
7.1 mIU/ml 
4.4 mIU/ml 
[38, 40, 
49-52] 
Infertile   10.2 mIU/ml [50] 
HCV+ 2.4 mIU/ml [52] 
Infertile (spinal cord injury) 2.8 mIU/ml [50] 
Normospermia 4.1 ng/ml 
6.07 mIU/ml 
[40, 48] 
Oligozoospermia 8.8 ng/ml 
7.78 mIU/ml 
6.8 mIU/ml 
[38, 40, 
48] 
Asthenozoospermia 6.49 mIU/ml 
7.3 mIU/ml 
[38, 40] 
Oligoasthenozoospermia 9.5 mIU/ml [38] 
Azoospermia 19.9 ng/ml [48] 
Fructose  
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 Healthy 1.5 – 3.63 mg/ml 
Abnormal 2.18 – 2.49 mg/ml 
Healthy  2.72mg/ml 
3.63 mg/ml 
[32, 40] 
20 – 25 y old males 1.89 mg/ml [47] 
50 – 55 y old males 1.5 mg/ml [47] 
Infertile Normospermia 2.49 mg/ml [40] 
 Oligozoospermia 2.18 mg/ml [40] 
Asthenozoospermia 2.32 mg/ml [40] 
Glucose  
 Healthy  102 mg/ml 
(highly 
variable) 
[32] 
LH  
 Healthy 1.53 – 7.94 mIU/ml 
Abnormal 3.1 – 6.87 mIU/ml; 2.9 – 7.3 ng/ml 
Healthy  1.53 mIU/ml 
6.58 mIU/ml 
7.94 mIU/ml 
5.5 mIU/ml 
6.2 mIU/ml 
6.2 mIU/ml 
4.7 mIU/ml 
[38-40, 49-
52] 
Infertile   3.5 mIU/ml [50] 
HCV+ 2.8 mIU/ml [51] 
Infertile (spinal cord injury) 3.1 mIU/ml [50] 
Normosperimia 2.9 ng/ml 
6.87 mIU/ml 
[40, 48] 
Azoospermia 7.3 ng/ml  [48] 
Oligoasthenozoospermia 6.0 mIU/ml [38] 
Asthenozoospermia 3.82 mIU/ml 
6.1 mIU/ml 
[38, 40] 
Oligozoospermia 5.1 ng/ml 
4.02 mIU/ml 
5.9 mIU/ml 
[38, 40, 
48] 
Magnesium  
 Healthy  0.11 mg/ml,  
0.07 mg/ml 
[32{Colaga
r, 2009 
#85]	[43] 
Fertile (smoker) 0.06 mg/ml [43] 
Infertile  0.06 mg/ml [43] 
Infertile (smoker) 0.05 mg/ml [43] 
Noradrenaline  
 Healthy  9.29 ng/ml [41] 
Infertile Normozoospermia 5.41 ng/ml [41] 
 Oligozoospermia 4.12 ng/ml [41] 
Asthenozoospermia 3.44 ng/ml [41] 
PAP  
 Healthy 20 – 25 y old males 608 IU/ml [47] 
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50 – 55 y old males 497 IU/ml 
PGE2  
 Healthy  19.67 μg/ml 
0.016 μg/ml 
[8, 53] 
Infertile Oligoterato-asthenoazoospermia + 
genital infection 
7.67 μg/ml [53] 
Potassium  
 Healthy  1.09 mg/ml,  
0.78 mg/ml 
[32, 43] 
Fertile (smoker) 0.74 mg/ml [43] 
Infertile  0.74 mg/ml [43] 
Infertile (smoker) 0.67 mg/ml [43] 
PRL  
 Healthy 7.10 – 290 ng/ml; 320 – 344 pmol/L 
Abnormal 6.5 – 10.57 ng/ml; 110 – 384 pmol/L 
Fertile  290 ng/ml 
7.10 ng/ml 
320 pmol/L 
352 pmol/L 
344 pmol/L 
[39, 40, 
50-52] 
Infertile   110 pmol/L [50] 
HCV+ 384 pmol/L [51] 
Infertile (spinal cord injury) 362 pmol/L [50] 
Normospermia 8.2 ng/ml 
7.21 ng/ml 
[40, 48] 
Asthnozoospermia 7.78 ng/ml [40] 
Azoospermia 6.5 ng/ml [48] 
Oligozoospermia 8.8 ng/ml 
10.57 ng/ml 
[38, 48] 
Putrescine  
 Healthy 20 – 25 y old males 113 μM [47] 
50 – 55 y old males 32.3 μM 
Sodium  
 Healthy  3 mg/ml, 2.2 
mg/ml 
[32, 43] 
Fertile (smoker) 2.1 mg/ml [43] 
Infertile  2.1 mg/ml [43] 
Infertile (smoker) 2.1 mg/ml [43] 
Sodium Citrate  
 Healthy
  
 5.28 mg/ml [32] 
Spermidine  
 Healthy 20 – 25 y old males 251 μM [47] 
50 – 55 y old males 256 μM 
Spermine  
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 Healthy 20 – 25 y old males 2.29 mM [47] 
50 – 55 y old males 2.20 mM 
Testosterone  
  Healthy 6.6 – 17.73 ng/ml; 0.98 – 17.2 nM 
Abnormal 3.51 – 5.80 ng/ml; 11.6 – 20.4 nM 
Healthy  6.6 ng/ml 
17.73 pg/ml 
7.09 ng/ml 
16.3 nM 
17.2 nM 
17.7 nM 
16.2 nM 
[38-40, 49-
52] 
 20 – 25 y old males 0.98 nM [47] 
50 – 55 y old males 0.99 nM 
Infertile   11.6 nM [50] 
HCV+ 7.8 nM [51] 
Infertile (spinal cord injury) 12.1 nM [50] 
Normospermia 4.1 ng/ml 
5.80 ng/ml 
[40, 48] 
Asthenozoospermia 4.32 ng/ml 
20.4 nM 
[38, 40] 
Azoospermia 4.7 ng/ml [48] 
Oligoasthenozoospermia 15.2 nM [38] 
Oligozoospermia 4.6 ng/ml 
3.51 ng/ml 
16.6 nM 
[38, 40, 
48] 
Vitamin A  
 Healthy  28.61 μg/dL [40] 
Infertile Normozoospermia 17.86 μg/dL [40] 
Oligozoospermia 16.86 μg/dL [40] 
Asthenozoospermia 15.23 μg/dL [40] 
Vitamin C  
 Healthy  5.64 mg/dL [40] 
Infertile Normozoospermia 4.18 mg/dL [40] 
Oligozoospermia 4.95 mg/dL [40] 
Asthenozoospermia 5.05 mg/dL [40] 
Vitamin E  
 Healthy  0.143 mg/dL [40] 
Infertile Normozoospermia 0.109 mg/dL [40] 
Oligozoospermia 0.089 mg/dL [40] 
Asthenozoospermia 0.078 mg/dL [40] 
Zinc  
 Healthy  0.17 mg/ml  
0.14 mg/ml 
[32, 43] 
20 – 25 y old males 2.41 mM [47] 
50 – 55 y old males 3.12 mM [47] 
Fertile (smoker) 0.12 mg/ml [43] 
Infertile   0.10 mg/ml [43] 
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Table 2.1B 
Infertile (smoker) 0.08 mg/ml [43] 
Cytokine/ 
Chemokine/ 
Factor 
State of 
fertility/ 
disease 
Concentration Reference 
IFN-α  
 Healthy  15.6 pg/ml [42] 
Infertile Normozoospermia 92.0 ng/ml [48] 
 Azoospermia 132.6 ng/ml [48] 
Oligospermia 162.4 ng/ml [48] 
IFN-γ  
 
 
Healthy ND – 79 pg/ml; ND – 0.31 IU/ml 
Abnormal 26.8 – 4900 pg/ml; 0.33 – 0.43 IU/ml 
Healthy 
 
 ND 
ND 
28.7 pg/ml 
45 pg/ml 
0.25 IU/ml 
0.31 IU/ml 
3.7 pg/ml 
32.2 pg/ml 
3.68 fmol/ml 
79 pg/ml 
[10, 15, 
36, 42, 44, 
54-56] 
+ Schistosoma haematobium infection 
(low seminal egg secretion)  
21.4 pg/ml [54] 
+ Schistosoma haematobium infection 
(high seminal egg secretion) 
120.6 pg/ml [54] 
Infertile Infertile 0.33 IU/ml, 
6.36 fmol/ml 
[44, 56] 
Immunoinfertile (sperm abs) 0.43 IU/ml [56] 
Normospermia 3600 pg/ml 
1.62 pg/ml 
[48, 57] 
Genital infection 30.5 pg/ml [36] 
Varicocele 28.2 pg/ml [36] 
Cryptorchidism 29.8 pg/ml [36] 
Mumps orchitis 26.8 pg/ml [36] 
Idiopathic testicular lesion 28.3 pg/ml [36] 
Klinefelter syndrome 28.3 pg/ml [36] 
Oligozoospermia 4900 pg/ml 
608 pg/ml 
[48, 55] 
Azoospermia 11600 ng/ml [48] 
Azoospermic obstructive 1049.5 pg/ml [55] 
Azoospermic non-obstructive 901 pg/ml [55] 
Ashthenospermia 563 pg/ml 
1.88 pg/ml 
[55, 57] 
Oligoasthenospermia 629 pg/ml [55, 57] 
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1.2 pg/ml 
IL-1α  
 Healthy  150 pg/ml 
4.67 pg/ml 
4.7 pg/ml 
[8, 42] 
IL-1β  
 Healthy ND – 19 pg/ml 
Abnormal ND – 59.3 pg/ml 
Healthy  7.97 pg/ml 
19 pg/ml 
5.0 pg/ml 
4.9 pg/ml 
ND 
8 pg/ml 
2.3 pg/ml 
14.7 pg/ml 
[15, 42, 
49, 56, 58-
61] 
Infertile Infertile 11.9 pg/ml 
7.0 pg/ml 
ND 
37.8 pg/ml 
[49, 56, 
59] 
Normozoospermia 2.8 pg/ml 
0.41 pg/ml 
[57, 62] 
Normozoospermia + infection 3 pg/ml [61] 
Leukocytospermia 26 pg/ml [60] 
Oligozoospermia 1.5 pg/ml [62] 
Oligoasthenospermia 0.76 pg/ml [57] 
Asthenospermia 0.37 pg/ml [57] 
Immunoinfertile (sperm abs) ND [56] 
Infertile + genital infection 59.3 pg/ml 
11.7 pg/ml 
[49, 61] 
IL-6  
 Healthy 3 – 118 pg/ml 
Infertile 12.4 – 272 pg/ml 
Healthy  6.94 pg/ml 
10.8 pg/ml 
118 pg/ml 
18 pg/ml 
19 pg/ml 
23.84 pg/ml 
21.5 pg/ml 
23.6 pg/ml 
27.7 pg/ml 
6.2 pg/ml 
3 pg/ml 
50 pg/ml 
6.4 pg/ml 
42.2 pg/ml 
25.3 pg/ml 
36 pg/ml 
31.6 pg/ml 
[8, 15, 18, 
36, 42, 44, 
45, 49, 54-
56, 58-61, 
63] 
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+ Schistosoma haematobium infection 
(low seminal egg secretion)  
100.2 pg/ml [54] 
+ Schistosoma haematobium infection 
(high seminal egg secretion) 
591.4 pg/ml [54] 
Infertile Infertile 22.9 pg/ml 
63.1 pg/ml 
46 pg/ml 
34.4 pg/ml 
[44, 49, 
56, 59] 
Normozoospermia 18 pg/ml 
29.61 pg/ml 
[57, 62] 
Normozoospermia + infection 244 pg/ml [61] 
Immunoinfertile (sperm abs) 40.5 pg/ml [56] 
Infertile + genital infection 272 pg/ml 
196 pg/ml 
[49, 61] 
Azoospermic obstructive 42 pg/ml [55] 
Azoospermic non-obstructive 37 pg/ml [55] 
Leukospermia 21.05 pg/ml 
15 pg/ml 
[18, 60] 
Non-leukospermia 3.24 pg/ml [18] 
Ashthenospermia 69.5 pg/ml [55] 
Oligozoospermic 38 pg/ml 
40.62 pg/ml 
25 pg/ml 
[55, 62, 
63] 
Oligoasthenospermia 31 pg/ml [55, 57] 
Asthenospermia 40.09 pg/ml [57] 
Azoospermia 12.4 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
varicocele 
12.9 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
genital infection 
42.5 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
testicular lesion 
18.2 pg/ml [36] 
IL-12  
 Healthy 3.1 – 21.5 pg/ml 
Abnormal 0 – 25 pg/ml 
Healthy  21.5 pg/ml 
3.1 pg/ml 
11 pg/ml 
[42, 45, 
55] 
Infertile Ashthenospermia 11 pg/ml [55] 
Oligospermic 6 pg/ml [55] 
Oligoasthenospermia 0 pg/ml [55] 
Azoospermic obstructive 25 pg/ml [55] 
Azoospermic non-obstructive 18 pg/ml [55] 
IL-17  
 Healthy  7.1 pg/ml [42] 
IL-18  
 Healthy 332.4 pg/ml 
Abnormal 386.5 – 650.1 pg/ml 
Healthy  332.4 pg/ml [64] 
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Infertile Genital infection 650.1 pg/ml [64] 
Varicocele 389.6 pg/ml [64] 
Cryptorchidism 390.1 pg/ml [64] 
Mumps orchitis 386.5 pg/ml [64] 
Idiopathic testicular lesion 377.7 mg/ml [64] 
Klinefelter syndrome 417.5 pg/ml [64] 
IL-23  
 Healthy  5.87 pg/ml [63] 
Infertile Oligospermia 11.14 pg/ml [63] 
 50 – 55 y old males 497 IU/ml  
MIF  
 Healthy  3 μg/ml [65] 
Infertile Oligoterato-asthenoazoospermia + 
genital infection 
7.67 μg/ml [53] 
TNF-α  
 Healthy ND – 37 pg/ml 
Abnormal 0 – 62.5 pg/ml 
Healthy  ND 
ND 
2.5 pg/ml 
0 pg/ml 
37 pg/ml 
1.5 pg/ml 
4.3 pg/ml 
9 pg/ml 
19.5 pg/ml 
[8, 15, 45, 
49, 54-56, 
61] 
+ Schistosoma haematobium infection 
(low seminal egg secretion)  
7.3 pg/ml [54] 
+ Schistosoma haematobium infection 
(high seminal egg secretion) 
78.3 pg/ml [54] 
Infertile Infertile 0 pg/ml 
18.7 pg/ml 
[56, 66] 
Normozoospermia 5.5 pg/ml 
2.56 pg/ml 
[57, 62] 
Normozoospermia (+ infection) 33.3 pg/ml [61] 
Immunoinfertile (sperm abs) 0 pg/ml [56] 
Infertile + genital infection 62.5 pg/ml 
3.3 pg/ml 
[49, 61] 
Ashthenospermia 0 pg/ml 
5.88 pg/ml 
3.43 pg/ml 
[55, 57, 
63] 
Oligozoospermic 0 pg/ml 
6.27 pg/ml 
5.6 pg/ml 
[55, 62, 
63] 
Oligoasthenospermia 0 pg/ml 
1.69 pg/ml 
[55, 57] 
Azoospermic obstructive 23 pg/ml [55] 
Azoospermic non-obstructive 0 pg/ml [55] 
  
  
	
38 
Table 2.1C 
Cytokine/ 
Chemokine/ 
Factor 
State of 
fertility/ 
disease 
Concentration Reference 
IL-5  
 Healthy  39.7 pg/ml [42] 
IL-10  
 Healthy 2.4 – 76.5 pg/ml 
Abnormal 0.9 – 186 pg/ml 
Healthy  5.6 pg/ml 
6.0 pg/ml 
76.5 pg/ml 
9.8 pg/ml 
2.4 pg/ml 
6.7 pg/ml 
70.25 pg/ml 
[35, 42, 45, 53, 55, 
60] 
Fertile (+ infection) 5.2 pg/ml [35] 
+ Schistosoma haematobium infection 
(low seminal egg secretion)  
9.3 pg/ml [54] 
+ Schistosoma haematobium infection 
(high seminal egg secretion) 
26.8 pg/ml [54] 
Infertile Oligoterato-asthenoazoospermia 3.7 pg/ml [53] 
Normospermia 20.58 pg/ml [57] 
Azoospermic 8.2 pg/ml [53] 
Azoospermic obstructive 186 pg/ml [55] 
Azoospermic non-obstructive 93 pg/ml [55] 
Genital infection + 
Oligoteratoasthenoazoospermia 
0.9 pg/ml [53] 
Leukospermia + infection 7.1 pg/ml [35] 
Leukospermia 4.2 pg/ml 
4 pg/ml 
[35, 60] 
Ashthenospermia 158 pg/ml 
10.80 pg/ml 
[55, 57] 
Oligospermic 78 pg/ml [55] 
Oligoasthenospermia 122 pg/ml 
18.70 pg/ml 
[55, 57] 
TGF-β  
Total TGF-β1 Healthy 61 – 238 ng/ml 
Abnormal 112.7 – 130.7 ng/ml 
Free TGF-β1 Healthy 0.383 – 37 ng/ml 
Abnormal 0.87 – 2.32 ng/ml 
TGF-β1 Healthy Total 219 ng/ml 
92.4 ng/ml 
238 ng/ml 
85,548 pg/ml 
71 ng/ml 
61 ng/ml 
[4, 58, 67-
70] 
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Free 0.383 ng/ml 
1.82 ng/ml 
2.3 ng/ml 
2.0 ng/ml 
9.22 ng/ml 
37 ng/ml 
1.6 ng/ml 
0.9 ng/ml 
[4, 8, 58, 
60, 67-70] 
Infertile Leukocytospermia 0.5 ng/ml [60] 
Normozoospermia 0.554 ng/ml [62] 
Oligozoospermia 0.534 ng/ml [62] 
Secretory testicular pathology (total) 130.7 ng/ml [68] 
Secretory testicular pathology (free) 2.32 ng/ml [68] 
Epididymal occlusion (total) 105.8 ng/ml [68] 
Epididymal occlusion (free) 0.87 ng/ml [68] 
Non-obstructive genital tract pathology + 
testicular pathology (total) 
112.7 ng/ml [68] 
Non-obstructive genital tract pathology + 
testicular pathology (free) 
1.69 ng/ml [68] 
TGF-β2 Healthy Total 5.3 ng/ml 
18 ng/ml 
2.933 ng/ml 
1.5 ng/ml 
[4, 58, 67, 
69, 70] 
 Free 0.25 ng/ml 
0.148 ng/ml 
9 ng/ml 
0.01 ng/ml 
0.3 ng/ml 
[4, 58, 67, 
69, 70] 
TGF-β3 Healthy Total 172.2 ng/ml [4, 58, 69] 
Free 3.5 ng/ml [4] 
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Table 2.1D 
Cytokine/ 
Chemokine/ 
Factor 
State of 
fertility/ 
disease 
Concentration Reference 
IL-8  
 Healthy 7.2 – 2120 pg/ml 
Diseased 28 – 9490 pg/ml 
Healthy  2120 pg/ml 
720 pg/ml 
1300 pg/ml 
664.59 pg/ml 
4452 pg/ml 
7.2 pg/ml 
900 pg/ml 
1583 pg/ml 
1900 pg/ml 
1150 pg/ml 
491 pg/ml 
[8, 15, 18, 
36, 37, 42, 
45, 55, 61, 
63, 67] 
Infertile  Infertile (no pathogen infection) 28 pg/ml [37] 
Infertile + pathogen infection 34 pg/ml, 803 
pg/ml 
[37, 61] 
Normozoospermia 2005 pg/ml 
6935 pg/ml 
[15, 57] 
Normozoospermia (+ infection) 656 pg/ml [61] 
Leukospermia 1650 pg/ml [18] 
Non-leukospermia 610 pg/ml [18] 
Ashthenospermia 2850 pg/ml 
919.2 pg/ml 
[55, 57] 
Oligozoospermic 1450 pg/ml 
1113.86 
pg/ml 
2058 pg/ml 
[15, 55, 
63] 
Oligoasthenospermia 1750 pg/ml 
1049.7 pg/ml 
[55, 57] 
Azoospermic obstructive 2050 pg/ml [55] 
Azoospermic non-obstructive 2100 pg/ml [55] 
Azoospermia 4950 pg/ml [36] 
Oligo-terato-asthenozoospermia + varicocele 5450 pg/ml [36] 
Oligo-terato-asthenozoospermia + genital 
infection 
9450 pg/ml [36] 
Oligo-terato-asthenozoospermia + testicular 
lesion 
5450 pg/ml [36] 
IP-10  
 Healthy  1.8 nM [71] 
I-TAC  
 Healthy  0.6 nM [71] 
MCAF/MCP-1  
 Healthy  2.78 ug/L [8, 18, 42] 
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8000 pg/ml 
3251 pg/ml 
Infertile  Leukospermia 11.19 ug/L [18] 
Non-leukospermia 3.24 ug/L [18] 
MIG  
 Healthy  25 nM [71] 
MIP-1α  
 Healthy  375 pg/ml 
6.9 pg/ml 
[8, 42] 
MIP-1β  
 Healthy  400 pg/ml 
54.1 pg/ml 
[8, 42] 
RANTES  
 Healthy  400 pg/ml 
119.9 pg/ml 
[8, 42] 
SDF-1α  
 Healthy  5087.7 pg/ml [42] 
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Table 2.1E 
Cytokine/ 
Chemokine/ 
Factor 
State of 
fertility/ 
disease 
Concentration Reference 
BDNF  
 Healthy  3.4 ng/ml [72] 
Infertile Oligoasthenozoospermia 2.8 ng/ml [72] 
Asthenzoospermia 3.4 ng/ml [72] 
EGF  
 Healthy  34.9 ng/ml [73] 
Infertile  26.5 ng/ml [73] 
Infertile + abs 37.4 ng/ml [73] 
G-CSF  
 Healthy  250 pg/ml 
47.5 pg/ml 
[42, 58] 
Infertile Normoszoospermia 82 pg/ml [62] 
Oligozoospermia 50 pg/ml [62] 
GM-CSF  
 Healthy  5.6 pg/ml 
200 pg/ml 
1.5 pg/ml 
[8, 42, 58] 
IL-2  
 Healthy ND – 1.2 pg/ml; ND – 261 fmol/ml 
Abnormal 0.89 – 415.1 pg/ml; 219 – 444.3 fmol/ml 
Healthy  ND 
251.3 fmol/ml 
261 fmol/ml 
215.2 pg/ml 
6.2 pg/ml 
3.6 pg/ml 
1.2 pg/ml 
[10, 36, 
37, 42, 54, 
59, 74] 
Infertile Infertile 444.3 fmol/ml 
241 fmol/ml 
17 pg/ml 
[37, 59, 
74] 
Infertile + pathogen infection 26 pg/ml [37] 
Normospermia 0.76 pg/ml [57] 
Oligoasthenospermia 0.72 pg/ml [57] 
Asthenospermia 0.89 pg/ml [57] 
Azoospermia 219 fmol/ml 
390 pg/ml 
[36, 59] 
Oligo-terato-asthenozoospermia + 
varicocele 
415.1 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
genital infection 
405 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
testicular lesion 
389.1 pg/ml [36] 
sIL-2R  
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 Healthy 25.9 – 425 units/ml   
Infertile 22.1 – 310 units/ml   
Healthy  425 units/ml 
5.5 fmol/ml 
350 units/ml, 
25.9 units/ml 
[44, 53, 
59, 67] 
Infertile Infertile 5.6 fmol/ml,  
22.1 units/ml 
[44, 59] 
Oligoterato-asthenoazoospermia 310 units/ml [53] 
Genital infection + Oligoterato-
asthenoazoospermia 
240 units/ml [53] 
Azoospermic 310 units/ml [53] 
sIL-6R  
 Healthy 4 – 2250 pg/ml 
Diseased 4.8 – 2250 pg/ml 
Healthy  2250 pg/ml 
4 pg/ml 
[53, 59] 
Infertile Infertile 4.8 pg/ml [59] 
 Oligoterato-asthenoazoospermia 1900 pg/ml [53] 
Genital infection + Oligoterato-
asthenoazoospermia 
2100 pg/ml [53] 
azoospermic 2250 pg/ml [53] 
IL-7  
 Healthy 2365.8 pg/ml [42] 
IL-11  
 Healthy 18.5 – 6472 pg/ml 
Abnormal 21.1 – 9529 pg/ml 
Healthy  6472 pg/ml 
18.5 pg/ml 
3575 pg/ml 
[36, 45, 
55] 
Infertile Ashthenospermia 4602.5 pg/ml [55] 
Oligospermic 5815 pg/ml [55] 
Oligoasthenospermia 4125 pg/ml [55] 
Azoospermic obstructive 9529 pg/ml [55] 
Azoospermic non-obstructive 4991.5 pg/ml [55] 
Azoospemia 24.9 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
varicocele 
21.1 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
genital infection  
215.6 pg/ml [36] 
Oligo-terato-asthenozoospermia + 
testicular lesion 
22.7 pg/ml [36] 
IL-13  
 Healthy  3.2 pg/ml [42] 
NGF  
 Healthy  0.82 ng/ml [46] 
Infertile Oligoasthenozoospermia 0.68 ng/ml [46] 
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Asthenozoospermia 0.79 ng/ml [46] 
VEGF  
 Healthy  772 ng/ml [58] 
Infertile  Normozoospermia 523.94 ng/ml [62] 
Oligozoospermia 474.64 ng/ml [62] 
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2.4 Factors in semen modulate immunity essential to establishing 
fertilization 
Factors in seminal fluid must be present at optimal concentrations in order 
to achieve successful reproduction. Fertility is more than just a function of sperm 
count; the components of seminal fluid not only control the concentration of sperm 
in semen, but also influence the quality of the spermatozoa and alter the 
environment within the FRT to orchestrate tolerance of the paternal antigens in 
support of fertilization and embryo implantation. Many studies of healthy human 
males, infertile human males, and animals have provided insights into the intricate 
processes that take place in the FRT during reproduction. 
Events begin with the deposition of semen in the FRT. Initially, semen is 
recognized by the local female innate immune system as a foreign entity due to 
the presence of paternal antigens and MHC class I and II on spermatozoa [75]. As 
a result, an inflammatory reaction is incited, characterized by a massive infiltration 
of neutrophils that are likely recruited by the high concentrations of IL-8 (Table 
2.1D) and GM-CSF (Table 2.1E) found in seminal fluid [76]. The initial phase of 
inflammation is important to clear excess and abnormal sperm as well as various 
waste products found within semen [70, 76]. It is vital, however, that the 
inflammatory phase be quickly resolved, as uncontrolled inflammation could lead 
to the clearance of the healthy sperm cells by neutrophils and result in a reduced 
capacity for fertilization. In order to suppress the female immune system and allow 
the paternal antigens to go unrecognized, a state of tolerance must be induced, 
likely mediated by the pleiotropic cytokine TGF-β. Both pro-TGF-β and active TGF-
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β are secreted into semen by the seminal vesicles and prostate, and are present 
at very high concentrations within the seminal fluid (Table 2.1C) [76, 77]. In 
combination with seminal IL-15, TGF-β tilts the immune balance from the initial 
Th1 response to a Th2 type response through the induction of regulatory T (Treg) 
cell differentiation of T cells from the periphery [5, 77]. As Treg cells increase in 
number, a concurrent opposing shift in the local immune cell population results in 
the suppression of Th17 switching, the overabundance of which has been 
correlated with preeclampsia [78]. Additional studies suggest that semen may 
further bias a type 2 response by inducing the production of type 2 cytokines from 
local and intraepithelial T cells and dendritic cells (DCs), possibly through semen-
associated prostaglandins [58, 79]. These studies highlight the active role of 
semen in inducing the immune changes that prevent the semi-allograft fetus from 
being recognized as a foreign antigen and protect it from clearance [76]. 
TGF-β, however, is in no way the only important immunomodulatory factor 
found in semen. Another important suppressive component found in high 
concentrations is prostaglandin E2 (PGE2), which also originates in the seminal 
vesicles (Table 2.1A). Prostaglandins are key in dampening the immune response 
through inhibition of macrophage cytokine production and T cell proliferation [70, 
76, 77, 80, 81]. Like IL-15, PGE2 also works in combination with TGF-β to promote 
tolerance of paternal and fetal antigens, contributing to the differentiation and 
expansion of Treg cells in the FRT [5, 77]. Abnormalities in any one of the functions 
directed by the factors in seminal fluid, such as embryo implantation and 
development, could lead to a state of dysregulation, as evidenced by the many 
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types of male infertility that have been identified and described in literature (Table 
2.1). 
 
2.5 Changes in semen-associated immune factors correlated with infertility 
in the MRT 
Due to the complex composition of seminal fluid, male infertility may be 
correlated with an increase or decrease in a multitude of factors noted for their 
immunomodulatory activities (Table 2.1). The presence of interleukin 1β (IL-1β), a 
pro-inflammatory cytokine, has been inversely correlated with sperm motility 
(Table 2.1B). Similarly, increases in interleukin 6 (IL-6), possibly secreted by 
lymphocytes in semen or hormonally regulated Sertoli cells in the MRT, have been 
correlated with decreases in sperm count and motility, as well as decreases in 
semen volume (Table 2.1B)	 [35, 55, 56]. Interleukin 8 (IL-8), a chemotactic 
cytokine found at higher levels in the semen of individuals diagnosed with infertility 
due to leukocytospermia, has been suggested to be responsible for recruiting 
excessive numbers of white blood cells (WBCs), resulting in abnormally high T-
lymphocyte counts in semen as well as a decrease in spermatozoa viability (Table 
2.1D) [56]. Increased IL-8 has also been correlated with increases in pro-
inflammatory cytokines interleukin 1α (IL-1α) (Table 2.1B) and granulocyte colony-
stimulating factor (G-CSF) (Table 2.1E), which may be released into semen by 
macrophages or endothelial cells lining the MRT. IL-1α and G-CSF are responsible 
for activating T cell proliferation and stimulating neutrophil production, which are 
both key to eliciting an inflammatory immune response [82]. Increased interleukin 
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18 (IL-18), which was shown to be present at higher concentrations in semen of 
men suffering from combined infertility/urogenital infections, was correlated with 
decreased sperm concentration and mobility (Table 2.1B) [64]. Several studies 
have noted an increase in tumor necrosis factor alpha (TNF-α) in semen in 
conjunction with low or undetectable sperm counts (Table 2.1B). TNF-α has also 
been correlated with reductions in testosterone and sperm motility, alterations in 
sperm morphology, and increases in reactive oxygen species (ROS) [35, 55, 63]. 
Similarly, increases in interferon gamma (IFN-γ) across multiple infertility 
conditions were also associated with decreased sperm count, motility, and 
morphology (Table 1B) [55].  
The protein monocyte chemotactic and activating factor (MCAF) provides a 
particularly illustrative example of a biological factor contained in semen that may 
impact reproductive fitness through variations in concentration. Levels of MCAF in 
seminal fluid of men with leukocytospermia are increased over those of other 
infertile-type conditions or fertile males (Table 1D), indicating that specific infertility 
diagnoses can be associated with specific cytokine concentrations [18]. Increased 
levels of MCAF may originate from monocytes, endothelial cells, or fibroblasts 
present in the MRT and be involved in protecting the reproductive tract from 
infection by bacterial pathogens [18]. The role of MCAF in reproductive biology, 
however, is not limited to the male. It has been speculated that once semen has 
been deposited into the FRT, MCAF may be responsible for the local recruitment 
and activation of monocytes, which are important in clearing excess sperm [18]. In 
leukocytospermia, MCAF stimulation has also been associated with the release of 
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IL-6 from monocytes, which in conjunction with increased IL-8, results in further 
activation and differentiation of monocytes into macrophages and recruitment of 
neutrophils [18]. An increase in the local presence and activation of phagocytes 
could result in increased clearance of sperm cells, hindering fertility. Cumulatively, 
these factors and effects directly influence mechanisms that may alter local 
immune responses that affect not only reproductive events, but may also 
contribute to the risk of STD pathogen infection within the FRT [29]. 
2.6 Effects of seminal factors in the FRT 
In addition to its direct influence on immune cells, semen can also have 
indirect effects on the immune response mediated through the epithelial cells lining 
the reproductive tract of the female. While the FRT is a large and complex 
environment, the epithelial lining can essentially be broken down into three main 
regions: the vagina, which has the largest surface area in the FRT and is 
characterized by a squamous epithelium that can be up to 25 cell layers thick; the 
ectocervix, which encompasses the portion of the epithelium that transitions from 
a multi-layer squamous phenotype into a simple columnar phenotype 
characterized by low tight junction expression; and the endocervix, which is 
described as a single columnar epithelial layer with high levels of tight junction 
expression [83]. Interestingly, our group and others have observed that each of 
these regions is not only unique in phenotype or tight junction expression, but in 
responsiveness to stimuli, such as seminal fluid, revealing that the epithelium is 
more than just a mechanical barrier – it is also a dynamic tissue [84]. In fact, 
seminal fluid seems to elicit this response on tight junctions on epithelial cells in a 
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variety of environments [85]. When epithelial cells derived from the three main 
regions of the reproductive tract were incubated with seminal fluid in submerged 
culture, a wide array of factors were released, the most predominant of which were 
the inflammatory cytokines [58, 84]. However, the concentrations and specific 
cytokine release profiles were unique to each region [84]. In one study, cells 
derived from the ectocervix were the most responsive compared to cells of the 
vaginal tract. These results suggest that the vaginal epithelium, which is regularly 
exposed to bacteria, pathogens, irritants, and foreign entities (including semen), 
has a greater tolerance for damage or inflammatory stimuli [84]. The cervix, on the 
other hand, is considered to be essentially sterile due to its remote placement 
relative to the vaginal opening, and is protected from external insults by a layer of 
mucus. Because this region is exposed to a lower level of stimuli relative the 
vaginal epithelium, the tolerance of the epithelium might be lower and its 
responsiveness to insults correspondingly higher [84]. Studies have shown that 
even in the cervix there are regional differences, with the endocervix (higher up in 
the FRT) having a greater response to foreign stimuli [86]. Perhaps this robust 
response is due to the fact that the upper cervical region sees fewer foreign stimuli 
than the lower region and stands poised to provide a more effective response to 
stop colonization of the upper cervix [86]. 
Factors that are released by epithelial cells in a basolateral direction in 
response to apical exposure to semen also orchestrate reproductive 
inflammatory/tolerance events by influencing local immune cells [87]. For example, 
the transition of uterine natural killer cells (uNK) from a cytotoxic to a “helper” 
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phenotype is essential to fetal development [88], insofar as having uNKs recognize 
fetal development as “self,” or non-foreign, and therefore not attacking the 
developing fetus through induced tolerance. During embryogenesis, uNK cells 
release IFN-γ to aid in angiogenesis and vascularization of the uterus in order to 
support the developing fetus [88, 89]. Although it remains controversial, the shift in 
uNK phenotype leading to tolerance may be induced by IL-15 and IL-7 [90]. 
Release of IL-15 from the epithelium is increased 22-fold in the subepithelial space 
as early 4 h post-semen exposure [91]. As mentioned previously, the combination 
of IL-15 and TGF-β increases T cell switching to a Treg phenotype, further 
contributing to key events that initiate fetal tolerance [77]. Interestingly, the number 
of Tregs and uNK cells present in the uterus are higher relative to the peripheral 
blood, implicating the intensive role these cell types play in local reproductive 
immunity [92]. The shift from inflammation to tolerance in the FRT during semen 
exposure has been likened to the changes that occur in the tumor 
microenvironment, both of which provide protection from immune clearance and 
allow cells to proliferate in a similar manner [93]. Combined, the activity of the 
reproductive epithelium added to the effects of factors contained in semen creates 
a biphasic local immune response that is key to clearing excess sperm and 
essential to developing tolerance to the nascent fetus in the FRT during 
reproduction. 
In the context of pathogen transmission, the same factors that are important 
to reproduction may also contribute to susceptibility to sexually transmitted 
infections (STIs). When CD4+ T cells were incubated directly in seminal plasma, 
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there was an observed increase in CCR5 surface expression, resulting in 
preferential R5 infection in the presence of human immunodeficiency virus type 1 
(HIV-1) [7]. There is also evidence that the same type 2 responses that are 
responsible for tolerance of sperm may also protect the virus from clearance. 
Prostaglandins in semen that drive a local type 2 response, as described 
previously, may also inhibit IL-12 release and upregulate IL-10 production by DCs, 
possibly reducing the capacity for clearance of virus [79]. Combined with the data 
demonstrating that IL-7 – which is increased in the seminal fluid of HIV-1-infected 
males and also released by the epithelium after semen exposure – can enhance 
HIV-1 transmission to T cells in cervicovaginal explants [94], these findings further 
highlight the potential effects of combined factors from both seminal fluid and the 
reproductive epithelium in directly modulating transmission of HIV-1, as well as 
other STD pathogens. 
 
2.7 Future directions 
Studies that strive for a better understanding of the interplay between 
seminal factors and the FRT will provide new insights into reproductive biology as 
well as failures in reproduction attributable to disease or infection. Such studies 
will also give rise to the development of new model systems in which critical 
aspects of this important interplay can be readily manipulated and studied. For 
example, in vitro studies using a simple model consisting of semen and 
cervicovaginal epithelial cells may attribute a failure to modulate key innate 
immune responses in a timely manner to decreased concentrations of TGF-β in 
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seminal plasma. Such information could be the catalyst for the development of new 
drugs that effectively treat infertility. This review highlights the importance of the 
major constituents of semen and provides the first stepping stones toward future 
experiments of this nature. 
Outside of reproduction, immunomodulatory factors in semen may also 
affect key events that influence the transmission of STD pathogens, such as HIV-
1, resulting in an increased or decreased risk of male-to-female transmission. 
Having greater knowledge about the dynamics of biologically active factors in 
semen will increase our understanding of not only reproductive biology, but also 
STD pathogen transmission. More detailed information about the role of semen in 
modulating the risk of pathogen transmission will likely reveal new strategies for 
preventing STD acquisition by women. For example, a greater understanding of 
seminal factors that result in FRT inflammation and the chemotaxis of HIV-1-
susceptible immune cells to the cervicovaginal epithelium may provide a path 
toward the development of next generation topical microbicides that reduce 
semen-associated immune cell recruitment and reduce the risk of male-to-female 
HIV-1 transmission. It is our hope that this review will also serve as a supporting 
resource for these types of studies. 
 
2.8 Summary 
Semen is a biologically active fluid capable of orchestrating and influencing 
immune responses within the FRT. Some of the numerous agents in semen that 
profoundly affect the immunological environment of the FRT include cytokines, 
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chemokines, growth factors, and other biologically active molecules. Said 
components disrupt the normal immune response of the female, which may leave 
her susceptible to further complications. Although the MRT is highly 
compartmentalized, semen composition can be influenced by reproductive tract 
disease and conditions outside the MRT, resulting in changes in concentration of 
key seminal components that are important in guiding reproductive processes in 
the FRT. Significant changes in factors present in semen may result in infertility or 
reproductive dysfunction. Similarly, indirect changes induced by semen, such as 
the release of factors by the epithelium or changes in immune cell populations, 
may also influence the delicate pro-inflammatory and anti-inflammatory phases of 
reproduction.  
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3.1 Abstract 
When semen comes in contact with the female reproductive tract (FRT), it 
activates a biphasic immune response. Immune cell recruitment to the site of 
deposition is followed by a dampening of the immune response. In this regard, 
semen alters the immune cell populations already present in the female 
reproductive tract. The already high levels of CD8+ and CD4+ T lymphocytes are 
increased in numbers, along with natural killer cells, macrophages, and other 
antigen presenting cells. This is especially true in the immune microenvironment 
of the transformation zone, where the squamous epithelium of the lower cervix 
becomes a single columnar epithelium in the upper cervix. When exposed to 
seminal factors, the transformation zone becomes a “hot spot” for human 
immunodeficiency virus type 1 (HIV-1) transmission. In this review, we cover the 
transduced effect semen has on cells in the subepithelial space of the FRT and its 
potential for modulating pathogen transmission, with a focus on HIV-1. This review 
also briefly examines changes in seminal content due to HIV-1 infection and how 
the changes in semen content may further alter the risk of HIV-1 transmission from 
male-to-female. By understanding semen-dependent changes in the subepithelial 
environment of the FRT, we can draw conclusions about early events occurring in 
male-to-female pathogen transmission and, perhaps, identify mechanisms as 
possible targets for prevention therapies. 
 
 
 
  
  
	
57 
3.2 Introduction 
Semen is a dynamic fluid comprised of multiple cytokines, chemokines, 
growth factors, and whole cells. One function of semen is to serve as a vehicle for 
sperm delivery to a recipient female, who will, in turn, utilize the provided paternal 
genetic material to generate an embryo and initiate the process of reproduction 
[29]. When applied to the female reproductive tract (FRT), semen initiates tissue 
remodeling and release of cell signaling factors that are part of the innate immune 
response [95]. 
The innate immune response in the FRT is activated by interactions 
between the genital epithelium and foreign stimuli. To that end, the FRT epithelium 
is lined with polarized cells that express pattern recognition receptors (PRRs) such 
as Toll-like receptors (TLRs) and Nod-like receptors (NLRs)	[96]. These sensors 
allow the female to quickly react to different pathogens introduced into the FRT. A 
response to foreign stimuli may include activation of transcription factors and the 
production of cytokines and chemokines [29, 96, 97]. The cascade of cytokines 
produced will be reliant on the type of pathogen encountered and the specific 
pattern of PRR activation. While semen is not a pathogen, it is a source of “non-
self" antigens and can be considered analogous to a pathogen with respect to 
innate immune responses and inflammation in the FRT. Upon introduction of 
semen into the FRT, an inflammatory response is initiated to clear the semen [98, 
99] (Fig. 3.1A). However, to facilitate successful reproduction, semen must counter 
the innate immune response by “re-writing” the female immune response to accept 
the paternal antigens as “self” (Fig. 3.1B). 
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To counteract the inflammatory response, semen initiates a biphasic 
immune response, meaning that inflammation is soon abated, allowing the female 
to tolerate the presence of sperm [28, 100]. However, these changes in the FRT 
may make for an environment more suitable for pathogen transmission. In fact, by 
inducing tolerance in the latter half of the biphasic immune response, semen 
inadvertently creates an environment suitable for pathogen transmission. In the 
case of human immunodeficiency virus type 1 (HIV-1) induction of tolerance will 
produce an influx of T lymphocytes to the site of deposition [5, 28], which will 
provide more target cells for HIV-1 to infect; further facilitating disease 
transmission. Therefore, semen-dependent changes in the FRT, that are part of 
the normal process of fertilization, lead to changes in the risk of pathogen 
transmission [87].  
Previous studies of semen and its constituents in conjunction with HIV-1 
transmission have mainly focused on how HIV-1 changes the composition of 
semen [1, 42, 101]. Rarely have studies been used to determine how these 
changes affect the FRT or their downstream effects. Furthermore, almost no 
connections have been made between changes in semen content and changes in 
the subepithelial immune cell populations in the FRT, and how these changes may 
increase the risk of male-to-female HIV-1 transmission.  
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Figure 3.1 
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Fig. 3.1. Flow diagram of semen’s biphasic effect in the female reproductive 
tract 
 In the (A) inflammatory response factors in semen elicit a pro-inflammatory 
cytokine cascade from the epithelium that interact with monocytes, DCs, T 
lymphocytes, and macrophages. The resulting effect is a network of 
interplay among all immune cells present causing an increased release of 
TNF-α and interferon gamma (IFN-γ), promoting a further inflammatory 
response. Shortly after inflammation and the recruitment of T lymphocytes, 
seminal TGF-β and IL-15 produce an anti-inflammatory response from the 
epithelium causing a (B) tolerogenic environment. T cells become Tregs, 
which through the production of IL-10 and TGF-β, dampen the immune 
response by depleting the subepithelium of all other T lymphocyte lineages 
while simultaneously auto-expanding the Treg pool.  
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3.3 Immune Cell Changes in the Female Reproductive Tract  
3.3.1 Immune cells present in the female reproductive tract before 
exposure to semen 
Examining the immune cells present in the subepithelium of the FRT before 
and after semen deposition will allow one to draw conclusions about the effect 
semen has on the changes in the local immune environment in the subepithelial 
tissue. Prior studies of the subepithelium revealed that T lymphocytes, natural killer 
cells (NKs), macrophages, B lymphocytes, granulocytes, and dendritic cells (DCs) 
make up the majority of the populations present in the FRT [102]. However, the 
FRT can be divided into three anatomically distinct regions: two being the vagina 
and cervix, with the cervix being further subdivided into the ecto- and endocervix. 
Furthermore, in the cervix there is a transformation zone: the point where the 
squamous epithelium of the ectocervix (lower portion of the cervix) becomes the 
single columnar epithelium of the endocervix (higher portion of the cervix).  
The different regions of the FRT are not just anatomically distinct; they each 
represent immune microenvironments. Each region - the vagina, ectocervix, 
endocervix, and transformation zone - respond differently to stimuli and, as such, 
have varied populations of immune cells that make up their immune 
microenvironments. Pertaining to CD3+ lymphocytes, unlike in peripheral blood, 
the entirety of the FRT has more CD8+ T lymphocytes than CD4+ T lymphocytes 
[102]. In the vagina, increased numbers of CD8+ T lymphocytes are found in the 
lamina propria, and, although some CD4+ T lymphocytes can also be found in the 
lamina propria, the CD8+ T lymphocytes outnumber the CD4+ cells [102]. CD68+ 
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macrophages and HLA-DR+ DC-like cells can also be found in small numbers in 
the vagina [102]. Toward the upper portion of the vagina, close to the ectocervix, 
the immune cell populations shift slightly. Increasing in numbers in the lamina 
propria are CD1a+ immature DCs, yet still, CD8+ cells make up the majority of 
lymphocytes found in the lamina propria and epithelium [102]. Of these T 
lymphocytes, the majority are memory T cells (CD45RO+). However, naïve T 
lymphocytes (CD45RA+) are still present [102], albeit in smaller numbers. 
As the epithelium transitions from the vagina to the cervix, the immune 
microenvironment shifts. Some similarities between the vagina and ectocervix can 
be seen, i.e. CD3+ T lymphocytes are most abundant, with 40% of the population 
being CD4+ T lymphocytes and 60% being CD8+ T lymphocytes in the ectocervix 
[102]. The majority of the CD4+ T lymphocytes are of the effector/memory or 
effector/T cell phenotype [103]. Of the other CD45+ mononuclear cells, only ~2.7% 
are NK cells and ~0.9% are CD19+ B lymphocytes [102]. However, the ectocervix 
has abundantly more CD4+ T lymphocytes and CD1a+ DCs as compared to the 
vagina [102].  
The biggest differences in the FRT, with respect to immune 
microenvironments are found further up the FRT in the endocervix. The endocervix 
prevents infections from pathogens ascending the FRT by utilizing mucus glands 
that trap foreign stimuli [103]. Therefore, the endocervix doesn’t usually encounter 
pathogens, unlike the ectocervix, which is routinely exposed to probiotics, 
commensal flora, and pathogens [103]. Perhaps as a result of the sterility of the 
endocervix, there are half as many CD3+ T lymphocytes found in the upper cervix 
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relative to the lower cervix [102]. Therefore, CD4+ and CD8+ T lymphocytes are 
more abundant in the ectocervix than in the endocervix [103]. B lymphocytes follow 
the same pattern. However, NK subsets were about even in numbers between the 
ecto- and endocervix [103].  
The squamous epithelia of the vagina and ectocervix also harbor 
interstitially dispersed cells among the layers of cells. For example, in the vagina 
and ectocervix, Langerhans cells can be found in abundance in between adjacent 
cells, whereas in the endocervix Langerhans cells may be present but in fewer 
numbers [102]. The interstitial location of the Langerhans cells may permit them to 
reach the luminal side of the FRT, where they can interact with foreign stimuli and 
act as first responders [104]. One such interaction may be between Langerhans 
cells and HIV-1. Langerhans cells are thought to be initial targets for HIV-1, 
perhaps because they sample the luminal side of the FRT and are thus the first 
immune cells HIV-1 may contact in the FRT [105, 106] . It is unclear, however, if 
Langerhans cells are the first cells to become infected by HIV-1. It is therefore 
unknown if Langerhans cells may facilitate transmission of the disease. It is known, 
however, that Langerhans cells may act as a reservoir for HIV-1 [105, 107] . In 
doing so Langerhans cells act as a primary defense against HIV-1 and prevent the 
virus from reaching target CD4+ T lymphocyte populations in the subepithelium 
[102, 105, 107] .  
Again, other types of immune cells present in the FRT are found at varying 
concentrations in each tissue and region. Immune cell populations in the vagina 
and cervix generally have T lymphocytes in the greatest abundance, followed by 
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NKs, with B lymphocytes as the least concentrated in number [102]. In the context 
of HIV-1, T lymphocytes are important populations to focus on because CD4+ T 
lymphocytes (T helper cells) are primary targets for the virus since they express 
CD4, which is one of the cell surface co-receptors necessary for HIV-1 entry and 
infection [108]. In fact, recent ex vivo studies have shown that infection of immune 
cells by HIV-1 occurred more frequently in T cell subsets than in other types, 
suggesting that T helper cells may be the first to become infected by HIV-1 [109, 
110]. In that study, CD4+ Th17 cells were the most readily infected subset [109, 
110]. CD4+ Th17 cells are involved in the innate immune response of the FRT and 
vary in concentration across the FRT, with the greatest concentration being 
harbored by the ectocervix [109, 110]. Because these cells are involved in 
maintaining mucosal surfaces as well as clearance of pathogens at said surfaces 
[109, 110], their abundance in the ectocervix is consistent with their function.  
In fact, CD4+ Th17 cells are one of the T lymphocyte subsets found in great 
numbers in the transformation zone [103], where the ectocervix becomes the 
endocervix. The immunological microenvironment of the transition zone, unlike the 
surrounding tissues, has an increased concentration of T lymphocyte populations 
and antigen presenting cells (APCs) [103]. Interstitially placed in the transition zone 
are an abundance of CD8+ T lymphocytes [102, 103], which, again, make up the 
most abundant immune cells in the FRT. With increased numbers of all cell types 
in the transformation zone, it seems plausible to identify this region as the central 
hub for cell-mediated immunity in the FRT [103]. Consistent with this concept, 
inflammation associated with cervicitis and vaginitis was found to result in 
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increased intraepithelial numbers of CD8+ and CD4+ T lymphocytes and APCs in 
the transformation zone [107]. These pathogen-induced responses suggest that 
the transformation zone may also be a “hot-spot” [111] for HIV-1 transmission 
during inflammation, as well as the central hub for cell mediated immunity [103]. 
These findings are backed up by non-human primate studies that showed that 
simian immunodeficiency virus (SIV) transmission, which occurs within hours of 
the viral challenge, takes place predominantly in across the ectocervical epithelium 
[112, 113]. In related reproductive biology studies in mice, an influx in T 
lymphocytes was seen in the ectocervix within four hours after coitus [5, 77, 114]. 
Cumulatively, these results point to the transformation zone as a potential hot-spot 
for HIV-1 infection. 
3.3.2 Seminal factors interact with the FRT to induce a pro-
inflammatory environment in the subepithelium 
Therefore, semen influences immune cell populations in the subepithelium 
of the FRT by acting through the mucosal epithelial tissues. Biologically active 
factors in semen are unlikely to penetrate the epithelium to influence underlying 
immune cell populations [29]. In fact, the generation of Treg cells in the ectocervix 
so quickly after coitus in animal models is direct evidence of semen’s effect on 
female immunity [5, 77] .  
Semen is comprised of a multitude of biologically active factors: hormones, 
cytokines/chemokines, fructose, vitamin D, and immune cells [29]. Together, these 
factors induce a pro-inflammatory environment in the subepithelium of the FRT 
[87, 99, 114] (Fig. 3.1A). However, variability in semen may also account for 
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differences in immune activation [49, 82, 115]. Changes in fertility, age, sexually 
transmitted diseases (STDs), medication, and diet [29] are only a few variables 
that induce variability in semen. It is known that infertility in males may be attributed 
to adverse changes in cytokine and chemokine content in semen [29, 63]. By 
extension, innate immune responses mounted in the FRT to these individuals may 
differ from the immune responses mounted against normal, healthy male semen. 
As result of altered semen content, the innate immune response in the FRT 
becomes altered. This may result in an over-abundance of immune cell recruitment 
to the subepithelium of the FRT. In the context of HIV-1 transmission, more target 
CD4+ T lymphocytes may become available due to the higher pro-inflammatory 
nature of semen inducing an inflammation response through the epithelial barrier.  
In mice, colony stimulating factor 2 (CSF2), interleukin-6 (IL-6), interleukin-
8 (IL-8), and interleukin-1 alpha (IL-1α) were all detected by quantitative RT-PCR 
in cervical tissues following coitus [28]. This led to the recruitment of macrophages, 
DCs, and memory T lymphocytes to the cervix [28]. Normal, healthy semen is able 
to induce changes in the FRT that would further facilitate HIV-1 transmission via 
induction of CD4+ T lymphocytes. Thus also goes back to the latter stage of the 
biphasic effect semen elicits, which is to dampen inflammation to allow fertilization 
to occur (Fig. 3.1B).  
The biphasic effect of semen starts with inducing inflammation through 
seminal constituents (Fig. 3.1A). Reproductive studies in mice show that semen 
induces a pro-inflammatory response from the FRT that is absent in virgin mice 
[99]. In fact, semen from mice without seminal vesicles failed to induce 
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macrophages and DCs after mating, suggesting that the seminal vesicle is 
responsible for providing the constituents in semen that elicit an inflammatory 
response in the FRT [99]. Furthermore, granulocyte-macrophage colony 
stimulating factor (GM-CSF) and tumor necrosis factor alpha (TNF-α) are also not 
generated from the female epithelium when seminal vesicle deficient male semen 
interacts with the FRT [99]. Cumulatively, semen expands the immune cell 
populations through interactions with the FRT epithelial barrier. During the initial 
inflammation stage of semen exposure, pro-inflammatory cytokines, such as tumor 
necrosis factor alpha (TNF-α), are released from the epithelium (Fig. 3.1A). These 
cytokines interact with immune cells in the subepithelium, which then produce their 
own cytokines (Fig. 3.1A). These cytokines then go on to interact with DCs, NK 
cells, naïve T lymphocytes (Th0), and others (Fig. 3.1A). The inflammatory 
response recruits T lymphocytes to the site of semen deposition and expands the 
pool of Th0 cells into Th1, Th2, and Th17 subsets (Fig. 3.1A) to further enhance 
inflammation. 
However, seminal interleukin-15 (IL-15) and transforming growth factor beta 
(TGF-β) acting through the epithelium will also induce a tolerogenic environment 
(Fig. 3.1B). Interestingly, increased epithelial production of IL-15 (~22-fold) in a 
basolateral direction in response to apical exposure to semen has also been 
reported [23]. In fact, early recruitment of CD3+ T lymphocytes to the site of semen 
deposition will further facilitate a tolerogenic state through the induction of T 
regulatory (Treg) cells [5, 77] (Fig. 3.1B). The pool of T helper and Treg cells 
expands with the basolaterally produced IL-15, interleukin 10 (IL-10), and TGF-β, 
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as a response to semen. The expanded pool of Tregs further act to shut down 
inflammatory inducing immune cells such as Th1 and Th2 cells (Fig. 3.1B). In fact, 
Tregs dampen the inflammatory cascade through inhibition of most cells types and 
processes (Fig. 3.1B), thereby leaving the environment in a state to tolerate the 
semen, until full clearance. Therefore, healthy male semen already primes the FRT 
for immune tolerance and may further facilitate HIV-1 transmission from male-to-
female. The increased amount of HIV-1 target cells abundant in the subepithelium 
coupled with a severe reduction in female defenses allows HIV-1 to enter and 
replicate in T cells. 
3.3.3 Modulation of seminal factors by HIV-1 may have downstream 
effects in the FRT 
Studies have also categorized differences in seminal constituents between 
healthy males and those with HIV-1. Specific factors like IL-1α [8, 10, 29], 
interleukin-4 (IL-4) [6, 29], IL-6 [6, 10, 14, 15, 24, 29], interleukin-7 (IL-7)	[6, 24], 
interleukin-8 (IL-8) [6, 10, 14, 15, 24, 29], interleukin-16 (IL-16)	[24], macrophage 
inflammatory protein alpha and beta (MIP-1α and MIP-1β) [8, 24], regulation on 
activation normal T cell expressed and secreted (RANTES)	[8, 13, 24], and TGF-
β [8, 24] are all increased in HIV-1 infected male’s semen [29]. Examining these 
increased factors as a whole, however, and not as single entities, provides a 
network of interplay that would further enhance HIV-1 transmission in the female 
(Fig. 2). Increased levels of IL-6 and IL-8 will induce recruitment of more lymphoid 
cells by acting through the FRT. Both cytokines, when interacting with epithelial 
cells induce inflammation, and therefore recruitment to the site of their interaction. 
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Because these cytokines are signs of inflammation, the female will increase 
chemotaxis of neutrophils [116]. At the same time, the increased numbers of 
neutrophils will begin to differentiate into T lymphocytes due to increased levels of 
IL-2 being produced by the interaction between the FRT and IL-1α . Because there 
is an increase in IL-1α concentration in HIV-1 infected semen, there will be more 
IL-2 produced by the epithelium as a response, thus promoting T helper cell 
subsets. The Increased levels in IL-16 in the FRT will further enhance the 
recruitment of CD4+ T lymphocytes to the site of inflammation perhaps by 
interacting with the interstitially placed T lymphocytes in the ectocervical epithelium 
[117]. Increased TGF-β levels in semen serve a dual purpose: further dampening 
of the innate immune response and, in doing so, enhancing the recruitment of T 
helper cells to the site of inflammation [4]. Interactions between the epithelium and 
TGF-β will release more TGF-β in the basolateral direction as well as induce IL-16 
release [4]. Working together, TGF-β and IL-16 will induce a Th17 phenotype of 
some T lymphocytes. As discussed earlier, CD4+ Th17 lymphocytes were the first 
immune cells to be infected by HIV-1 [109, 110], therefore increasing their overall 
numbers to the site of inflammation may further enhance HIV-1 transmission. Most 
of, if not all, the increased cytokines in HIV-1 infected male’s semen increase CD3+ 
T lymphocyte recruitment to the site of inflammation (Fig. 2). IL-7 may be 
connected by, in a way, “trapping” the T lymphocytes in the inflamed area by 
preventing T lymphocyte depletion through apoptosis [94]. In fact, a study revealed 
that increased IL-7, in conjunction with HIV-1, may help the expanded pool of T 
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lymphocytes from being depleted and therefore keep the founder pool of HIV-1 
infected cells alive for further expansion [94]. 
Increased levels of the CC chemokine RANTES are particularly interesting 
in that RANTES may interact with the interstitially found Langherans cells. 
RANTES induced chemokines through DCs include macrophage inflammatory 
protein 2 (MIP-2), MIP-1α, MIP-1β, IL-6, and TNF-α [13, 118, 119]. As stated 
before these cytokines are very much involved in the recruitment, expansion, and 
activation of CD4+ T lymphocytes [119]. Therefore, it stands to say that HIV-1 
infected semen is focused on expanding and activating the CD4+ T cell subsets. 
In doing so, the induction of a tolerogenic state may be reached quicker than with 
healthy semen, allowing the virus to persist for longer periods of time.  
 
3.4 Conclusions  
 Semen is a complex medium that can rapidly manipulate the female innate 
immune response post-coitus [29, 77] . Manipulation of the FRT immune response 
functions, most broadly, to prime the female for fertility and reproduction. Evidence 
of this is the fact that semen elicits the FRT to produce large quantities of IL-8 and 
TGF-β, which are both key players in angiogenesis and reproduction, respectively. 
However, in causing the innate immune response to switch from a pro-
inflammatory state to a tolerant state, semen may inadvertently increase a female’s 
risk to further pathogen infection, such as HIV-1. By recruiting HIV-1 specific target 
cells to the site of semen deposition, specifically the transformation zone, the 
introduction of semen may cause an increased risk of transmission. 
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 However, this is all in the context of healthy male semen. As noted HIV-1 
infected male semen contains some of the same factors as healthy male semen, 
except in varying concentrations with certain major cytokines present in higher 
quantities [29]. These higher quantities, as explained before, may have 
downstream implications on the immune cells present in the FRT, which will have 
downstream effects on how the innate immune response is manipulated. 
Conversely, some factors may be decreased in concentration and therefore lead 
to their own immune remodeling [29]. This change in the biphasic nature of semen 
in the FRT will further enhance HIV-1 transmission. This may very well go all the 
way back to how HIV-1 manipulates the contents of semen in males before the 
semen acts on any genital tract, be it male or female, which may be an evolutionary 
advantage selected for in HIV-1 variants transmitted throughout the course of HIV-
1 infections.  
 More information and studies are needed that take into account every step 
from semen creation in the male to ending immune cell populations in the female 
and everything in between. The constituents in semen have profound effects for 
the FRT, which responds with its own immunodulatory factors. These released 
factors then impact the immune cells present in the subepithelium of the FRT. 
Knowing what factors are in semen and how these factors interact with the FRT 
will provide insights to development of novel therapies. Vaccines to prevent 
pathogen transmission, as well as treatments for infertility may be developed 
based on immunological responses seen in the FRT. This review provides a 
starting point for identifying key aspects of the interaction between semen and the 
  
  
	
72 
FRT, which may lead to further analysis of the interaction between semen and the 
FRT or to the development of said treatments. 	
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4.1 Abstract 
Semen is known to modulate the response of the female reproductive tract 
(FRT) when both are in contact. Indeed, semen has a physical effect through 
strengthening tight junctions and thus reducing permeability. Semen also elicits a 
pro-inflammatory response from the FRT, causing the subepithelial space to 
become rife with immune cells that further attenuate inflammation. However, what 
is not known is if the presence of semen on the apical side of the FRT could 
influence HIV-1 infection in CD4+ T on the basolateral side of the FRT. To elucidate 
this, we have updated our transwell model system to include a co-culture of 
primary blood mononuclear cells (PBMCs). By doing so we can see preliminary 
results of semen’s transduced effect through the epithelial barrier. We hypothesize 
that semen will modulate human immunodeficiency virus type 1 (HIV-1) target cells 
(CD4+ T cells) to become more susceptible to HIV-1. To extend this idea further, 
we wanted to also garner answers to the bottleneck hypothesis, which states that 
HIV-1 transmission in discordant, heterosexual couples is almost always R5-tropic 
driven; using CD4 and CCR5 as co-receptors over CD4 and CXCR4. Our results 
indicate that the presence of semen on the apical side of an ECT1 epithelium had 
a rescue effect of CCR5 on CD4+ T cells in basolateral compartment while not 
affecting CXCR4. When the PBMCs were challenged with a pseudovirus infection 
using a R5 or X4 envelope, viral infection and gene expression with a R5-tropic 
pseudovirus were enhanced in the presence of semen. This leads us to conclude 
that semen plays a significant role in the bottleneck hypothesis.  
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4.2 Introduction 
Studies that stemmed from identifying components in semen associated 
with infertility have begun characterizing semen [9, 15, 35, 42, 49, 59, 74, 120]. 
Semen is no longer thought of as an inert vehicle for sperm or pathogen delivery, 
but as a biologically active substance	 [9, 16, 29, 62, 70, 84, 99, 121-123]. The 
constituents of semen; sugars, whole cells, cytokines, proteins, etc. have been 
shown to interact with tissues they come in contact with [9, 28, 29, 85, 99, 106, 
121, 124] (Appendix Chapters 1 and 2). Previous work of ours has identified 
calcium and proteins in semen as potent activators of tight junctions in cell lines 
derived from the female reproductive tract (FRT) (Appendix Chapter 2). Semen 
does not just induce mechanical alterations to reproductive epithelia, it also elicits 
an immunological response, which we have previously reported as being pro-
inflammatory (Appendix Chapter 1).  
Indeed, when semen interacts with the FRT it triggers the innate immune 
response mounted by the female [95, 99, 100]. The initial inflammation associated 
with the innate immune response is pivotal in identifying paternal MHC Class I and 
II receptors of abnormal or non-functional spermatozoa [9, 29, 99, 104]. However, 
inflammation must soon be abated or all spermatozoa, including healthy, viable 
sperm, will be cleared. Therefore, in order to ensure the survival of healthy sperm, 
semen modulates the innate immune response to go from inflammation to 
tolerance [70, 76, 95, 99, 125, 126]. A tolergenic state in the FRT will allow for 
semen, and its constituents, to initiate the early stages of pregnancy and embryo 
development.  
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Induction of tolerance is carried out quickly when semen is deposited in the 
FRT [99]. Early induction of T regulatory cells (Tregs) have been shown in animal 
models and the generation of Tregs dampen the immune response to paternal 
antigens [28, 124]. The remodeling of the female immune system is paramount to 
pregnancy but also has consequences downstream of sperm survival. Indeed, the 
interaction of constituents like transforming growth factor beta (TGF-β) with 
reproductive epithelia release cytokines like tumor necrosis factor alpha (TNF-α) 
and interferon gamma (IFN-γ) to the subepithelial space [4, 9, 29]. Cytokines like 
these have lasting impacts on immune cells naturally found beneath, and 
interstitially to, the epithelia. Release of chemokines from the epithelium brings 
about an influx of immune cells from peripheral blood such as monocytes, 
macrophages, dendritic cells (DCs), natural killer cells (NKs), B cells, and T 
lymphocytes. Each immune cell recruited to the site of inflammation adds their own 
effect to the immune cascade, which can include further immune cell chemotaxis, 
maturation of naïve or immature immune cells, or adding immune cell-specific 
cytokines to the milieu [95, 126, 127]. In fact, semen deposition in the FRT has 
been shown to increase immune cell concentrations in the ectocervix, the lower 
portion of the cervix, through chemoattractant molecules [103, 104].  
The ectocervix represents the transformation zone, which is the portion of 
the FRT that contains the highest concentration of all immune cells [102-104]. 
Considered the central hub for cell-mediated immunity, the ectocervix is 
immunologically very active compared to the rest of the FRT [103]. Therefore, 
when semen comes in contact with the FRT, the transformation zone will 
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coordinate the innate immune response mounted against semen [103], i.e. by 
increasing the concentration of effector T cells, which carry out cell-mediated 
responses.  
However, effector T cells, specifically CD4+ T cells, are of note because of 
their involvement in human immunodeficiency virus type 1 (HIV-1) transmission. 
During heterosexual intercourse the chances of a woman acquiring HIV-1 are twice 
as much as her male counterpart [9, 29]. Perhaps this is why in 2013, 62% of all 
new HIV-1 infections in adolescents occurred among females [128]. In Ethiopia 
about 60% of new HIV-1 infections occur in discordant heterosexual couples [129]. 
In sub-Saharan Africa 58% of people living with an HIV-1infection are women 
[129]. Therefore, worldwide, women are disproportionately affected by HIV-1.  
During heterosexual transmission of HIV-1, studies have pinpointed specific 
genetic variants as being predominant isolates that initiate infection in females 
[130, 131]. Known as R5-tropic viruses, they establish infection early on during 
transmission and can lead to systemic infection [130-132]. Often, tracing back the 
genetic isolate that started infection leads to R5-tropic viruses, even down to a 
single R5-tropic virion [131]. It is known that HIV-1 needs to come in contact with 
a CD4 receptor on a cell to initiate entry, however the virus also needs a co-
receptor; either CCR5 or CXCR4. Depending on which co-receptor the virus 
utilizes with CD4 it is termed either R5 (CCR5-utilizing) or X4 (CXCR4-utilizing). 
Despite infection being initiated by primarily R5-tropic viruses both viral types may 
be present during transmission events and can both initiate infection [132]. 
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However, it is still unknown why R5-tropic viruses are, almost exclusively, the virus 
that initiates infection in a female.  
Studies attempting to understand the R5-tropic bias of HIV-1 transmission 
from male-to-female have identified key aspects affecting genetic variants of HIV-
1, collectively called the bottleneck hypothesis [130-132] . Indeed, the bottleneck 
hypothesis posits that there are various filtering points that select out for specific 
genetic variants [132]. These checkpoints exist from the male reproductive tract all 
way through semen deposition in the FRT. At each step along the way the 
bottlenecks select for the advancement of specific variants through many biological 
factors, however the most stringent bottleneck is when semen is introduced in the 
FRT [131, 132].  
Therefore, using a previously established in vitro transwell system as an 
analog of the polarized topography of the FRT epithelium (Appendix Chapters 1 
and 2) we aimed to elucidate if the response of the FRT to semen would favor 
infection of one HIV-1-tropic strain over the other. The transwell model system 
used an ectocervical cell line derived from the FRT [133] that was grown in a 
polarized manner on a mesh insert, which allowed the independent sampling of 
both the apical and basolateral chamber. Literature suggests that the ectocervix is 
the site of HIV-1 infection during male-to-female transmission [9, 29, 95, 103, 113, 
131]. Thus, in this study we used the ectocervix derived cell line ECT1/E6E7 
(ECT1). By advancing the model system to incorporate peripheral blood 
mononuclear cells (PBMCs) in the basolateral chamber, we can elucidate if semen 
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transduces its effect across the epithelium to enhance the infectivity of one HIV-1-
tropic strain over the other.  
Indeed, by co-culturing PBMCs with ECT1 cells it was found that semen 
elucidated factors to be released from the epithelium that interacted with peripheral 
blood cells, which induced an immunological environment that enhanced infections 
by both R5- and X4-tropic viruses. However, the fold-change of CD4+ T cells that 
were infected by R5-tropic viruses in the presence of semen compared to those in 
the absence of semen was higher than X4-tropic viruses. These data suggest that 
the interaction between semen and the epithelium is enough to drive R5-tropic 
infection during HIV-1 transmission from male-to-female.  
 
4.3 Materials and Methods 
4.3.1 Cell line maintenance 
Experiments were performed using a cell line derived from one of the three 
regions of the human female reproductive tract: ectocervical cells (ECT1/E6E7) 
[133]. 
 Prior to seeding, cells were grown and maintained in T150 tissue culture 
flasks (Grenier Bio One, Monroe, NC) at 37°C with 5% CO2. ECT1 cells were 
cultured using the Keratinocyte Serum-Free Medium (Gibco, Grand Island, NY), 
which included 50 μg/ml bovine pituitary extract (BPE), 0.1 ng/ml epithelial growth 
factor (EGF), 50X penicillin/streptomycin solution, and with the addition of 0.4 mM 
calcium chloride (EMD Millipore, Billerica, MA).  
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4.3.2 Transwell culture system 
ECT1 cells were cultured as a confluent, polarized monolayer by seeding 
into the apical chamber of a 6.5 mm, 0.4 μm pore size, polyester (PET) transwell 
insert in a 24-well receiver plate (Corning, Corning, NY). 200 μl of 1.5 x 105 cells 
were placed in the apical chamber, with 600 μl of media in the basolateral 
chamber. Time to confluence varied between 14 and 17 days post-seeding. TEER 
readings were taken every other day to testthe growth and potential of the plate. 
4.3.3 Semen 
Semen was purchased as 20 ml of pooled semen from a mixture of ≥3 
healthy donors between 26 and 34 years of age (Lee Biosolutions, St. Louis, MO). 
Specimens were shipped overnight on dry ice and immediately divided into 500 μl 
aliquots and frozen at -20°C upon arrival. In all descriptions, semen refers to whole 
semen; containing sperm. 
4.3.4 Peripheral Blood Mononuclear Cells (PBMCs) 
PBMCs were obtained from Comprehensive NeuroAIDS Center (CNAC) 
Mammalian Cell and Virus Core cohort at Temple University. The PBMCs were 
then cultured overnight in RPM1-1640 supplemented with 2% (10 ml) heat-
inactivated FBS and 1% (5 ml) HEPEs (R1H medium). Additional interleukin 2 (10 
U/ml) was added to the medium for overnight activation. After 16-18 h incubation 
the cells were then spun down at 2500 rpm for 5 minutes. The supernatant was 
discarded and the cells were resuspended in the appropriate amount of R1H to 
reach a concentration of 1 x 106 cells/ml. Unless stated otherwise PBMCs were 
seeded at 1 x 106 cells/ml.  
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4.3.5 Conditioned media collection of semen exposed ECT1 cells  
Transwells of confluent ECT1 monolayers had both their apical and 
basolateral chambers aspirated and then were washed with 1X HBSS twice. The 
basolateral chamber was then re-supplemented with 600 μl of media. The apical 
chamber was then supplemented with 25% semen in duplicate for 4 h. 4 h was 
chosen because this time is consistent with the literature to be the time it would 
take for semen to have an interaction with the epithelial tissue and be cleared from 
the FRT. During the 4 h the plates were incubated at 37°C + 5% CO2. After 4 h the 
basolateral chamber media was collected and stored at -80°C. Below is a 
schematic representation of conditioned media collection. 
 
4.3.6 Collection of conditioned media of ECT1 cells co-cultured with 
PBMCs 
Transwells of ECT1 monolayers at confluency had both their apical and 
basolateral media aspirated and discarded. Each well was washed twice with 1X 
HBSS. The basolateral chamber was then supplemented with 600 μl of 1 million 
IL-2 activated PBMCs. The ECT1 cells and PBMCs were in co-culture for 4 h and 
incubated at 37°C + 5% CO2. Again, 4 h was chosen because it is an accepted 
time frame, in the literature, for the innate immune response to have been initiated 
and taking effect. After 4 h the conditioned media were harvested by collecting the 
basolateral chamber media and PBMCs and then spinning down the sample at 
  
  
	
82 
2500 rpm for 5 min. The supernatant was placed into a separate tube and stored 
at -80°C. The PBMC pellet was resuspended in 500 μl R1H medium for further 
testing using flow cytometry. Below is a schematic representation of conditioned 
media collection. 
 
4.3.7 Conditioned media collection of semen exposed ECT1 cells co-
cultured with PBMCs 
Transwells of ECT1 monolayers had both the apical and basolateral 
chambers aspirated and discarded. Each well was washed twice with 1X HBSS. 
The basolateral chamber was supplemented with 600 μl of 1 million IL-2 activated 
PBMCs while the apical chamber had 200 μl of 25% semen added to it. The 
transwells were incubated at 37°C + 5% CO2 for 4 h. After 4 h the basolateral 
chambers were harvested and spun down at 2500 rpm for 5 min. The supernatant 
was collected and stored at -80°C while the PBMC pellet was resuspended in 500 
μl of R1H medium and kept for flow cytometry analysis.  
 
4.3.8 ELISArray 
The collected supernatants were analyzed by the Qiagen Human TLR-
induced Cytokines II: Microbial-induced Multi-Analyte ELISArray Kit (Qiagen, 
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Maryland). As per the protocol conditioned media was added to each well of a pre-
coated 96-well plate with 12 different antibodies. After incubation and washing 
three times, a detection antibody was added. After incubation and washing three 
times, Avidin-HRP was added to each well. After another incubation and washing 
4 times, a development solution was added to each well. After a 15 minute 
incubation, in the dark, a stop solution was added to each well. The plate was then 
read on a spectrophotometer at OD450 with wavelength correction at OD570. The 
results were analyzed in Microsoft Excel. 
4.3.9 Flow Cytometry 
PBMCs collected from transwells of ECT1 cells apically exposed to 25% 
semen were spun down for conditioned media (supernatant) collection. The cells 
were then resuspended in R1H medium for antibody staining for Flow Cytometry. 
5 μl of anti-CCR5 antibody conjugated to PE (eBioscience, San Diego, CA) was 
applied first and left to incubate for 45 minutes at room temperature (25ºC). The 
cells were then washed with 2 ml of R1H and spun down at 2500 rpm for 5 minutes. 
The PBMCs were then resuspended in a volume of R1H medium for further 
staining. 5 μl of anti-CD4 conjugated to APC (eBioscience, San Diego, CA), 5 μl 
of anti-CXCR4 conjugated to BV 421 (BioLegend, San Diego, CA), and 3 μl of anti-
CD3 conjugated to APC-Cy7 (BioLegend, San Diego, CA) were then added to 
each tube. The antibodies were left to incubate for 40 minutes at 4ºC. After 40 
minutes, 1 μl of a Live/Dead stain, conjugated to BV 510 (AmCyan or Aqua) 
(eBioscience, San Diego, CA) was applied to each tube. The final solution was left 
to incubate at 4ºC for another 15 minutes. After total incubation the PBMCs were 
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washed with 2 ml R1H medium and spun down at 2500 rpm for 5 minutes. The 
cells were resuspended in 500 μl of 1% paraformaldehyde (PFA) for 40 minutes at 
room temp. After incubation the cells were washed with 2 ml R1H medium and 
spun down at 2500 rpm for 5 minutes. After this final spin the cells were 
resuspended in 500 μl of a filter sterilized buffer consisting of 500 ml of HBSS 
supplemented with 3% (15 ml) heat-inactivated FBS, 2.5 mM (1.25 ml of a 1 M 
solution) of CaCl2, and 0.02% (0.1 g) sodium azide (Flow/Facs Buffer). The cells 
were then analyzed via flow cytometry on a LSR Fortessa. All data were then 
analyzed in FlowJo software (version 10.1r5) and Microsoft Excel.  
4.3.10 Pseudovirus Propagation 
Pseudovirus was created using a copy of the HIV-1 backbone plasmid 
pNL4.3-∆E-EGFP (NIH AIDS Reagent Program, Bethesda, MD) and a copy of the 
envelopes HXB2 and a previously identified Transmitted Founder envelope (T/F) 
(NIH AIDS Reagent Program Reagent p1012.TC21.3257). The HIV-1 backbone 
plasmid and one of the envelope plasmids were co-transfected into HEK 293 cells 
(ATCC, Manassas, VA). Pseudovirus produced will be in the supernatant, 
therefore the supernatant was harvested and kept at -80ºC until use. 
4.3.11 Pseudovius Infections 
Pseudovirus (PSV) with either HXB2 (X4 Virus) or T/F (R5 Virus) envelopes 
were used in transmission studies. Immediately after a 4 h 25% semen exposure 
each transwell insert was removed. In the exposed basolateral chamber 600 μl of 
diluted PSV of either envelope (1:10 for X4 envelope PSV and 1:4 for R5 envelope 
PSV) type was added, but no more than one type per well. The infection took place 
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for 4 h. After 4 h the samples were collected and spun down at 2500 rpm for 5 
minutes. The supernatant was discarded and the cells were resuspended in 500 
μl of R1H medium. They were then placed back in the 37ºC incubator + 5% CO2 
for 48 h. After such time the samples were spun down at 2500 rpm for 5 minutes. 
With the supernatant discarded, the PBMCs were then resuspended in R1H 
medium for staining. 5 μl of anti-CD4 conjugated to APC (eBioscience, San Diego, 
CA) and 3 μl of anti-CD3 conjugated to APC-Cy7 (BioLgened, San Diego, CA) was 
added to each tube. After incubating for 40 minutes, a Live/Dead stain conjugated 
to BV 521 (eBioscience, San Diego, CA) was added and the tubes re-incubated 
for another 15 minutes. After such time, the tubes were washed with 2 ml R1H 
medium and spun down at 2500 rpm for 5 minutes. The PBMCs were then 
resuspended in 500 μl of 1% PFA for 40 minutes. After incubation the cells were 
washed and spun down as noted before and resuspended in 500 μl of Flow/Facs 
Buffer and immediately assayed on a LSR Fortessa flow cytometer. All data were 
analyzed in FlowJo software and Microsoft Excel. 
4.3.12 Statistical analyses 
p-Values were calculated for the difference between pairs of treatments 
conditions using a two-tailed Student’s t-test, and a value of less than 0.05 was 
the limit for statistical significance. p-Values are indicated on the figures and 
within the figure legends. 
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4.4 Results 
4.4.1 Semen initiated a pro-inflammatory environment from ECT1 cells 
 Our purpose was to introduce subepithelial immune cell populations into our 
transwell model of the FRT for the purpose of examining the combined responses 
of epithelial keratinocytes and immune cells to the apical application of semen. In 
these first experiments we examined the output of soluble immunomodulatory 
factors in the basolateral chamber after application of semen. After semen 
exposure basolateral chambers from transwells were collected and assayed for a 
panel of 12 pro-inflammatory cytokines. The concentrations were then expressed 
as a fold-change over mock conditions, which were wells that were not apically 
exposed to semen. These data served as a base line for the effect of semen on 
ECT1 cells so when PBMCs are incorporated into the system the combined effect 
can be further evaluated. 
 Semen elicited a pro-inflammatory response, which included release of 
select pro-inflammatory cytokines TNF-α, interleukin 1 beta (IL-1β), interleukin 6 
(IL-6), interleukin 12 (IL-12), interleukin 17A (IL-17A), interleukin 8 (IL-8), monocyte 
chemoattractant protein 1 (MCP-1), regulated on activation normal T cell 
expressed and secreted (RANTES), macrophage inflammatory protein 1 alpha 
and 1 beta (MIP-1 α and MIP-1β), macrophage derived chemokine (MDC), and 
Eotaxin (Fig. 4.1). Most of the cytokines had about a 1-fold change increase in 
concentration over mock conditions (Fig. 4.1A). IL-8 concentration had about a 3-
fold increase over mock, which was the largest change in concentration (Fig. 4.1A). 
The next largest fold-change in concentration came from Eotaxin and MCP-1 with 
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1.19- and 1.15-fold change over mock, respectively. IL-17A had the lowest 
concentration with a 0.89-fold change over mock. Therefore, almost every analyte, 
with the exception of IL-8, was in the range of about 0.9-1.2-fold change over mock. 
These data suggest that exposure to semen to ECT1 cells elicited a pro-
inflammatory environment in the basolateral chamber that was replete with 
chemokines and chemoattractant factors. 
4.4.2 PBMCs co-cultured with ECT1 cells attenuated inflammation to a higher 
degree 
 To establish a baseline for the effect PBMCs had on immunomodulatory 
factor release from the ECT1 epithelium we co-cultured primary human immune 
cells in the basolateral chamber of transwells that had ECT1 cells grown as a 
polarized monolayer on the mesh insert. Fresh PBMCs were first grown overnight 
in media containing additional interleukin 2 (IL-2) to ensure the survival of T 
lymphocytes. The next day the PBMCs were seeded into the basolateral chambers 
of some transwells. Some wells were devoid of PBMCs to serve as a mock, termed 
control wells. After a 4 h co-culture the basolateral chamber was collected and the 
supernatants were assayed for the panel of 12 cytokines. These data represent 
the cross-talk between peripheral blood cells and the ECT1 epithelium, which will 
act a baseline for the next set of experiments. All concentrations are expressed as 
a fold-change of PBMC exposed wells over control wells. 
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Figure 4.1A 
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Figure 4.1B 
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Figure 4.1C 
 
 
 
 
 
 
 
 
 
 
 
  
  
	
91 
Figure 4.1D 
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Figure 4.1E 
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Figure 4.1F 
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Fig. 4.1. The ectocervical epithelium releases soluble immunomodulatory 
factors basolaterally in response to 25% semen and PBMCs treatment. 
Changes in factor concentrations in the basolateral chambers are shown as a heat 
map of fold-change over conditions of 12 analytes detected in conditioned media 
collected from the basolateral supernatants at 4 h after epithelial exposure to either 
(A) 25% semen, (C) PBMCs, or (E) both together. (B) Analytes released 
basolaterally in response to 25% semen were predominated by IL-8. (D) Analytes 
released basolaterally in response to co-culture with PBMCs included the pro-
inflammatory cytokines TNF-α, MCP-1, RANTES, and MIP-1α. (F) After 4 h 
epithelial exposure to both 25% semen and PBMCs analyte concentrations of 
TNF-α and MIP-1α were reduced, however RANTES concentration was slightly 
increased. Semen had a focused, direct effect of these analytes when compared 
to PBMCs alone. 
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 When PBMCs were co-cultured with the ECT1 epithelium, every analyte 
was increased by at least 1.5-fold (Fig. 4.1E). On the lower end of modulation, IL-
12, IL-17A, MIP-1β, and Eotaxin were present with 1.95-, 1.44-, 1.93-, and 1.74-
fold changes over control wells (Fig. 4.1E). IL-17A, again, had the lowest fold-
change over mock conditions like it did during the semen only experiments. The 
slight increase in IL-12 concentration may account for the reason why there was a 
9.62-fold increase over control wells in TNF-α concentration (Fig. 4.1E). IL-12 is 
an inducer of TNF-α from T cells to further extend inflammation [134] and like IL-
12, IL-17A regulates IL-6 expression from T cells [104]. Perhaps the 1.44-fold 
change over control wells in IL-17A could explain the almost 3.5-fold increase over 
control wells in IL-6 (Fig. 4.1C).  
 Interestingly, MIP-1β was increased in concentration about 2.0-fold over 
control wells (Fig. 4.1C). However, MIP-1β is one form of macrophage 
inflammatory protein, with the other being MIP-1α. MIP-1α, in this experiment, had 
a large increase in concentration over control wells with close to a 12-fold increase 
(Fig. 4.1C). Both forms of macrophage inflammatory protein induce the release of 
TNF-α and IL-6, which, again, may explain their increased concentrations.  
 Of note, there was a greater than 25-fold increase in MCP-1 concentration 
over control wells (Fig. 4.1C). However, the largest fold-change over control wells 
was IL-8 with about a 58-fold increase (Fig. 4.1C).  
 Looking at the data as a whole, ECT1 cells, and the peripheral blood cells 
they were co-cultured with, generated a very pro-inflammatory environment replete 
with large increases in factor concentrations involved in cellular recruitment.  
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 4.4.3 Semen exposure further increased MCP-1, RANTES, and MIP-1β 
concentrations in transwells of ECT1 cells co-cultured with PBMCs 
 The macrophage inflammatory proteins highlight the fact that immune cell 
released factors, like MIP-1α and MIP-1β, recycle back to other peripheral blood 
cells to induce the release of other cytokines. These released cytokines further 
interact with other peripheral blood cells as well as the ECT1 epithelium to induce 
the release of more chemokines. Therefore, establishing the baseline of the 
interplay between PBMCs and ECT1 cells was paramount to identifying semen-
specific changes during co-culture of PBMCs and semen exposure. Our purpose 
with these set of data was to identify what factors are released from the ECT1 
epithelium, above and beyond what is normally released due to the interplay of 
peripheral blood cells and ECT1 cells. This data informed on how semen 
modulates an already pro-inflammatory environment. 
 Transwells containing confluent monolayers of ECT1 cells grown on the 
mesh insert were basolaterally supplemented with IL-2 treated PBMCs just before 
semen exposure as in the other experiment. However, in this case some wells 
were apically exposed to semen. After 4 h, basolateral chambers from all 
transwells were collected and the supernatant was assayed for cytokine 
concentration changes between variables. Cytokine concentrations are expressed 
as fold-changes of semen exposed wells over mock, termed non-semen exposed 
wells. 
 As with the other conditions, IL-8 had the largest increase in concentration 
with almost a 5-fold change over non-semen exposed wells (Fig. 4.1E). This was 
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in addition the large, 58-fold change over control wells associated with just PBMCs 
alone (Fig. 4.1C). Indeed, the fold-changes of analytes in this experiment (Fig. 
4.1E) are all in addition to the fold-changes obtained when peripheral blood cells 
are co-cultured with just ECT1 cells alone (Fig. 4.1C).  
 Therefore, analytes like TNF-α, IL-1b, IL-6, IL-12, IL-17A, MIP-1α, and 
Eotaxin all had about the same concentration in semen exposed co-cultured wells 
as they did in non-semen exposed co-cultured wells with fold-changes of 0.29-, 
0.47-, 0.25-, 0.11-, 0.12-, 0.05-, and 0.25-fold changes over non-semen exposed 
wells, respectively (Fig. 4.1E). Semen did not further increase their release from 
either the epithelium or immune cells. However, TNF-α, IL-1b, IL-6, and MIP-1α 
are already increased 9.62-, 5.92-, 3.56-, and 12.19-fold over control wells (Fig. 
4.1C). Thus, even though the analyte concentrations did not seem to be further 
enhanced by semen exposure their relative concentrations were already high due 
to the co-culture of PBMCs and ECT1 cells. α 
 MCP-1, RANTES, and MIP-1Β all had further increases due to semen with 
1.14-, 1.19-, and 1.54-fold changes over non-semen exposed wells (Fig. 4.1E). 
MCP-1, when measured against its concentration at base level, was still over 25-
fold increased due to semen (Figs. 1B and 1C). RANTES and MIP-1β, when 
examined in the same way, were now at 6- and 3.5-fold higher concentrations 
(Figs. 1B and 1C). Therefore, semen increased MCP-1, RANTES, and MIP-1β 
release from either the ECT1 epithelium or PBMCs co-cultured with the epithelium. 
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4.4.4 Semen exposed or non-semen exposed CD3+CD4+ T cells co-
cultured with ECT1 cells do not differ in relative abundance or CD4 
surface expression 
Our first purpose was to identify what type of cytokines were produced from ECT1 
cells co-cultured with PBMCs during semen exposure. In doing so we identified 
key cytokines that may further modulate the peripheral blood cells. Therefore, the 
next set of experiments were aimed at identifying if these cytokines had a lasting 
impact on HIV-1 target cells in such a way that would favor the infection of either 
HIV-1 tropic viruses over the other. In order to obtain these data PBMCs co-
cultured with ECT1 cells either exposed to semen or not were harvested. The 
peripheral blood cells were then stained with antibodies for CD3, CD4, CCR5, and 
CXCR4 conjugated to fluorochromes. Using flow cytometry, the cells were 
assayed for relative cell numbers and surface expression of each co-receptor. Our 
thought process is that the cytokine environment will have lasting impacts on co-
receptor availability, which will have direct implications on infection by R5- or X4-
tropic viruses. 
The first step in this process was to evaluate if the ECT1 epithelium and cytokine 
environment affected CD3+CD4+ T cells. If CD3+CD4+ T cells were diminished in 
these conditions, then both HIV-1 tropic strains would have an equally harder 
chance at initiating infection due to either the reduced cell numbers of CD3+CD4+ 
T cells or the reduced surface expression of CD4. In order to justify the effect of 
the ECT1 epithelium in the absence of semen, PBMCs grown overnight with IL-2 
supplemented media were assayed as well, termed input cells. These data will 
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provide a background for any effect the ECT1 epithelium has on peripheral blood 
cells it is co-cultured with. 
CD3+CD4+ T cells comprised 47.75% of all lymphocytes found in input cells (Fig. 
4.2B). When compared to PBMCs co-cultured with ECT1 cells, the relative 
abundances of the total lymphocyte populations were comparable (Fig. 4.2B). 
CD3+CD4+ T cells co-cultured without semen comprised 43.63% of total 
lymphocytes and CD3+CD4+ T cells co-cultured with ECT1 wells exposed to 
semen comprised 40.18% of total lymphocytes (Fig. 4.2B). Therefore, the ECT1 
epithelium and semen exposure had no effect on the abundance of CD3+CD4+ T 
cells found in the total lymphocyte population.  
Indeed, the populations of CD3+CD4+ T cells in each condition, when overlaid on 
one another on a histogram, show no changes (Fig. 4.2C). Surface expression of 
CD4 on input CD3+CD4+ T cells, ECT1 co-cultured CD3+CD4+ T cells, and semen 
exposed ECT1 co-cultured CD3+CD4+ T cells were not statistically different from 
one another (Fig. 4.2D)  
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Figure 4.2A 
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Figure 4.2B 
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Figure 4.2C 
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Figure 4.2D 
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Fig. 4.2. Semen does not affect CD3+CD4+ T cells.  
(A) PBMCs from transwells were collected at 4 h from the basolateral chambers 
from mock and semen wells. The number of CD3+CD4+ T cells is expressed as a 
percentage of the total Lymphocyte population found in the harvested PBMCs. (B) 
Co-culturing of CD3+CD4+ T cells with the ECT1 epithelium did not change the 
population of CD3+CD4+ T cells. (C) and (D) There were no population shifts in 
CD3+CD4+ T cells during any condition and the surface expression density of CD4 
did not change when semen was applied to the system. MFI is median 
fluorescence intensity; blue is mock treated, red is semen treated, and gray is 
PBMCs alone without co-culture. 
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These data suggested that CD3+CD4+ T cells in each condition were not affected 
by culturing conditions. 
 
4.4.5 Semen elicits a protective effect on CD3+CD4+CCR5+ T cells co-cultured 
with ECT1 cells 
Because CD3+CD4+ T cells remain constant in each culturing condition, scrutiny 
falls to the HIV-1 co-receptors. Further classifying CD3+CD4+ T cells into 
CD3+CD4+CCR5+ T cells and measuring relative abundance of CD3+CD4+CCR5+ 
T cells out of the parent CD3+CD4+ T cells provided key insight on how semen 
modulated immune cells in the subepithelium. Surface expression of CCR5 plays 
a role in HIV-1 infection and was also evaluated for potential differences due to 
semen. 
CD3+CD4+CCR5+ T cells were only 1.85% of the total CD3+CD4+ T cell population 
in input cells (Fig. 4.3B). This population reduced 25.4-fold when CD3+CD4+CCR5+ 
T cells were co-cultured with ECT1 cells (Fig. 4.3B). Co-culture of 
CD3+CD4+CCR5+ T cells with the ECT1 epithelium significantly reduced their 
abundance by 1.78% (Fig. 4.3B). However, when CD3+CD4+CCR5+ T cells co-
cultured with ECT1 cells were exposed to semen, the percent of CD3+CD4+ T cells 
that were positive for CCR5 increased 13.7-fold (Fig. 4.3B). Indeed, analysis via 
histogram showed a dramatic decrease in the CD3+CD4+CCR5+ T cell population 
when co-cultured with ECT1 cells versus input cells (Fig. 4.3C). This reduction was 
seen to be partially abrogated by the addition of semen (Fig. 4.3C).  
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Figure 4.3A 
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Figure 4.3B 
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Figure 4.3C 
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Figure 4.3D 
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Fig. 4.3. Semen prevents the reduction of CD3+CD4+CCR5+ T cells.  
(A) PBMCs were collected from the basolateral chamber of transwells at 4 h post 
25% semen exposure from mock and semen wells. The number of 
CD3+CD4+CCR5+ T cells is expressed as a percentage of the total CD3+CD4+ T 
cells population. (B) Co-culturing of CD3+CD4+CCR5+ T cells with the ECT1 
epithelium reduced the population of CD3+CD4+CCR5+ T cells. (C) and (D) The 
surface expression density of CCR5 increased when in the presence of the semen. 
* is p<0.05; ** is p<0.005; MFI is median fluorescence intensity; blue is mock 
treated and red is semen treated.  
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Interestingly, the cell surface expression of CCR5 on CD3+CD4+CCR5+ T cells co-
cultured with ECT1 cells was significantly higher when the cells were exposed to 
semen (Fig. 4.3D). Therefore, despite the severe reduction in population 
percentages, CD3+CD4+CCR5+ T cells co-cultured with the ECT1 epithelium had 
more CCR5 receptors abundant (Fig. 4.3D) and increased in population (Fig. 
4.5B). Taken together, semen elicits a protective effect on CD3+CD4+CCR5+ T 
cells and increases the surface density of CCR5 on said cells. 
 
4.4.6 Surface expression of CXCR4 on CD3+CD4+CXCR4+ T cells co-cultured 
with ECT1 cells is reduced 
The next set of experiments explored if semen modulated CXCR4 on 
CD3+CD4+CXCR4+ T cells co-cultured with ECT1 cells. These data, when 
conferred with the CCR5 data, provided insight into how, and if, semen 
differentially altered surface expression of HIV-1 co-receptors.  
CD3+CD4+CXCR4+ T cells comprised 87.5% of CD3+CD4+ T cells in input cells 
and when co-cultured with the ECT1 epithelium the population of 
CD3+CD4+CXCR4+ T cells out of the total CD3+CD4+ T cells did not change, even 
in the presence of semen (Figs. 4.4B and 4.4C). In fact, the only change in CXCR4 
that was evident was surface expression (Fig. 4.4D). The surface expression of 
CXCR4 on CD3+CD4+CXCR4+ T cells from input cells was significantly higher than 
when CD3+CD4+CXCR4+ T cells are co-cultured with the ECT1 epithelium, with or 
without semen (Fig. 4.4D). Therefore, semen did not enhance, or reduce, CXCR4 
surface expression. 
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Figure 4.4B 
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Figure 4.4C 
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Figure 4.4C 
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Figure 4.4D 
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Fig. 4.4. CD3+CD4+CXCR4+ T cells remain unchanged in the presence of 
semen.  
(A) PBMCs were collected from the basolateral chamber of transwells at 4 h 
post 25% semen exposure from mock and semen wells. The number of 
CD3+CD4+CXCR4+ T cells is expressed as a percentage of the total CD3+CD4+ 
T cells population. (B) Co-culturing of CXCR4+ T cells with the ECT1 
epithelium, with or without 25% semen, did not reduce the population of 
CD3+CD4+CXCR4+ T cells. (C) and (D) The surface expression density of 
CXCR4 decreases when in the presence of the epithelium, by itself, and when 
25% semen is applied to the system. * is p<0.05; MFI median fluorescence 
intensity; blue is mock treated and red is semen treated. 
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4.4.7 Semen increased infections by R5-tropic viruses by 24.5% when 
CD3+CD4+ T cells were co-cultured with ECT1 cells 
Our original purpose of elucidating how semen modulates the immune response 
by ECT1 cells co-cultured with CD3+CD4+ T cells and what downstream, lasting 
effects this may have on HIV-1 co-receptors led to identification that semen had a 
protective effect on CD3+CD4+CCR5+ T cells. This effect was not evident with 
CD3+CD4+CXCR4+ T cells and, in fact, semen did not appear to alter populations 
of CD3+CD4+CXCR4+ T cells nor surface expression of CXCR4.  
These data suggest semen has an indirect effect on CCR5 and not CXCR4. In 
order to elucidate if this effect translates to an increase in R5-tropic infection of 
CD3+CD4+ T cells an infection assay was performed. Peripheral blood cells co-
cultured with ECT1 cells were subject to semen exposure and then immediately 
collected and challenged with an HIV-1-tropic specific pseudovirus. The 
pseuodvirus used in this study was created using the HIV-1 genome, except a 
reporter enhanced green fluorescent protein (eGFP) gene was cloned in the 
middle of the envelope gene. Because of this, when the virus entered and infected 
a CD3+CD4+ T cells it couldn’t have undergone a second round of infection due to 
the fact that an envelope protein was not able to be made and thus prevented the 
viruses from re-packaging and leaving the cell. Instead of an envelope, eGFP was 
created and was used as a marker for infection. Therefore, all CD3+CD4+eGFP+ T 
cells are cells that were infected. These data elucidated if semen exposure to 
CD3+CD4+ T cells co-cultured with ECT1 cells skewed infection in favor of one 
HIV-1 tropic strain over the other.  
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In the absence of semen 13.7% of CD3+CD4+ T cells were infected by R5-tropic 
viruses and 26.1% of CD3+CD4+ T cells were infected by X4-tropic viruses (Fig. 
4.5A). However, in the presence of semen 38.2% and 32.6% of CD3+CD4+ T cells 
were infected by R5- and X4-tropic viruses, respectively (Fig. 4.5A). Semen 
enhanced R5-tropic infections by 24.5% and X4-tropic infections by 6.5% (Fig. 
4.5A).  
Furthermore, the level of eGFP expression correlated to long terminal 
repeat activity, which, by extension, is a measure of viral gene expression. 
Therefore, in the absence of semen CD3+CD4+ T cells infected with X4-tropic virus 
had 23.8% more viral gene expression than CD3+CD4+ T cells infected with R5-
tropic viruses. However, in the presence of semen viral gene expression was 
enhanced in CD3+CD4+ T cells infected by R5-tropic viruses and decreased in 
CD3+CD4+ T cells infected by X4-tropic viruses (Fig. 4.5B). Indeed, semen 
enhanced viral gene expression by 9.56% in CD3+CD4+ T cells infected by R5-
tropic viruses (Fig. 4.5B).  
When CD3+CD4+ T cells were co-cultured with ECT1 cells and exposed to 
semen, R5- and X4-tropic infections were increased. Semen elicited an effect 
through the ECT1 epithelium that modulated infection in the basolateral chamber. 
Semen also transduced its effect through the epithelium to increase viral gene 
expression in R5-tropic infections and decrease viral gene expression in X4-tropic 
infections.  
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Figure 4.5A 
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Figure 4.5B 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
	
121 
Fig. 4.5. R5-tropic infections are increased in the presence of semen.  
(A) PBMCs from mock and semen exposed wells were collected 4 h after 25% 
exposure and immediately challenged with either a R5- or X4-tropic 
pseudovirus infection for 4 h. The cells were then washed and given 48 h 
recovery. The number of cells infected is expressed as a percent of total 
CD3+CD4+ T cells. (B) Viral gene expression can be expressed as a function 
of GFP median fluorescence intensity because GFP was in place of an 
envelope protein. Viral gene expression was increased in R5-tropic viruses 
when exposed to semen, but decreased in X4-tropic viruses, when exposed to 
semen. MFI is median fluorescence intensity. 
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4.5 Discussion 
The cytokine data generated here used a transwell culture system to 
recapitulate early aspects in HIV-1 infection from male-to-female. Apical exposure 
to semen in this system allowed for the direct manipulation and sampling of both 
the apical and basolateral chambers. When assayed for cytokine content it was 
found that semen, alone, elicited a robust response from the ECT1 epithelium. 
These data are supported by other studies involved in cytokine profiling of the FRT 
[84] (Appendix Chapter 2). Indeed, release of factors like TNF-α and IL-6 from the 
epithelium promote a pro-inflammatory environment. Again, the release of these 
factors falls in line with the inflammation first associated with semen deposition in 
the FRT [29].  
However, in in vivo conditions the pro-inflammatory response is not 
mediated by semen alone, but by the interaction between the exposed epithelium 
and the immune cells present at the time [102-104]. The ectocervix has the highest 
concentration of immune cells in the subepithelial space of any other portion of the 
FRT and therefore, the response of the immune cells will drive inflammation due 
to semen exposure [102]. In order to take the in vitro system one step closer to 
being more physiological PBMCs were co-cultured in the basolateral chamber to 
ECT1 epithelia grown on the mesh insert. In this respect, the interplay between 
peripheral blood cells and the epithelium were elucidated and served as the basis 
for any effects semen had on the epithelium, when co-cultured with PBMCs. 
Indeed, when co-cultured with ECT1 cells, in the absence of semen, the immune 
environment in the basolateral chamber was pro-inflammatory in nature with some 
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analytes, like IL-8 and MCP-1, reaching concentrations up to 58- and 25-fold 
higher than when PBMCs were absent. TNF-α was almost 10-fold higher in wells 
that contained PBMCs versus those that did not have PBCMCs. Therefore, the 
subepithelial space is in constant flux [102, 103] due to the recruitment of fresh 
immune cells by chemokines like MDC, MIP-1α, and RANTES, which were all 
further concentrated in wells that contained PBMCs versus those that did not.  
Therefore, apical exposure to semen would give insight to how semen may 
modulate the immune response that was being produced by the peripheral blood 
cells at constitutive levels. Interestingly, semen had little effect on the release of 
factors when semen exposed and non-semen exposed basolateral supernatants 
were compared. Indeed, cytokines released from immune cells, such as IL-12, had 
a small fold-change in semen exposed wells from non-semen exposed wells. 
Cytokines involved in immune cell recruitment, such as IL-8, MCP-1, RANTES, 
and MIP-1β were all increased due to semen exposure. However, it is important to 
note that where MCP-1 had a 1.14-fold increase in semen exposed wells versus 
non-semen exposed wells the non-semen exposed wells saw a 25-fold increase. 
Therefore, cytokines, like MCP-1, compound on their previous fold-changes to 
bring about a 26.14-fold change in concentration. However, despite the large 
increases in concentrations caused by the interaction of PBMCs and the ECT1 
cells, semen only increases chemokines associated with recruitment.  
 The recruitment of peripheral blood cells to the ectocervix, especially CD4+ 
T cells increases the number of targets for HIV-1 to infect. In this in vitro system, 
though, CD3+CD4+ T cells were not increased due to semen exposure. Of course, 
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this system is closed and the recruitment of cells can not be measured because 
the basolateral chamber does not have the capacity for exposure and recruitment 
at the same time. CD3+CD4+CXCR4+ T cells also remained constant in the 
presence of semen. Indeed, the only T cell subset that diminished in this study 
were CD3+CD4+CCR5+ T cells.  
By co-culturing CD3+CD4+CCR5+ T cells with the ECT1 epithelium there 
was a significant reduction in the number of CD3+CD4+CCR5+ T cells out of the 
total CD3+CD4+ T cells population. Perhaps the fact that MIP-1α, MIP-1β, and 
RANTES were all increased to higher levels during the co-culture of 
CD3+CD4+CCR5+ T cells and ECT1 cells could explain the loss in 
CD3+CD4+CCR5+ T cells. MIP-1α, MIP-1β, and RANTES are all ligands of CCR5 
[135-138], and being high in concentration they may have preferentially been 
bound to the receptor. However, the surface expression of CCR5 on 
CD3+CD4+CCR5+ T cells did not decrease in any condition, in fact surface 
expression increased on CD3+CD4+CCR5+ T cells collected from semen exposed 
wells. The surface expression was significantly higher in this condition than in the 
others. Previous studies have shown that interferon alpha (IFN-a) was highly 
upregulated in ECT1 cells due to semen exposure (Appendix Chapter 2). Perhaps 
the increased levels of IFN-a are the cause for the increase in surface expression 
of CCR5 [139]. 
When semen is apically applied to the transwell the collected 
CD3+CD4+CCR5+ T cells comprised a higher percentage of the total CD3+CD4+ T 
cell population suggesting that semen elicits a protective effect of 
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CD3+CD4+CCR5+ T cells, while increasing surface expression of CCR5. This effect 
may be due to a factor released from the epithelium in response to semen 
exposure. 
Co-culturing CD3+CD4+ T cells with the ECT1 epithelium also had 
deleterious effects on CXCR4 surface expression. In the absence or presence of 
semen, surface expression of CXCR4 was significantly lower than CD3+CD4+ T 
cells that were not exposed to the epithelium, at all. Despite the surface expression 
of CXCR4 being slightly lowered when co-cultured with the ECT1 epithelium there 
were still more CD3+CD4+CXCR4+ T cells represented than CD3+CD4+CCR5+ T 
cells in the total CD3+CD4+ T cell population. CD3+CD4+CXCR4+ T cells comprise 
almost 90% of the CD3+CD4+ T cell population, compared to the 1% of the 
population that is CD3+CD4+CCR5+. This may be due to the overnight IL-2 
stimulation. A recent study determined that CCR5 is slowly increased when 
cultured with IL-2 versus the quick increase in CXCR4 [108]. CCR5 reached peak 
levels in a longer time in culture with IL-2, whereas CXCR4 was much earlier [108]. 
The two co-receptors are largely reciprocal and, generally, mutually exclusive 
[108]. Therefore, the difference in their representation in the total CD3+CD4+ T cell 
population may be due to the fact that they were stimulated with IL-2.  
Despite the fact that CD3+CD4+CCR5+ T cells are underrepresented, over 
38% of the population from semen exposed well was infected with a R5-tropic 
pseudovirus, which was a 24.5% increase from non-semen exposed wells. 
CD3+CD4+CXCR4+ T cells infected with a X4-tropic pseudovirus were only 
increased by 6.5%. These results differ from the expectations inherent in the 
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bottleneck hypothesis, which has, at its core, the exclusive acquisition of a single 
R5-tropic founder virus [130, 132]. Indeed, we report here that X4-tropic 
pseuodviruses are able to infect CD3+CD4+ T cells to a comparable degree to R5-
tropic pseudoviruses. However, our model system was designed to assess if apical 
semen exposure could influence greater infection in peripheral blood cells in the 
basolateral compartment. Unlike what is seen in in vivo conditions, the virus was 
not mixed with semen and then apically applied [98]. Our system assumes that 
HIV-1 transverses across the FRT and is located in the basolateral compartment. 
And assuming that HIV-1 is across the epithelium we wanted to understand if 
semen could enhance infection by acting on the apical side of the epithelium.  
Indeed, these results suggest that semen enhances viral infection of 
immune cells. Perhaps one reason for this is due to semen-derived enhancer of 
virus infection (SEVI), which has been shown, in vitro, to increase HIV-1 infections 
[140-143]. However, SEVI is still debated as an effector of viral infection [140]. In 
studies using primary tissue SEVI was found to act differently than it did in in vitro 
models [140]. In primary tissues SEVI binds HIV-1 and sequesters it from the 
epithelium, preventing impactful penetration of the tissue [140]. Thus, SEVI 
restricts HIV-1 infection in primary tissues [140]. However, in culture systems SEVI 
greatly enhances HIV-1 infections [140, 143]. Again, HIV-1 pseudovirus was not 
added to the semen before apical exposure, so to what extent SEVI has on the 
basolateral compartment is unknown here. Perhaps SEVI can modulate CD4+ T 
cells from the luminal side of an epithelium, but that is just speculation.  
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Curiously, however, in the presence of semen viral gene expression was 
enhanced in R5-tropic viruses, suggesting that during initial HIV-1 infection viral 
fitness is increased. X4-tropic associated viral gene expression was decreased 
due to semen exposure, therefore semen may inadvertently reduce fitness of X4-
tropic viruses [144] due to some released factor from the epithelium or immune 
cells. In the bottleneck hypothesis infection is started by a R5-tropic virus, however 
there exists a small subset of infections that are initiated by X4-tropic viruses [130]. 
Perhaps both virus types are present in the subepithelium, but R5-tropic viruses 
become enhanced by semen, thus establishing infection quicker than X4-tropic 
viruses. Indeed, assuming both virus types are present in the subepithelium, this 
study reports that R5-tropic viruses will more easily enter and infect CD3+CD4+ T 
cells due to semen.  
This study took a simplistic approach to the very complex issue. However, 
the presence of semen on the apical side of an epithelium enhances R5-tropic 
infections to a greater degree than X4-tropic infections. Semen has even been 
shown to reduce X4 viral fitness by reducing the viral gene expression. Taken 
together, semen preferentially enhances R5-tropic infections in vitro. The 
bottleneck hypothesis is a series of checkpoints filtering out viruses until there is 
only a single isolate that initiates infection in the FRT [130, 132] and this study 
adds another clue as to why the interaction between the FRT and semen is the 
most stringent bottleneck. Future studies will need to address the limitations of an 
in vitro system.  
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5.1 Abstract 
 
The female reproductive tract (FRT) is comprised of three distinct anatomical 
regions. The epithelia in each region – the vagina, ectocervix, and endocervix – all 
respond to foreign stimuli differently, which may result in regional differences in the 
risk of pathogen infection. In the context of human immunodeficiency virus type 1 
(HIV-1) transmission, epithelial responses to foreign stimuli may alter the 
susceptibility of subepithelial immune cells to viral infection, particularly with 
respect to viral co-receptor-tropism. HIV-1 tropism plays a major role in male-to-
female HIV-1 transmission; R5 viruses (those that use CD4 and CCR5 for entry) 
are highly favored during heterosexual transmission over X4 viruses (viruses that 
use CD4 and CXCR4 for entry). Using three cell lines derived from the three 
regions of the FRT, we report that the differential response to semen by ECT1 cells 
favors R5 viral transmission of HIV-1 over X4, where VK2 and END1 cells favor 
X4 viral transmission of HIV-1. These data provide new insights into the underlying 
mechanisms of HIV-1 transmission and may point to new opportunities for 
preventing HIV-1 acquisition in women at risk for infection.  
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5.2 Introduction 
Although the introduction of semen into the female reproductive tract (FRT) 
is a key step in conception [114], semen is not just an inert vehicle for sperm 
delivery. Rather, semen is comprised of immunomodulatory factors, whole cells, 
sugars, and other factors [29]. These constituents modulate responses in the FRT 
that are critical for successful conception [29]. It is known that semen has a 
biphasic effect in the FRT, characterized by initial inflammation followed by 
changes that lead to immunological tolerance [5, 99]. In doing so, semen ensures 
the survival of sperm cells that would otherwise be targeted by the female immune 
system [9, 29]. Therefore, semen plays an integral part in not only in conveying 
sperm cells but also in the manipulation of immunological responses of the FRT 
[28, 84, 99]. 
The FRT functions as disparate regions [103, 104] that are separated into 
different regions: the vagina, the cervix, and the uterus. The vagina is the region 
closest to the outside of the body and is characterized by a multi-layered, 
squamous epithelium [104]. The cervix is divided into two separate regions: the 
ectocervix and the endocervix. The ectocervix is the lower portion of the cervix 
where the vaginal epithelium meets the cervical epithelium [104]. Both the vagina 
and the ectocervix have stratified, squamous epithelia that help protect the 
underlying tissue from pathogens and foreign antigens. In contrast to the vagina 
and ectocervix, the endocervix (the upper portion of the cervix) is thought of as a 
sterile environment [103]. Comprised of a single layer of columnar cells, the 
relatively thin epithelium of the endocervix may be a more likely site for a pathogen 
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to cross the epithelial barrier. However, the location of the endocervix reduces the 
probability that these tissues will be exposed to outside stimuli or pathogens [126]. 
The endocervix is also unique in that it has a layer of cervicovaginal mucus 
covering the luminal side of the epithelium. This mucus has been shown to “trap” 
particles and slow their progression of coming in contact with the epithelial barrier, 
and any immune cells that may be found interstitially in the barrier [145]. The 
mucus may also have some anti-human immunodeficiency virus type 1 (HIV-1) 
properties aside from physically slowing down the virus so it becomes sloughed 
off when the mucus is refreshed in the FRT [145, 146].  
Semen, which can also be considered a foreign stimulus, does not come in 
direct contact with the endocervix [9]. The vagina and, sometimes the ectocervix, 
are the primary regions that come in physical contact with semen. However, the 
presence of semen in the other portions of the FRT has consequences for the tract 
as a whole. Indeed, previous studies that characterized semen’s effect on the FRT 
have shown that each region acts differently when exposed to semen [29, 84, 95, 
99, 100, 103, 104, 106] (Appendix Chapters 1 and 2). When cell lines representing 
each region of the FRT were apically exposed to semen each cell line had a unique 
time-, direction-, and tissue-dependent release of immunomodulatory factors 
(Appendix Chapter 1). ECT1/E6E7 (ECT1) cell lines, representing the ectocervix, 
showed the largest response to semen exposure. The least responsive cell line 
was END1/E6E7 (END1), which represents the endocervix (Appendix Chapter 1). 
The ECT1 cell line having the largest response to foreign stimuli is due to the fact 
the ectocervix is also the transformation zone [29, 103]. This region is the portion 
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of the cervix where the squamous, stratified epithelium of the ectocervix transitions 
into the single columnar epithelium of the endocervix [103]. The transformation 
zone is viewed as the central hub for cell mediated immunity in the FRT due to the 
increased presence of subepithelilal antigen presenting cells (APCs), dendritic 
cells (DCs), monocytes, macrophages, and T lymphocytes as compared to the 
other regions [95, 102-104]. Indeed, the ectocervix contains a higher concentration 
of immune cells than the vagina, which, in turn, hosts a larger population of immune 
cells than the endocervix [102]. This may be due, in part, to the fact that the 
endocervix is located higher up in the FRT (more distal from the vaginal opening), 
which, again, makes it more sterile than the other regions that are routinely 
exposed to external antigens [102]. In fact, the ectocervix is suggested as a “hot-
spot” for HIV-1 transmission; however that does not preclude the other regions 
from supporting transmission [4, 5] (Appendix Chapter 1, Appendix Chapter 2). 
Immunomodulation by semen also appears to increase the risk of pathogen 
transmission [9, 29]. Semen has been shown to increase leukocyte recruitment to 
the site of deposition, which, again, is part of the biphasic effect of semen [28, 61, 
99, 106, 109, 127, 147]. The initial inflammation is replete with an influx of immune 
cells, many of which are CD4+ T lymphocytes, such as Th17 cells and T regulatory 
cells (Tregs) [5, 77, 109, 124]. In the case of human immunodeficiency virus type 
1 (HIV-1), the introduction of more T lymphocytes may increase the likelihood of 
HIV-1 transmission because of the increase in target cells. Furthermore, the 
resolution of the effect of semen – tolerance – may further increase the risk of HIV-
1 transmission [95, 126, 139, 147]. Tolerance in the FRT, due to semen, is 
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mediated by the recruitment of Tregs [5, 124, 125]. These Tregs will further 
dampen the immune response and induce a state that may be favorable to HIV-1 
transmission [103, 104]. Tregs produce high concentrations of transforming growth 
factor beta (TGF-ß) and interleukin 10 (IL-10), which will induce naïve T cells to 
differentiate into more Tregs, further enhancing Treg proliferation (Chapter 3).  
Just as important as available immune cells are to male-to-female HIV-1 
transmission so is viral tropism. HIV-1 tropism is defined by co-receptor usage 
during the initial steps of infection. R5 viruses enter cells via interactions with CD4 
and the chemokine receptor CCR5, while X4 viruses use CXCR4 as the co-
receptor. The bottleneck hypothesis of HIV-1 transmission attempts to explain the 
phenomenon that R5 viruses are almost exclusively transmitted between partners 
in heterosexual, discordant couples [130, 132]. During heterosexual transmission 
of HIV-1, R5 viruses are generally the transmitted/founder virus—the virus that 
initiates infection by draining to the lymph nodes [132]. That is not to say that X4 
viruses never initiate infection, it’s just more uncommon, which may be partly 
explained by the most stringent checkpoint in the bottleneck hypothesis—when 
semen comes in contact with the FRT [130] (Chapter 4). A recent finding by our 
group has shown that in the absence of semen X4 viruses were the most common 
virus to infect CD3+CD4+ T helper cells co-cultured with ECT1 cells (Chapter 4). 
However, when CD3+CD4+ T helper cells were co-cultured with ECT1 cells in the 
presence of semen, the bias toward R5 viruses was seen, which suggested that 
there was a factor (or more) released from the epithelium in response to semen 
that aided R5 viruses in entry and infection of target cells (Chapter 4).  
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The bottleneck hypothesis is not about a singular checkpoint that filters all 
viruses down to one specific genetic variant, but multiple checkpoints that filter out 
variants over the course of transmission. Because of this the most stringent 
bottleneck would be when semen comes in contact with the FRT [130, 132]. Once 
in contact the checkpoint becomes the female, who has defenses like 
cervicovaginal mucus. The mucus, for example, contains a myriad of factors, one 
of them being lectins—which may preferentially bind to heavy methylated HIV-1 
virions and, thus, prevent them from being passed on to the female [132, 146]. 
Therefore, each portion of the FRT could be a different filtering process that might 
leave one area, or more, as a place where R5 viruses are favored and, thus, 
promote R5 HIV-1 transmission. From previous work we have demonstrated that 
each region of the FRT responds differently to semen exposure with respect to 
immunomodulatory factor release, therefore each region of the FRT might serve 
as a different checkpoint for filtering out genetic variants (Appendix Chapter 1). 
The notion of each region acting independently of one another is not new. 
Previous studies of the FRT epithelial cells have used submerged cultures, 
in which representative cell lines are maintained on a flat surface. Unfortunately, 
this approach is not physiologically relevant since submerged cultures prevent the 
manipulation and scrutiny of the basolateral side of the cells. To circumvent this 
limitation, our previous studies used a transwell cell culture system (Appendix 
Chapter 1, Appendix Chapter 2) that allows for the polarized cell growth and 
independent manipulation of the apical and basolateral media [8, 148]. Using this 
transwell culture system, we demonstrated a time-dependent and polarized 
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release of cytokines from epithelilal cells of the FRT in as little as 4 h post semen 
exposure (Appendix Chapter 1). Indeed, ECT1 cells had the largest response to 
semen with cytokines like interleukin 12 (IL-12), interleukin 6 (IL-6), interleukin 7 
(IL-7), vascular endothelial growth factor (VEGF), and interleukin 2 receptor (IL-2r) 
all having concentrations increase greater than 10-fold change over non-semen 
exposed monolayers (Appendix Chapter 1). The next largest response came from 
VK2 cells exposed to semen, which displayed fewer cytokines that had a greater 
than 10-fold change over non-semen exposed monolayers (only IL-7 and 
interleukin 15 (IL-15)) (Appendix Chapter 1). The least responsive were END1 
cells, which had no cytokines reach a 10-fold change over non-semen exposed 
monolayers (Appendix Chapter 1).  
Identifying semen’s interaction with each cell line was only a starting point. 
Here we take the polarized FRT in vitro model system further by incorporating 
peripheral blood mononuclear cells (PBMCs) to assess how the interplay between 
epithelial cells and semen acting on the immune cells may modulate the immune 
environment in the subepithelial space. Once it was identified how semen changed 
the immune environment the next step was to elucidate if this effect by semen 
further modulated the PBMCs co-cultured with each cell line to either be more or 
less susceptible to infection by R5 or X4 HIV-1 pseudovirus. Our findings suggest 
that the pro-inflammatory environment induced by semen exposure had an effect 
that increased infection of X4 pseuodviruses in PBMCs co-cultured with each cell 
type. However, semen exposure only increased R5 infections in CD3+CD4+ T 
helper cells co-cultured with ECT1 cells, while decreasing R5 infections in 
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CD3+CD4+ T helper cells cultured with VK2 or END1 cell lines. Therefore, semen 
transduces its effect through each epithelium to produce disparate outcomes in 
each cell line, thus in each region of the FRT. These effects may contribute to 
establishing preferred sites of HIV-1 transmission and to the apparent transmission 
bottleneck.   
 
 
5.3 Materials and Methods 
5.3.1 Cell line maintenance 
Experiments were performed using cell lines derived from three regions of 
the human female reproductive tract: vaginal keratinocytes (VK2/E6E7), 
ectocervical cells (ECT1/E6E7), and endocervical cells (END1/E6E7) [133] . Each 
cell line was retained in T150 tissue culture flasks (Grenier Bio One, Monroe, NC) 
at 37°C with 5% CO2. All cell lines were cultured using Keratinocyte Serum-Free 
Medium (Gibco, Grand Island, NY), with the added supplements of 50 μg/ml bovine 
pituitary extract (BPE), 0.1 ng/ml epithelial growth factor (EGF), 50X 
penicillin/streptomycin solution, and 0.4 mM calcium chloride (EMD Millipore, 
Billerica, MA).  
5.3.2 Transwell culture system 
Confluent, polarized monolayers of each cell line were cultured by seeding 
into the apical chamber of a 6.5 mm, 0.4 μm pore size, polyester transwell insert 
in a 24-well receiver plate (Corning, Corning, NY). Cells were seeded in the apical 
chamber at a density of 1.5 x 105 cells in 200 μl. Media, in a volume of 600 μl, was 
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aliquoted in the basolateral chamber. Time to confluence varied between 14 and 
17 days post-seeding and was measured by transepithelial electrical resistance 
(TEER). TEER readings were taken every other day to moniter the growth and 
potential use of the transwell plate. 
5.3.3 Semen 
Semen from more than 3 healthy donors between the ages of 26 and 34 
years was pooled and purchased in 20 ml volumes (Lee Biosolutions, St. Louis, 
MO). Samples were shipped overnight on ice and immediately separated into 500 
μl aliquots and frozen at -20°C upon arrival. In all descriptions, semen refers to 
whole, unfractionated semen. 
5.3.4 Peripheral Blood Mononuclear Cells (PBMCs) 
PBMCs were obtained from the Comprehensive NeuroAIDS Center 
(CNAC) Mammalian Cell and Virus Core cohort at Temple University. PBMCs were 
then cultured overnight in RPM1-1640 supplemented with 2% (10 ml) heat-
inactivated FBS and 1% (5 ml) HEPES (R1H medium). Interleukin 2 (10 U/ml) was 
added to the medium for overnight activation and to ensure T lymphocyte survival. 
After 16-18 h incubation the cells were then spun down at 2500 rpm for 5 minutes. 
Cells were then resuspended in the appropriate amount of R1H to reach a 
concentration of 1 x 106 cells/ml. Unless stated otherwise, PBMCs were seeded at 
1 x 106 cells/ml. 
5.3.5 Collection of conditioned media 
Transwells containing confluent cell line monolayers were washed twice 
with HBSS. For some wells, the basolateral chamber was then supplemented with 
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600 μl of 1 million IL-2-activated PBMCs. For other wells, PBMCs were not added. 
The apical chambers were then supplemented with 25% semen in duplicate for 4 
h for all wells, in the absence or presence of PBMCs. After 4 h, basolateral media 
containing PBMCs were collected and spun down at 2500 rpm for 5 minutes. The 
supernatant was collected and stored at -80°C. For wells not containing PBMCs, 
the supernatants was collected immediately after 4 h apical exposure to 25% 
semen. The PBMCs were kept for further analyses (see below). Wells with just the 
cell line monolayers and without 25% semen or PBMCs were designated mock 
wells, while wells with the cell monolayers and PBMCs, but without 25% semen 
were termed PBMCs. Wells with the cell line monolayers, PBMCs, and 25% semen 
were designated semen. 
5.3.6 ELISArray 
The collected supernatants were analyzed by the Qiagen Human TLR-
induced Cytokines II: Microbial-induced Multi-Analyte ELISArray assay (Qiagen, 
Maryland). Conditioned media samples were analyzed as directed by the 
manufacturer’s instructions. The results were analyzed in Microsoft Excel. 
5.3.7 Flow Cytometry 
PBMCs collected from each transwell exposed apically to 25% semen were 
pelleted to separate cells from conditioned media. The cells were then 
resuspended in R1H medium for antibody staining and flow cytometry. Anti-CCR5 
antibody conjugated to PE (5 μl) (eBioscience, San Diego, CA) was applied first 
and alone. The antibody was left to incubate for 45 minutes at room temperature 
(25 ºC). The cells were then washed with 2 ml of R1H and pelleted at 2500 rpm for 
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5 minutes. The PBMCs were then resuspended in a volume of R1H medium for 
further staining. Anti-CD4 antibody (5 μl) conjugated to APC (eBioscience, San 
Diego, CA), 5 μl of anti-CXCR4 antibody conjugated to BV 421 (BioLegend, San 
Diego, CA), and 3 μl of anti-CD3 antibody conjugated to APC-Cy7 (BioLegend, 
San Diego, CA) were then added to each tube. The antibodies were left to incubate 
for 40 minutes at 4ºC. After 40 minutes, 1 μl of a Live/Dead stain, conjugated to 
BV 510 (AmCyan or Aqua) (eBioscience, San Diego, CA) was added to each tube. 
The final solution was incubated at 4 ºC for another 15 minutes. After the final 
incubation, the PBMCs were washed with 2 ml R1H medium and pelleted at 2500 
rpm for 5 minutes. The cells were then resuspended in 500 μl of 1% 
paraformaldehyde (PFA) for 40 minutes at room temp. After incubation, the cells 
were washed with 2 ml R1H medium, pelleted at 2500 rpm for 5 minutes, and then 
resuspended in 500 μl of a filter-sterilized buffer consisting of 500 ml of HBSS 
supplemented with 3% (15 ml) heat-inactivated FBS, 2.5 mM (1.25 ml of a 1 M 
solution) of CaCl2, and 0.02% (0.1 g) sodium azide (Flow/Facs Buffer). The cells 
were then analyzed via flow cytometry using an LSR Fortessa. All data were 
analyzed in FlowJo software (version X.0.7) and Microsoft Excel.  
5.3.8 Pseudovirus Propagation 
Pseudoviruses were created using the HIV-1 pseudovirus plasmid pNL4.3-
∆E-eGFP (NIH AIDS Reagent Program, Bethesda, MD) and expression vectors 
containing gp120 coding sequences from HIV-1 strain HXB2 and a previously 
identified transmitted founder (T/F) strain (NIH AIDS Reagent Program Reagent 
p1012.TC21.3257). The HIV-1 pseudovirus plasmid and one envelope plasmid 
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were co-transfected into HEK 293 cells (ATCC, Manassas, VA). Media samples 
containing nascent pseudoviruses were collected 48 h post-transfection and 
stored at -80 ºC until needed. The substitution of the envelope gene for an eGFP 
gene ensures that the viral particles are transcribed and translated but not 
packaged so the virus cannot leave and re-infect another cell. In lieu of the 
envelope eGFP protein will be made and can be used as a marker for infection 
5.3.9 Pseudoviral Infections 
Pseudoviruses with either HXB2 (X4) or T/F (R5) envelopes were used in 
transmission studies. Immediately after a 4 h 25% semen exposure, each transwell 
insert was removed. In the exposed basolateral chamber containing PBMCs, as 
previously described, 600 μl of diluted pseudovirus of one envelope type was 
added. X4 pseudovirus was diluted down 1:10 and R5 pseudovirus was diluted 
down to 1:4 to ensure even GFP and infection signal. After a 4 h infection, the 
entire volume of media in the basolateral chamber was collected and centrifuged 
at 2500 rpm for 5 minutes. With the supernatant discarded, the PBMCs were then 
resuspended in R1H medium for staining. Anti-CD4 antibody (5 μl) conjugated to 
APC and 3 μl of anti-CD3 antibody conjugated to APC-Cy7 were added to each 
tube. After incubating for 40 minutes, a Live/Dead stain conjugated to BV 521 was 
added and the tubes incubated for another 15 minutes. The cells were then 
washed with 2 ml R1H medium and pelleted at 2500 rpm for 5 minutes. The 
PBMCs were then resuspended in 500 μl of 1% PFA for 40 minutes. After 
incubation, the cells were washed, pelleted, resuspended in 500 μl of Flow/Facs 
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Buffer, and immediately assayed on a LSR Fortessa flow cytometer. All data were 
analyzed in FlowJo software (version 10.1r5) and Microsoft Excel. 
5.3.10 Statistical analyses 
p-Values were calculated for the difference between pairs of treatments 
conditions using a two-tailed Student’s t-test, and a value of less than 0.05 was set 
as the limit for statistical significance. p-Values are indicated on the figures and 
within the figure legends. 
 
5.4 Results 
5.4.1 END1 cells were the most responsive to semen 
 When semen comes in contact with each region of the FRT, it transduces 
its effect to the underlying tissue and creates a specific immune microenvironment 
[84, 103]. Therefore, our first objective was to assess the effect of semen on 
basolateral cytokine release and to compare cytokine release profiles from all three 
regional cell lines. When three different cell lines representing the distinct regions 
of the FRT were cultured on transwells and either exposed to media only (referred 
to as mock) or semen, distinct patterns of cytokine release from each cell line were 
observed (Fig. 5.1A). Across each region, semen induces microenvironments that 
are pro-inflammatory in nature [103]. In these experiments, interleukin 8 (IL-8) 
increased in concentration approximately 2-fold, 3-fold, and 3.4-fold over mock in 
the VK2, ECT1, and END1 cell line, respectively (Fig. 5.1A). In fact, IL-8 was held 
constant as the cytokine that had the greatest fold change over mock in all three 
regions of the FRT (Fig. 5.1A). 
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 Most of the other analytes appeared to differ in fold-change over mock in 
each region of the FRT, with no two regions having the same response (Fig. 5.1A). 
IL-12, for example, had about a 0.7-fold change increase over mock in VK2 cells, 
about a 1.0-fold change over mock in ECT1 cells, and a moderate ~0.9-fold change 
over mock in END1 cells (Fig. 5.1A). Regulated on activation, normal T cell 
expressed and secreted (RANTES) had about a 1.0-fold change over mock in VK2 
cells and ECT1 cells, but going up to ~2.0 fold-change over mock in END1 cells, 
highlighting regional differences (Fig. 5.1A). Previous studies have pointed to 
ECT1 cells as being the most responsive to semen (Appendix Chapter 1). In these 
experiments, however, END1 cells had the largest response to semen. Cytokines 
like interleukin 6 (IL-6), interleukin 17A (IL-17A), RANTES, and MDC all had about 
a 1.9-fold change over mock in END1 cells, where in the other regions they were 
either ~1.0-fold change over mock or less (Fig. 5.1A).  
 
5.4.2 ECT1 cells were the most responsive when co-cultured with 
PBMCs in the basolateral chamber 
As the final goal was to examine the effect of semen on an early infection model 
that included polarized FRT epithelial cells as well as subepithelial immune cells, 
experiments were performed to examine the impact of adding PBMCs to the 
basolateral chamber of the transwell model. Since peripheral immune cells release 
their own immunomodulatory factors and presumably respond to factors released 
constitutively by the epithelial cells, these experiments were a necessary to 
establish baselines for experiments also involving semen. 
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Figure 5.1A 
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Figure 5.1B 
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Figure 5.1C 
 
 
 
Fig. 5.1. Pro-inflammatory cytokines released basolaterally in response to 
semen and PBMCs treatment in each cell line. Changes in factor concentrations 
in the basolateral chambers are shown as a heat map of fold-change over mock 
of 12 analytes detected in conditioned media collected from the basolateral 
supernatants at 4 h after epithelial exposure to either (A) 25% semen, (B) PBMCs, 
or (C) both together. 
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Each cell line was grown to a confluent monolayer on an insert of a transwell. Once 
confluency was reached, as measured by TEER, PBMCs, grown overnight in 
interleukin 2 (IL-2), were co-cultured in the basolateral chamber for 4 h. After 
exposure the basolateral chamber was collected and the supernatant was assayed 
for cytokine concentrations, which was expressed as a fold-change over transwells 
that were not exposed to PBMCs (control). The concentrations of cytokines 
released by each cell line were relatively similar with some exceptions (Fig. 5.1B). 
Indeed, an increased concentration (greater than ~25-fold change over control 
wells) in IL-8 and almost a 1.0-fold change in concentration of IL-12, IL-17A, 
macrophage inflammatory protein beta (MIP-1ß), and Eotaxin was seen in all 
regions (Fig. 5.1B). Most notable were the region specific differences, such as 
RANTES going from ~14.5-fold change over control wells in VK2 cells to just above 
5.0-fold change over control wells in ECT1 cells to half that (~2.5-fold change over 
control wells) in END1 cells (Fig. 5.1B). Aside from RANTES, ECT1 cells had the 
highest fold-changes of cytokine concentrations over control wells than the other 
cell lines (Fig. 5.1B). Tumor necrosis factor alpha (TNF-α) had the highest fold-
change over control wells in ECT1 cells (~9.5-fold change) when compared to VK2 
and END1 cells (both ~7.5-fold change) (Fig. 5.1B). Almost any other analyte had 
the highest fold-change over control wells in ECT1 cells when compared to the 
other cell lines, suggesting that ECT1 cells had the largest response to immune 
cells at basal level (Fig. 5.1B).  
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5.4.3 Semen did not profoundly affect cytokine concentrations 
released by FRT regional cell lines co-cultured with PBMCs 
A baseline for cytokine concentration during co-culture of each cell line and 
PBMCs had been established. The final step in assaying semen’s effect on an 
early infection model was to expose polarized FRT epithelial cell lines co-cultured 
with PBMCs to semen. Analysis of the supernatant from each basolateral chamber 
4 h post exposure gave insight to the response of each cell line. Cytokine 
concentration was expressed as a fold-change over wells that were co-cultured 
but without exposure to semen (termed non-semen exposed wells).   
Cytokine concentrations of most analytes were similar for each cell line (Fig 
1C). As with the other conditions, IL-8 had the largest increase over non-semen 
exposed wells (all above ~4.9-fold change) (Fig. 5.1C). In fact, cytokines that 
stimulate growth and differentiation were increased less over non-semen exposed 
wells relative to factors responsible for immune cell recruitment, except for IL-8 
(Fig. 5.1C). Cytokine concentrations for MCP-1, RANTES, and MDC were all 
around a 1-fold change over non-semen exposed wells in each cell line (Fig. 5.1C). 
Macrophage inflammatory protein one alpha (MIP-1α) and IL-1ß has similar 
concentrations of about 0.5-fold change over non-semen exposed wells in all three 
cell lines (Fig. 5.1C). The rest of the analytes had concentrations below a ~0.4-fold 
change over non-semen exposed wells in each cell line (Fig. 5.1C). Each cell line 
had analyte concentrations that were very similar to one another as well as what 
was observed after PBMC-only expsoure (Fig. 5.1B and 1C). The effect of semen 
on each cell line co-cultured with PBMCs may have been too small, compared to 
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the effect of each cell line co-cultured with just PBMCs, alone, to have been 
evident. That is not to say that semen’s effect was not seen, it was just that the 
immune cells further enhanced the effect of semen. Indeed, cytokine 
concentrations from cell lines co-cultured with PBMCs and exposed to semen 
followed the same pattern as that of PBMCs alone; ECT1 cells were the most 
responsive, and had the greatest fold-change over non-semen exposed wells of 
the analytes (Fig. 5.1C). Compared to the other cell lines ECT1 cells, as before, 
had either comparable cytokine concentrations or the greatest concentrations.  
 
5.4.4 Semen decreased the surface expression of CD4 on CD3+CD4+ 
T helper cells co-cultured with ECT1 cells but not when co-cultured with 
VK2 or END1 cells 
Once the effect semen had on immunomodulatory factors released from 
each cell line was measured the next step was to identify how that effect modulated 
the co-cultured PBMCs and their potential susceptibility to HIV-1 infection. PBMCs 
from the experiments above were isolated and evaluated for the abundance of 
HIV-1 target cells, CD3+CD4+ T cells (T helper cells), and the cell surface 
expression of CD4. These experiments were performed to test the hypothesis that 
regional differences in the response of each cell line to semen exposure result in 
differences in the availability of HIV-1-susceptible T lymphocytes and their ability 
to support infection by R5 or X4 viruses. 
With respect to T helper cells, there was not much of a difference between 
non-semen exposed wells or semen exposed wells (Fig. 5.2A). Indeed, the percent 
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of T- lymphocytes that were CD3+CD4+ did not change when VK2 wells or ECT1 
wells were exposed to semen (Fig. 5.2A). When non-semen exposed wells and 
semen exposed END1 wells were compared with themselves, however, there 
appeared to be a significant (~5%) reduction in T helper cells (Fig. 5.2A). Despite 
the reduction in T helper cells in END1 wells, the surface expression of CD4 on T 
helper cells co-cultured with END1 cells was significantly enhanced in the 
presence of semen when compared to T helper cells co-cultured with ECT1 cells 
by about 37.5% (Fig. 5.2B). This effect was not observed when comparing END1 
and VK2 cells (Fig. 5.2B). When compared the other cell lines, T helper cells co-
cultured with ECT1 cells had the significantly lowest surface density of CD4 in the 
absence or presence of semen as compared to the other cell lines by about 30.3% 
and 37.5% for VK2 and END1 cells, respectively (Fig. 5.2B). 
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Figure 5.2A 
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Figure 5.2B 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.2. Each cell line does not differ in CD3+CD4+ T cells in the presence of 
semen. (A) PBMCs from transwells were collected at 4 h from the basolateral 
chambers from mock and semen wells of each cell line. The number of CD3+CD4+ 
T cells is expressed as a percentage of the total Lymphocyte population found in 
the harvested PBMCs. (B) The surface expression density of CD4 on CD3+CD4+ 
T cells co-cultured with ECT1 cells is lower compared to VK2 and END1 cells. MFI 
is median fluorescence intensity. * is p<0.05. 
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5.4.5 Compared to CD3+CD4+ T helper cells co-cultured with VK2 or 
END1 cells, CCR5 surface expression is elevated on CD3+CD4+ T helper 
cells co-cultured with ECT1 cells  
The evaluation of CD4 on T helper cells provided insight to some of the 
effects semen had on immune cells that were co-cultured with representative cell 
lines of the FRT. However, the next step was to evaluate what effects semen had 
on the percent of CCR5+ T helper cells available and the surface expression of 
CCR5.  
The percent of CD3+CD4+CCR5+ T cells available were comparable across 
all three regional cell lines in either non-semen exposed or semen exposed wells 
(Fig. 5.3A). Although CD4+CD3+ T cells made up about 50% of the total 
lymphocytes that were present (Fig. 5.2A), the numbers of T cells that were also 
CCR5+ in this population were relatively small (~2%) (Fig. 5.3A). Semen had no 
effect on the size of this cell population (Fig 3A).  
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Figure 5.3A 
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Figure 5.3B 
 
 
 
Fig. 5.3. In the presence of semen, CD3+CD4+CCR5+ T cells co-cultured with 
ECT1 cells have an increase in CCR5 surface expression. (A) PBMCs were 
collected from the basolateral chamber of transwells at 4 h post 25% semen 
exposure from mock and semen wells of each cell line. The number of 
CD3+CD4+CCR5+ T cells is expressed as a percentage of the total CD3+CD4+ T 
cells. There is no difference in CD3+CD4+CCR5+ T cells between the three cell 
lines of the FRT. (B) The surface expression density of CCR5 is increased on 
CD3+CD4+CCR5+ T cells co-cultured with ECT1 cells compared to VK2 and END1 
cells, which are similar. MFI is median fluorescence intensity. * is p<0.05. 
 
  
  
	
155 
The levels of cell surface expression of CCR5 on T helper cells co-cultured 
with VK2 and END1 cells did not differ from non-semen exposed wells to semen 
exposed wells (Fig. 5.3B). In fact, the only difference in cell surface density of 
CCR5 was when CD3+CD4+ T helper cells were co-cultured with ECT1 cells and 
exposed to semen (Fig. 5.3B) CCR5 had a higher density on T helper cells co-
cultured with ECT1 cells than when compared to T helper cells co-cultured with 
VK2 or END1 cells, both in non-semen exposed wells and semen exposed wells 
(Fig. 5.3B). In non-semen exposed wells, the surface density of CCR5 was 24.8% 
and 35.2% greater on CD3+CD4+ T helper cells co-cultured with ECT1 cells than 
when CD3+CD4+ T helper cells were co-cultured with VK2 or END1 cells, 
respectively (Fig 3B). In semen exposed wells the surface density of CCR5 was 
22.2% and 19.3% greater on CD3+CD4+ T helper cells co-cultured with ECT1 cells 
than when CD3+CD4+ T helper cells were co-cultured with VK2 or END1 cells, 
respectively (Fig 3B). Interestingly, when exposed to semen CD3+CD4+ T helper 
cells co-cultured with ECT1 cells had a significant 8% reduction in cell surface 
density of CCR5 compared to when the same cells were non-semen exposed (Fig. 
5.3B).  
 
5.4.6 Semen increases CXCR4 surface expression on CD3+CD4+ T 
helper cells co-cultured with END1 cells 
Just as with CCR5 attention to CXCR4 was the next step. By evaluating 
semen’s effect on HIV-1 viral co-receptors, conclusions about viral tropism affected 
by semen could be drawn. Therefore, the percent of CD3+CD4+CXCR4+ T cells as 
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well as surface expression of CXCR4 on CD3+CD4+ T helper cells co-cultured with 
each cell line was elucidated.  
CD3+CD4+CXCR4+ T helper cells co-cultured with VK2 cells decreased by 
a significant 5% in semen exposed wells when compared to non-semen exposed 
wells (Fig. 5.4A). However, in the absence of semen, the percent of CD3+CD4+ T 
helper cells positive for CXCR4 is about the same when CD3+CD4+ T helper cells 
were co-cultured with every cell line (Fig. 5.4A). Therefore, semen seems to 
preferentially decrease CXCR4+ T helper cells in only CD3+CD4+ T helper cells co-
cultured with VK2 (Fig. 5.4A). 
The surface expression of CXCR4 on CD3+CD4+ T helper cells co-cultured 
with END1 cells significantly increased by about 36.3% from non-semen exposed 
wells to semen exposed wells (Fig. 5.4B). In fact, in semen exposed wells surface 
expression of CXCR4 was significantly higher on CD3+CD4+ T helper cells co-
cultured with END1 cells versus CD3+CD4+ T helper cells co-cultured with ECT1 
cells by 38.6% (Fig. 5.4B) 
 
5.4.7 Semen increases R5 HIV-1 infections in CD3+CD4+ T helper cells 
co-cultured with ECT1 cells but decreases infections in CD3+CD4+ T helper 
cells co-cultured with VK2 or END1 cells 
In order to determine if semen has some role in helping R5 viruses enter 
and infect cells over X4 viruses we performed a pseudovirus infection on PBMCs 
co-cultured with epithelial cells exposed to semen. After each cell line was exposed 
to semen, the PBMCs were immediately harvested and challenged in an in vitro 
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infection model with R5 or X4 pseudovirus for 4 h. The cells recovered for 48 h 
and were then assayed them for enhanced green fluorescent protein (eGFP) 
production via flow cytometry. CD3+CD4+ T helper cells co-cultured with VK2 cells 
had a reduction in percent of cells infected by R5 viruses (9.57%) when semen 
exposed wells were compared to non-semen exposed wells (Fig. 5.5A). Similarly, 
CD3+CD4+ T helper cells co-cultured with END1 cells displayed a 5.3% reduction 
in the percent of CD3+CD4+ T helper cells infected when semen exposed wells 
were compared to non-semen exposed wells (Fig. 5.5A). Unlike the other cell lines, 
CD3+CD4+ T helper cells co-cultured with ECT1 cells saw an increase in 
CD3+CD4+ T helper cells infected by R5 viruses by 24.5% (Fig. 5.5A). Therefore, 
semen appeared to preferentially enhance R5 infection in only CD3+CD4+ T helper 
cells co-cultured with ECT1 cells (Fig. 5.5A). 
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Figure 5.4A 
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Figure 5.4B 
 
 
 
Fig. 5.4. In the presence of semen, CD3+CD4+CXCR4+ T cells co-cultured with 
END1 cells have an increase in CXCR4 surface density. (A) After exposure to 
25% semen for 4 h PBMCs from basolateral chambers of mock and semen 
transwells were collected from each cell line. The number of CD3+CD4+CXCR4+ T 
cells is expressed as a percentage of the total CD3+CD4+ T cells. In the absence 
of semen CD3+CD4+CXCR4+ T cells are about even when co-cultured with each 
cell line, however in the presence of semen ECT1 and END1 cells have more 
CD3+CD4+CXCR4+ T cells. (B) The surface expression density of CXCR4 
increases on CD3+CD4+CXCR4+ T cells co-cultured with END1 cells but remains 
the same with VK2 and ECT1 cells. MFI is median fluorescence intensity. * is 
p<0.05. 
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The level of eGFP expression correlates to the level at which the infected 
cell supports higher levels of long term terminal repeat (LTR) activity and, by 
extension viral gene expression. This would suggest higher levels of replication, 
but because the pseudovirus is incapable of continued replication these data can’t 
be verified. Despite this, however, it was clear that CD3+CD4+ T helper cells co-
cultured with ECT1 cells promote greater levels of replication in semen exposed 
wells then non-semen exposed wells by 20% (Fig 5B). 
Unlike in R5 infections, semen enhanced all X4 infections by 5.9%, 6.5%, 
and 10.5% for CD3+CD4+ T helper cells co-cultured with VK2, ECT1, and END1 
cells, respectively (Fig. 5.6A). For CD3+CD4+ T helper cells co-cultured with VK2 
cells the levels of replication remained constant (Fig. 5.6B). But for CD3+CD4+ T 
helper cells co-cultured with ECT1 and END1 cells the replication levels of X4 
viruses reduced by 13% and 10.5% (Fig. 5.6B).  
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Figure 5.5A 
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Figure 5.5B 
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Fig. 5.5. Semen increases R5 viral infections in CD3+CD4+ T cells co-cultured 
with ECT1 cells reduces R5 infections in the other cell lines. (A) PBMCs from 
mock and semen exposed wells from each cell line were collected 4 h after 25% 
exposure and immediately challenged with a pseudovirus infection for 4 h. The 
cells were then washed and given 48 h recovery. The number of cells infected is 
expressed as a percent of total CD3+CD4+ T cells. CD3+CD4+ T cells co-cultured 
with ECT1 cells had more cells infected with pseudovirus than of those co-cultured 
with VK2 or END1 cells. (B) CD3+CD4+ T cells from ECT1 cells also have more 
viral gene expression in each infected cell versus the other cell lines of the FRT 
when exposed to semen. 
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Figure 5.6A 
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Figure 5.6B 
 
 
 
Fig. 5.6. X4 infections are increased in the presence of semen across each 
cell line (A) PBMCs from mock and semen exposed wells from each cell line were 
collected 4 h after 25% exposure and immediately challenged with a pseudovirus 
infection for 4 h. The cells were then washed and given 48 h recovery. The number 
of cells infected is expressed as a percent of total CD3+CD4+ T cells. In each cell 
line of the FRT, in the presence of semen, X4 infections are increased. (B) Viral 
gene expression is decreased in ECT1 cells but remains the same in the VK2, 
despite an increase in infections seen in VK2 cells.  
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5.5 Discussion 
HIV-1 transmission from male-to-female is a complicated process that 
involves multiple aspects of reproductive biology in both the male donor and 
female recipient. The male reproductive tract can influence which genetic variants 
out of a total become found in semen [79, 132]. From here, this pool of variants 
diminishes as semen is deposited in the FRT [132]. Indeed, these multiple 
checkpoints are part of the bottleneck hypothesis, which states that at points during 
transmission of HIV-1, there exist filtering steps that select for one or more HIV-1 
genetic variants [130]. This selection process eventually leads to the nearly 
exclusive transmission of R5 viruses	[131, 132].  
Of the checkpoints, the most stringent would be when semen comes in 
contact with the FRT [131, 132]. And most concepts in the literature take this to be 
the FRT, as a whole [130]. However, what we have shown here is that each region 
of the FRT acts as a different checkpoint independently of one another. This notion 
posits that the bottleneck hypothesis is a lot more complicated than previously 
thought, insofar the different regions of the FRT would have different mechanisms 
to filter out and/or select for specific genetic variants out of the pool they are 
presented with. 
In fact, looking at the cytokine profiles generated in this study we can see 
that no two region responded the same to stimuli. When only semen is cultured 
with each region of the FRT, we see a distinct profile in our analytes for each region 
[84]. IL-8 was one of, if not the only, cytokine that was constitutively upregulated 
in each region. However, IL-8 is a potent chemotactic agent for immune cells. 
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Indeed, the biphasic effect of semen sees an induction of a pro-inflammatory 
environment early on when semen comes in contact with the FRT [100, 102, 116, 
126, 127], therefore IL-8 will be one of the first cytokines upregulated [84]. When 
semen comes in contact with the FRT, the initial steps to pregnancy are started [5, 
59, 77, 99, 125] and in those initial steps IL-8 is one important cytokine because 
of its chemotactic properties but also because of its role in angiogenesis and 
embryo development [104]. 
TNF-α is another potent mediator of a pro-inflammatory environment and 
we did see a doubling of TNF-α concentrations across all regions of the FRT. The 
same can be said of any analyte in our panel. Though, interestingly enough, we 
see that END1 cells were the most responsive to semen alone. END1 cells also 
had the largest response with respect to IL-6, IL-17A, and RANTES. These 
chemokines are also involved in the beginning stages of pregnancy, with IL-6 have 
tissue remodeling properties [67, 76].  
Initially, we thought that ECT1 cells would be the most responsive to semen 
but what we see here was not the same. However, ECT1 cells was the most 
responsive region when co-cultured with PBMCs. Indeed, the cross-talk between 
ECT1 cells and the underlying peripheral blood cells seemed to attenuate the pro-
inflammatory response. As stated before, across all cell lines, the concentrations 
of chemoattractant cytokines was greater than that of the other cytokines, save IL-
8. This is especially true in ECT1 cells, where the fold-changes for analytes were 
higher than the other two cell lines. Again, this may be due, in part, to the fact that 
the transformation zone is biologically more active than the other areas of the FRT 
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and routinely sees an influx and turnover of immune cells that then drain to other 
parts of the body [103]. Therefore, ECT1 cells will appear to be more responsive 
to peripheral blood cells in the basolateral chamber than the other two cell lines 
[95, 103, 104]. 
When the three FRT derived cell lines are co-cultured with both semen and 
PBMCs, ECT1 cells still displayed the largest response. Even IL-8, which was the 
highest reported cytokine in all regions, was the highest in ECT1 cells, with about 
a 46.5-fold change over non-semen exposed wells. The closest region to this 
would be the vagina, which is at about a 42-fold change over non-semen exposed 
cells. However, what was not seen was an over active response, or underactive, 
response in any condition. Each region had about the same response to each 
stimulus. This is curious as each cell line has previously been shown to act 
independently of one another with distinct cytokine patterns (Appendix Chapters 1 
and 2). Perhaps the co-culture with peripheral blood cells has skewed the cell lines 
to mimic one another. Indeed, the ectocervix has the highest abundance of 
immune cells found in the subepithelium [102], but by co-culturing each cell line 
with the same amount of PBMCs the results would all mimic one another. If each 
cell line was co-cultured with their respective amount of immune cells, maybe each 
cytokine profile would better have reflected what was previously reported 
(Appendix Chapter 1).  
Apical exposure of semen on cell lines derived from regions of the FRT 
provided an idea of the immune microenvironment produced by each cell line as a 
response to semen. However, semen did not only modulate responses from an 
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epithelium, it also transduced its effect across the epithelium to affect peripheral 
blood cells co-cultured with each cell line. This eventually led to differential 
infection profiles of those immune cells. When exposed to semen, only CD3+CD4+ 
T helper cells co-cultured with END1 cells decreased by 5%. This reduction was 
most likely due to cell death as the immune microenvironment purported T cell 
proliferation and expansion. Indeed, PBMC treatment of IL-2 overnight and then 
placing the treated cells in culture may have induced a rapid turn-over of T cells 
and this snapshot was at a low point. Because, again, with the kind of immune 
microenvironment abundant T lymphocytes should flourish [95, 103, 126] . In fact, 
the high concentrations of IL-8 will further attenuate IL-8 from CD4+ T cells and 
thus bring about an influx of more T lymphocytes [149]. However, this is a closed 
system that does not allow for the influx of new, fresh immune cells. Actually, 
CD3+CD4+CCR5+ T helper cells co-cultured with any cell line did not increase or 
decrease in number unlike the <5% reduction in CD3+CD4+CXCR4+ T helper cells 
co-cultured with VK2 cells. The latter result may have been due to 10% reduction 
in CXCR4 surface expression when CD3+CD4+ T helper cells co-cultured with VK2 
cells and exposed to semen.  
In fact, the only differences we saw were about the surface expression of 
the HIV-1 co-receptors. CD4 is significantly less expressed on CD3+CD4+ T helper 
cells co-cultured with ECT1 cells when compared to the rest of the cell lines. This 
would suggest that HIV-1 would might have an easier time entering cells in the 
transformation zone because a determinative factor is relative abundance of the 
co-receptors on the surface of target cells [150-152].  
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Despite the reduction in surface expression of CD4 on CD3+CD4+ T helper 
cells co-cultured with ECT1 cells, CCR5 surface expression was significantly 
increased when CD3+CD4+ T helper cells co-cultured with ECT1 cells were 
exposed to semen when compared to VK2 and END1 cell lines. One explanation 
may be that ECT1 cells released more interferon alpha (IFN-α) subsequent to 
semen exposure (Appendix Chapter 1) [84]. IFN-α is known to induce CCR5 
expression on T lymphocytes, as well as IL-12 and TNF- α [67, 147, 153, 154]. 
From previous work we have identified IFN-α as having a greater than 10-fold 
change over mock when ECT1 cells were exposed to semen, which was 
significantly higher than VK2 or END1 cells (Appendix Chapter 1). The effects of 
these three cytokines on T lymphocytes is consistent with our observations. 
It seems as though CD3+CD4+ T helper cells co-cultured with VK2 or END1 
cells were similarly affected by the presence of semen. Indeed, the amount of 
CD3+CD4+ T helper cells and the surface expression of CCR5 and CXCR4 
remained similar to one another throughout this study. There was one exception—
CXCR4 surface expression increases on CD3+CD4+ T helper cells co-cultured with 
END1 cells when exposed to semen. CXCR4 has been shown to be involved in 
organogenesis and fetal development [155]. Therefore, the increase in receptors 
on immune cells in the upper portion of the female reproductive tract would be 
consistent with the fact that the upper FRT undergoes remodeling due to the 
presence of semen, whose main function is to induce pregnancy and embryo 
development.  
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In fact, by semen increasing CXCR4 on CD3+CD4+ T helper cells co-
cultured with END1 cells, we should have seen an increase in X4 HIV-1 infection 
in the endocervix. Actually, we saw that the other two regions also follow suit with 
having an increase in X4 HIV-1 infection in the presence of semen. However, the 
most interesting result was that in the presence of semen R5 HIV-1 infections 
decreased in CD3+CD4+ T helper cells co-cultured with VK2 or END1 cells but 
increased in CD3+CD4+ T helper cells co-cultured with ECT1 cells. ECT1 R5 HIV-
1 infections in the presence of semen significantly increased to just about the 
highest percentage of all infections performed.  
When CD3+CD4+ T helper cells co-cultured with ECT1 cells were exposed 
to semen, surface expression of CD4 was decreased, CCR5 surface expression 
was increased. These two factors would make for the perfect situation for R5 
viruses to enter and infect CD3+CD4+ T helper cells [150-152, 154]. Perhaps these 
factors are what drove the increase in R5 infections in only ECT1 cells.  
In conclusion, we have identified that the regions of the FRT are 
individualized and acted in an individual manner, yet the basic response of each 
region was very similar. However, the ECT1 cells did seem to be more responsive 
than VK2 cells, with END1 cells being the most responsive to semen and ECT1 
cells being the most responsive to semen when immune cells were present. 
Furthermore, when semen and immune cells were present, together, ECT1 cells 
enhanced infection by R5 HIV-1, where VK2 and END1 cells did not. The 
differences in CD3+CD4+ T helper cells co-cultured with ECT1 cells versus 
CD3+CD4+ T helper cells co-cultured with VK2 or END1 cells were attributable to 
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semen exposure. And it was those differences that created the kind of CD3+CD4+ 
T helper cells to be infected by R5 viruses: slight reduction in CD4 surface 
expression with an upregulation in CCR5 surface expression [150-152, 154]. The 
effect the FRT plays in the bottleneck hypothesis can be broken down to region-
specific differences attributed to their specific responses to semen. The 
immunological response elicited by each barrier will further modulate peripheral 
blood cells to make them more susceptible to R5 infections in the ectocervix only.  
Further elucidation of this pathway in the ectocervix using primary tissue 
and infectious virus will provide new insights into what specific factors are 
enhancing R5 infection over X4 infection. Understanding all key aspects may 
provide new targets for therapy or prevention medicines.  
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6.1 Abstract 
When semen comes in contact with the female reproductive tract, there is an 
almost immediate mechanical response by the epithelial barrier. This response is 
a reaction to protein and metal-ion factors found in semen, which reduces 
permeability of the barrier through upregulation of tight junctions between adjacent 
cells. Closing of the paracellular spaces prevents semen, its constituents, and 
pathogens from traversing the barrier. Furthermore, semen also elicits a biological 
response from the epithelium by way of cytokine and immunomodulatory factors. 
In doing so semen modulates female immunity to ensure the clearance of excess 
and abnormal sperm while promoting the acceptance of healthy sperm. This is 
known as the biphasic effect of semen. The inflammation associated with semen 
interaction starts the process and is carried out by transforming growth factor beta 
(TGF-β) releasing interleukin 6 (IL-6) and granulocyte macrophage colony-
stimulating factor (GM-CSF) from the epithelium. These cytokines will induce an 
influx of immune cells to the cervix where cell mediated immunity will provide the 
necessary components to clear said sperm. However, this initial inflammation is 
soon abated to tolerance by TGF-β released from the epithelium. This promotes 
the expansion and proliferation of T regulatory cells (Tregs), which act to dampen 
inflammation. Dampening the innate immune response ensures the survival of 
healthy sperm to establish pregnancy and embryo development. However, 
modulating the innate immune system has downstream effects involved in 
pathogen transmission from male-to-female.  
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6.2 Introduction 
There is a continuing need to elucidate interactions between semen and the 
female reproductive tract (FRT). Only recently has semen been thought of as more 
than an inert vehicle for sperm delivery [29]. Recent studies, including our own, 
have characterized semen as a biologically active substance that contains a 
myriad of factors such as sugars, whole cells, cytokines, and other 
immunomodulatory factors	[9, 33, 49, 51, 59, 61, 115, 120]. The concentrations of 
these factors differ greatly from one male to the next and are influenced by factors 
such as age, disease, diet, and lifestyle [9, 33, 42, 49, 120]. The concentrations of 
these factors can also influence downstream events, such a pregnancy and 
embryo implantation [9].   
Of these factors, the most prevalent is transforming growth factor beta 
(TGF-β) [4]. The interaction of TGF-β and the FRT has shown that TGF-β favors 
embryo development and implantation through modulation of the local immune 
immune environment [4, 9]. Cervical epithelial cells were shown to increase 
granulocyte macrophage stimulating factor (GM-CSF) and interleukin 6 (IL-6) 
when exposed to TGF-β [4], which initiates the necessary local inflammatory 
response in the female for fetal development [84]. TGF-β originates in the seminal 
vesicle of the male, where it is secreted into semen. However, the function of 
seminal vesicle is not just for TGF-β supplementation but for other factors as well, 
such as prostaglandin E2 (PGE2) [80]. PGE2 also helps control pregnancy through 
dampening of the female innate immune response [29, 81, 87].  
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The initial inflammation associated with semen deposition in the FRT is 
needed to clear abnormal sperm and excess sperm. However, if left unchecked, 
most of, if not all, the sperm will be cleared [9]. Therefore, factors like PGE2 work 
to dampen the immune response by inhibiting monocyte derived cytokines and 
increasing T lymphocyte proliferation into T regulatory (Treg) phenotypes [81]. This 
allows for not only paternal antigens to survive, but also developing fetal antigens 
[9]. Any abnormalities in semen content could lead to dysregulation of one of the 
functions of semen, such as fetal development and embryogenesis [9].  
Therefore, these factors have lasting impacts on the tissues they come in 
contact with and nowhere else is this more prevalent than when semen comes in 
contact with the FRT. Interactions between semen and the FRT elicit mechanical 
responses as well as biological responses [29] (Appendix Chapters 1 and 2). The 
goal of this review is to establish a base line for semen’s effect on the FRT and 
what implications these could have on immune modulation and pathogen 
transmission.  
 
6.3 Semen reduces paracellular permeability through upregulation of tight 
junctions  
Mechanical responses to semen deposition in the FRT largely include 
tightening of paracellular spaces through tight junction upregulation [156-159]. 
When semen comes in contact with reproductive epithelia, tight junctions increase 
which leads to the reduction in permeability across the epithelium [159]. In one 
study, after direct exposure to semen for 4 h, the transepithelial electrical 
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resistance (TEER) was measured and there was a large increase over basal levels 
(Appendix Chapter 2). TEER is a direct measurement to tight junctions through 
measuring the resistance of a current passing in-between adjacent cells from the 
apical side to the basolateral side. Therefore, if the resistance is higher, measuring 
as a higher TEER, then there is greater resistance between cells—signifying a 
greater abundance of tight junctions [157]. These tight junctions were shown to 
upregulate in as early as 5 min post semen exposure, which is too rapid for protein 
transcription and translation (Appendix Chapter 2). 
Therefore, there is some other mechanism behind the quick upregulation of 
tight junctions. This effect is due to the constituents of semen (Appendix Chapter 
2). As stated before semen is more than an inert vehicle for sperm delivery. The 
factors that make up semen have been extensively studied and it has been 
identified that a combination of calcium, lipids, and soluble proteins are responsible 
for the increase in tight junctions [9, 29, 156, 160] (Appendix Chapter 2). When 
polarized epithelia were exposed to physiological concentrations of metal-ions 
found in semen it was found out that each increased TEER by at least 113%-fold 
over non-treated wells [161] (Appendix Chapter 2). During co-incubation of semen 
with ethylenediaminetetracetic acid (EDTA), a known metal-ion chelator, the 
increase in TEER was abrogated to basal levels (Appendix Chapter 2). 
In fact, ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetracetic acid 
(EGTA) is known to chelate calcium, specifically, and when co-incubated with 
semen there was a reduction in TEER from semen-induced levels back down to 
basal levels (Appendix Chapter 2). This reduction of calcium, in specific, suggests 
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that calcium is the main metal-ion in semen affecting tight junctions (Appendix 
Chapter 2). It is known that calcium induces tight junction formation through 
upregulating zonula occludin 1 (ZO-1) [160, 162], a scaffolding protein that acts as 
an accessory to tight junction protein complexes of occludins and claudins [163]. 
Staining for ZO-1 one sees a mesh-like network at the periphery of each cell 
(Appendix Chapter 2). However, when the reproductive cell lines were co-
incubated with EDTA/EGTA and then stained for ZO-1 the network all but 
dispersed, suggesting that without calcium the tight junction network could not 
form, allowing paracellular transport of foreign antigens (Appendix Chapter 2). Of 
course, calcium is not the only major player in this phenomenon [27, 161, 162]. 
When semen was heat-inactivated, by any means, there was a significant, partial 
reduction in TEER suggesting that there is a protein component also acting on on 
the regulation of tight junctions (Appendix Chapter 2).  
By closing the paracellular space between cells in the FRT semen also 
prevents any foreign particles that may be found in the seminal fluid from easily 
crossing the epithelial barrier (Appendix Chapter 2). In an experiment to determine 
permeability of the epithelia, dextran conjugated to fluorescein isothiocyanate 
(FITC) was apically applied to epithelia grown in a polarized manner on a transwell 
after semen exposure (Appendix Chapter 2). The amount of FITC-dextran that 
diffused through the epithelium compared to input concentration denoted 
permeability, and, in the presence of semen, permeability was reduced (Appendix 
Chapter 2). Using EDTA, as a negative control for tight junction formation, 
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significantly increased permeability, suggesting that tight junctions were 
responsible for the barrier function the epithelia [164] (Appendix Chapter 2). 
The tight junctions act like links in a fence [164] (Appendix Chapter 2), which 
keep foreign particles from easily crossing the epithelium. However, the effect 
semen elicits on the FRT is not just mechanical. When semen comes in contact 
with the FRT it elicits a biphasic effect [9, 28] (Chapter 3), which is the induction of 
inflammation that is quickly abated to tolerance [5, 77, 87, 99, 125]. The biological 
importance of the biphasic effect is to establish pregnancy because when seminal 
antigens come in contact with the FRT they are viewed as foreign and would 
otherwise be targeted for removal by the female immune system [9, 29].  
 
6.4 Seminal constituents activate the innate immune response in the 
female reproductive tract 
The initial inflammation associated with semen exposure upregulates tumor 
necrosis factor alpha (TNF-α) [9, 28, 100, 106, 126], which is a potent pro-
inflammatory molecule. This cytokine will then attenuate inflammation through 
monocytes. In fact, TNF-α, as well as IL-6, interleukin 8 (IL-8), interleukin 1 
alpha/beta (IL-1α/IL-1β), and GM-CSF, will all further enhance the pro-
inflammatory cascade by acting on monocytes and macrophages [28, 70, 87, 99, 
102, 114, 126] (Chapter 3). The macrophages, with interferon gamma (IFN-γ), 
interact with mature dendritic cells (DC), which can activate natural killer cell (NK) 
populations with interleukin 12 (IL-12) (Chapter 3). DCs can also interact with T 
lymphocytes to increase pro-inflammatory signaling as well as increase T cell 
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proliferation and migration (Chapter 3). The influx of T lymphocytes to the site of 
semen deposition causes naïve T cells to differentiate into Th1, Th2, or Th17 cells 
(Chapter 3). Each of these T cell subsets produce more pro-inflammatory 
cytokines that further extend inflammation. 
However, semen exposure in the FRT also elicits interleukin 10 (IL-10) and 
TGF-β to be released from the epithelium [4, 9, 29, 67, 104, 124] (Chapter 3). As 
inflammation occurs, the concentrations of IL-10 and TGF-β are influencing CD4+ 
T cells to differentiate into T regulatory cells (Treg) [109, 124, 165, 166]. The anti-
inflammatory Tregs will shut down NK cells, Th1, Th2, and Th17 subsets by 
producing more IL-10 and TGF-β (Chapter 3). Tregs are also auto-inducing, in that 
they add to overall growing concentration of IL-10 and TGF-β, which will further 
attenuate Treg proliferation [78, 102, 125]. By having more Tregs present in the 
FRT the initial inflammation associated with semen will be quickly resolved to 
tolerance. In a mouse model, the generation of Tregs has been shown to be 
induced early after coitus [5, 77, 124]. The need for tolerance comes with the initial 
responsibility of semen, which is to survive the FRT to fertilize an ovum in the 
uterus. By dampening the immune response in the female, semen ensures that 
paternal antigens are not targets for degradation	[9, 29]. 
The biological effect of semen in the FRT is not limited to release of TNF-α 
and TGF-β from the epithelium [103, 104]. Indeed, the immune response to semen 
in the FRT is characterized by a much more pro-inflammatory nature, especially 
within 4 h of exposure (Appendix Chapter 1). Therefore, it is important to 
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understand what the immune microenvironment looks like in the FRT because this 
may have further downstream effects.  
Although semen elicits a pro-inflammatory response from the FRT as a 
whole, the tract is divided into specific regions; the vagina, the cervix, and the 
uterus. Each region has its own specific response to semen and other constituents 
found in the FRT [29, 103, 104, 126] (Appendix Chapters 1 and 2). The vagina, 
characterized by multiple layers of a squamous epithelium is the least internalized 
region. The vagina routinely comes in contact with a variety of foreign stimuli and 
because of this has the second most abundant concentration of immune cells in 
the FRT [102, 103]. Regular sloughing and replenishing of the top epithelial layers 
is common in the vagina and helps keep out foreign antigens and pathogens. This 
is especially helpful during semen clearance, as the vagina is first and most likely 
region to come in physical contact with semen [9, 29]. 
Using the VK2-E6E7 cell line to represent the vagina, the measured output 
of 30 different cytokines in a multiplex experiment revealed that the majority of 
cytokines expressed by the cell line when exposed to semen had roles in cell 
signaling and attenuating the pro-inflammatory environment [29] (Appendix 
Chapter 1). Interleukin 7 (IL-7) and interleukin 15 (IL-15) were expressed at greater 
than a 10-fold change over mock, which was defined as no semen exposure 
(Appendix Chapter 1). Vascular endothelial growth factor (VEGF), hepatocyte 
growth factor (HGF), and basic fibroblast growth factor (FGF-basic) were also 
expressed in the range of 5.1-10-fold change over mock (Appendix Chapter 1). 
Aside from those, interferon alpha (IFN-α), IL-12, IL-6, IFN-γ, and IL-1β were all 
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moderately expressed from the epithelium in concentrations up to a 5-fold increase 
over mock (Appendix Chapter 1). Taken together, the use of VK2 cells suggests 
that the vagina is rich in growth factors to promote the maturity of immune cells 
that are found in the subepithelium and immune cells being recruited to the 
subepithelial space	[29] (Appendix Chapter 1).  
The second area semen comes in contact with is the cervix, which is in 
between the vagina and the uterus. The cervix is divided into two distinct regions 
with the lower portion termed the ectocervix and the upper portion referred to as 
the endocervix. The two cervical regions act differently from one another, with 
respect to immunity [103]. Indeed, the ectocervix, with the vagina, is considered to 
be more representative of the lower FRT, while the endocervix is thought to be 
similar to the upper FRT. The ectocervix, like the vagina, is also characterized by 
layers of squamous epithelia whereas the endocervix is a single, columnar 
epithelium. Where the ectocervix meets the endocervix there is an immune 
microenvironment called the transformation zone—which is routinely represented 
as the ectocervix as a whole [102, 103, 111]. The transformation zone is unique 
and important for the FRT in that it has the highest concentration of all immune 
cells and and is thought of as the central hub for cell mediated immunity [103]. 
Therefore, the initial inflammation and abatement to tolerance is thought to begin 
in this region of the FRT.  
When apically exposing the cell line ECT1/E6E7, which represents the 
ectocervix, to semen the activation of the transformation zone is clear (Chapter 4) 
(Appendix Chapter 1). Just like the response of the VK2 cell line, the ECT1 line is 
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pro-inflammatory in nature with a large response in growth factors (Chapter 4) 
(Appendix Chapter 1). Of the pro-inflammatory cytokines IL-12 and IL-6 are 
increased in concentrations over 10-fold when compared to mock (Chapter 4) 
(Appendix Chapter 1). IFN-α and IL-1β were increased at about a 2-5-fold change 
over mock, while IFN-γ was increased up to about 10-fold over mock (Chapter 4) 
(Appendix Chapter 1). The dramatic increase in these pro-inflammatory cytokines, 
as compared to the other regions of the FRT, reinforces the idea that the 
transformation zone is the central hub for cell mediated immunity [102-104].  
The ECT1 cell line did not just increase in pro-inflammatory cytokines but 
also in growth factors and cell signaling molecules (Chapter 4; Appendix Chapter 
1). The greater than 10-fold increase over mock of IL-7, VEGF, and IL-2r suggests 
that an influx of immune cells from peripheral blood will be recruited and matured 
quickly (Appendix Chapter 1). The 5-10-fold change over mock concentrations of 
HGF, IL-15, and granulocyte colony-stimulating factor (G-CSF) further attenuate 
the proliferation of mature immune cells (Appendix Chapter 1). In fact, the ECT1 
cell line was the only to report an increase over mock of G-CSF (Appendix Chapter 
1), with the other cell lines having a non-detectable concentration further 
supporting the fact that the transformation zone is the central hub of immunity in 
the FRT [103]. 
Unlike the vagina and the ectocervix, the endocervix is not routinely 
exposed to foreign stimuli from the outside environment. As a result, the 
endocervix is mostly a sterile environment. When compared to the vagina and 
ectocervix, the endocervix has the lowest concentration of immune cells [102]. 
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Perhaps these two facts are one reason why the endocervix is mostly non-
responsive to semen (Chapter 5; Appendix Chapter 1). Indeed, when using the 
END1/E6E7 cell line to represent the endocervix, the END1 cells did not produce 
concentrations of IFN-γ and IL-1β over detectable limits (Appendix Chapter 1). 
Furthermore, the only pro-inflammatory cytokines that were increased over mock 
were I-6, IL-12, and IFN-α, with 2-5-fold changes and up to 1.9-fold change, 
respectively (Appendix Chapter 1). This data reports that the END1 cell line has a 
reduced pro-inflammatory response to semen exposure (Appendix Chapter 1).  
Looking at the same factors for growth and cell signaling as the other two 
cell lines, it is clear that the END1 cell line is not very responsive (Appendix 
Chapter 1). Where the other cell lines had a greater than 10-fold change over mock 
of IL-7, IL-15, VEGF, and IL-2r the END1 cell line produced no more than a 1.9-
fold change of each, except for VEGF, which was between the range of 2-5-fold 
change over mock (Appendix Chapter 1). Where the VK2 and ECT1 cell lines had 
an increase in concentration over mock for HGF, the END1 cell line had no 
detectable limit (Appendix Chapter 1). Therefore, the END1 cell line, and by 
extension the endocervix, does not seem to rapidly respond to semen (Appendix 
Chapter 1). Taken further the lower FRT is more responsive than the upper FRT 
[103, 104, 111] (Chapter 5). 
The response to semen shows that the different regions of the FRT act 
distinctly (Chapter 5) (Appendix Chapters 1 and 2). However, the lower FRT 
appears to have the same response, with minor differences [103, 104]. Despite 
these differences the entirety of the FRT has been reported to have a pro-
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inflammatory response to semen (Chapter 5) (Appendix Chapter 1). Again, this is 
the first step in the innate immunity of the female, which is to target foreign antigens 
for degradation [99, 104]. Only through tolerance induction does the female 
immune system start to “recognize” sperm as “self” [9, 29]. When cytokines are 
released from the epithelium, they interact with immune cells that are already found 
in the subepithelium of the FRT, which include NK cells, macrophages, B 
lymphocytes, T lymphocytes, granulocytes, and DCs [5, 28, 67, 84, 87, 103, 104, 
166]. 
 
6.5 Factors released from the female reproductive tract epithelia 
interact with immune cells present in the subepithelium to induce a pro-
inflammatory environment 
The interaction of the released cytokines with the present immune cells will 
further increase cell mediated immunity. As stated before, specific cytokines, like 
IL-6, IL-1β, and GM-CSF are released from the epithelia and initiate inflammation 
through interaction with immune cells [9, 28, 29, 58, 84, 116, 167]. These 
interactions will produce a cascade of different cytokines, which will influence the 
cytokine milieu in the subepithelium. A study aimed at recapitulating this idea in 
vitro co-cultured peripheral blood mononuclear cells (PBMCs) in the basolateral 
chamber of a transwell with a representative cell line of a region of the FRT grown 
on the mesh insert and then apically exposed each cell line to semen (Chapters 4 
and 5). Analysis of the basolateral supernatant provided insight into what kind of 
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cytokines were further elicited from the immune cells already present (Chapters 4 
and 5). 
In examinations of specific pro-inflammatory cytokines, there were almost 
no significant differences between all three cell lines, with the exception of TNF-α 
(Chapter 5). The END1 cell line had significantly more upregulated TNF-α than the 
VK2 or ECT1 lines (Chapter 5). Of note, however, were IL-8, IL-12, monocyte 
chemotactic protein one (MCP-1), RANTES, macrophage inflammatory proteins 1 
beta (MIP-1β), and macrophage derived chemokine (MDC). IL-8, which had an 
average of 5.14-fold change over PBMC only wells (PBMC co-culture without 
apical semen exposure), was the largest fold-change over PBMC only wells 
(Chapter 8). MCP-1, RANTES, and MDC were all just about doubled in the 
presence of semen with average fold-changes of 1.25, 0.93, and 1.03, respectively 
(Chapter 5). The doubling (and then some) of these chemokines leads to influx of 
more immune cells, specifically monocytes, to the area of inflammation [28].  
IL-12 is particularly interesting because the average fold-change of IL-12 
across all three cell lines was 0.11 fold-change over PBMCs alone (Chapter 5). 
What makes this cytokine interesting is that in the PBMCs alone, without semen 
exposure, the average fold-change was 1.59-fold change over mock (no PBMCs 
or semen) (Chapter 5). IL-12 is produced in the biphasic effect of semen during 
both inflammation and tolerance [29]. Indeed, CD4+ T lymphocytes interact with IL-
12, which differentiates them into Th1 phenotypes (Chapter 3). Th1 phenotypes will 
interact with B cells through MHC Class I TCRs and activate them (Chapter 3). IL-
12 is also secreted by Th17 T lymphocytes to induce IL-17/IFN-γ producing T cells 
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(Chapter 3). Furthermore, IL-12 is secreted by mature DCs to induce NK cells. IL-
12 is a potent pro-inflammatory inducer, and is represented in the cytokine milieu 
without semen 1.59-fold over mock. However, there is little increase beyond this 
concentration when semen is apically exposed to any of the three cell lines 
(Chapter 5).  
MIP-1β, as another cytokine of interest, goes from an average across all 
three cell lines of just above 2.0-fold change over wells that are only co-cultured 
with PBMCs to a little less of an average fold-change of 1.58 over PBMC wells 
only (Chapter 5). MIP-1β can activate granulocytes, which are found throughout 
the FRT to attenuate immune cell chemotaxis to the site of inflammation and in 
doing so also induce macrophages to produce IL-6 and TNF-α [102-104]. The 
increases seen in the supernatant do not seem to reflect this happening as IL-6 
and TNF-α were both an average of less than 0.55-fold change over PBMC only 
wells (Chapter 5). What does stand out about MIP-1β and RANTES, however, is 
that both of these are CCR5 ligands [135, 137, 168, 169].  
 
6.6 The effect of semen across the female reproductive tract epithelia 
has broader implications for pathogen transmission  
One of the most prevalent contexts for looking at how semen modulates the 
FRT is pathogen transmission. In the case of human immunodeficiency virus type 
1 (HIV-1) transmission, the increases in MIP-1β and RANTES could have 
implications with transmission, because CCR5 is one co-receptor the virus utilizes 
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to enter and infect target cells. However, the other effects of semen would have 
implications for other pathogen transmission. 
When semen increases tight junction formation and decreases permeability 
across the epithelium, any pathogens found in semen would not be able to move 
between cells across the epithelial barrier to establish infection in the subepithelial 
space [104, 121, 126, 170] (Appendix Chapter 2). The pathogens would have to 
traverse the barrier intracellularly, which poses a much greater challenge to 
pathogen. This effect is also going to be region specific as was seen with region 
specific changes in TEER due to semen (Appendix Chapter 2). END1 cells had a 
significant, sharp increase in TEER in as little as 5 minutes, which lasted over 4 h 
(Appendix Chapter 2). The other cell lines tested did not see this increase so 
quickly. Although characterized by a single, columnar epithelium, END1 cells may 
not provide a leakier barrier as compared to the squamous, stratified epithelia of 
VK2 or ECT1 cells (Appendix Chapter 2).  
However, the effect of semen across the different regions of the FRT may 
have broader implications for pathogen transmission requiring the use of immune 
cell hosts, such as HIV-1 [95, 97, 104, 126, 171, 172]. As stated above, CCR5 is 
one of the co-receptors needed for entry into target CD4+ T cells (T helper cells) in 
conjunction with the CD4 receptor. CXCR4 is another co-receptor that can be used 
in conjunction with CD4, by HIV-1, to enter and infect T helper cells. If an HIV-1 
virion utilizes CCR5 and CD4 it is termed R5, and if an HIV-1 virion utilizes CXCR4 
and CD4 it is termed X4 [108, 131, 139].  
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Viral tropism is an important consideration in the establishment of the initial 
infection [108, 132]. While both virus co-receptor phenotypes may be present in 
semen at the time of deposition in the FRT, in discordant, heterosexual 
transmission of HIV-1 R5 viruses are almost always the HIV-1 variants to enter 
and infect T helper cells that drain to the lymph nodes and establish a chronic 
infection [132]. While X4 viruses can be transmitted, the transmission of viruses 
that use CXCR4 as a co-receptor is rare [132].  In studies of semen and its ability 
to transduce its effect across the epithelial barrier and influence immune cells, it 
was found that the PBMCs co-cultured with Ect1 epithelial cells, which represents 
the transformation zone, were preferentially infected with R5 viruses than X4 
viruses in the presence of semen (Chapters 4 and 5). However, what was 
interesting about this study is that in the absence of semen, X4 viruses were the 
most abundant HIV-1 variant to enter and infect T helper cells (Chapters 4 and 5). 
Therefore, the presence of semen in the FRT releases some factor from the 
epithelium that acts on immune cells present in the subepithelial space to increase 
the chances of R5 viral entry and infection of X4 entry and infection (Chapters 4 
and 5).  
Aiding in the increased infection of R5 viruses in the presence of semen is 
the increased surface density of CCR5 (Chapter 5). When comparing the surface 
density of CCR5 on each regions’ T helper cells the ECT1 cell line induced a 
significantly higher density of CCR5 than the VK2 or END1 (Chapter 5). The 
cytokine milieu in the subepithelium of the ECT1 cells appears to favor CCR5 
upregulation (Chapter 5). However, the cytokine environment induced by ECT1 
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cells is the strongest pro-inflammatory signal of all three cell lines (Appendix 
Chapter 1), and a more pro-inflammatory environment will increase the surface 
density of CCR5 on T cells [139, 147, 153].  
When looking at CXCR4 surface density across all cell lines, we see the 
opposite (Chapter 5), insofar T helper cells co-cultured with ECT1 cells had the 
lowest surface density of CXCR4 compared to the other cell lines (Chapter 5). This 
fact might be one reason why T helper cells co-cultured with VK2 and END1 cell 
lines were largely infected with X4 viruses over R5 viruses in the absence and 
presence of semen (Chapter 5). This data together suggest that in the presence 
of semen there are factors released from the ECT1 cell line (and ectocervix, by 
extension) that are specific to that region that enhance CCR5 surface density and 
infection of R5 viruses (Chapters 4 and 5). 
 
6.7 Future Directions 
The dynamic interplay of semen and the FRT has direct implications in 
reproductive biology but can also contribute to pathogen transmission. As seen in 
this review constituents in semen interact with the epithelial barrier to induce 
mechanical changes to occlude paracellular pathogen transmission. Identifying the 
specific factors in semen that work together to rapidly induce tight junction 
regulation as early as 5 minutes-post semen exposure could lead to the 
development of powerful microbicides. The act of coitus is known to induce 
microabrasions in the FRT [127], therefore by developing a topical agent that 
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would help reduce the amount of paracellular permeability may offer an approach 
that reduces the risk of pathogen transmission from male-to-female. 
Not just with mechanical processes but by understanding what factors in 
semen contribute to the overall success of pregnancy and fetal development new 
conclusions can be made about the causes of infertility. Knowing what factors 
cause infertility and how they have long term effects could change how infertility is 
treated. However, those same immunomodulatory factors in semen have 
undesired consequences in pathogen transmission. As stated above, viral 
transmission of HIV-1 (either by R5 or X4 viruses) is enhanced in the presence of 
semen (Chapters 4 and 5). Therefore, uncovering what specific factor is released 
from the epithelium to enhance transmission would be important. This unknown 
factor could be an ideal target for microbicide development. Identifying the specific 
factor that enhances R5 viral transmission in the transformation zone will provide 
clues and insight to how viruses find, enter, and infect cells.  
 
6.8 Conclusion  
It is essential to understand the importance of semen and the downstream 
effects it may have in areas like the FRT. Semen is far from a chemically inactive 
substance that just delivers paternal antigens to the female to establish pregnancy. 
This review has shown that semen elicits a mechanical and biological effect on the 
FRT epithelia. Therefore, the need to understand how these effects take place is 
paramount to not only the safety and well-being of the female but the safety and 
well-being of, perhaps, a developing fetus. There are far more studies that need to 
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be done to elucidate the full effects of semen and how it changes the FRT relative 
to conception and pathogen transmission. 
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A1.1 Abstract 
Semen is a biologically complex fluid containing numerous 
immunomodulatory factors. Previous studies concerning the effects of semen on 
epithelial cell soluble factor secretion have relied on the use of submerged cell 
culture methods, which do not accurately reflect the polarized nature of the 
epithelium lining the female reproductive tract. To circumvent this limitation, a 
transwell tissue culture system was used to examine the effects of semen on 
polarized cervicovaginal epithelial cells. Cell lines derived from different regions of 
the reproductive tract – vagina, ectocervix, and endocervix – were grown into 
polarized, confluent monolayers and then exposed to 25% seminal fluid for 4 h. 
Quantification of analytes contained in conditioned media collected at 4 h and 24 
h post-exposure demonstrated time-, cell line-, and polarity-dependent cytokine, 
chemokine, and growth factor secretion in response to semen, with vaginal and 
endocervical cells being the most and least responsive, respectively. Differences 
in semen-induced factor release between different regions of the female 
reproductive tract may alter immune responses to pathogens within the FRT as 
well as modulate the risk of infection. 
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A1.2 Introduction 
Traditionally, studies of both reproduction and sexually transmitted 
infections have analyzed microbial and immunological events independent of 
seminal fluid, which has generally been viewed as an inert vehicle for the delivery 
of sperm and sexually transmitted disease (STD) pathogens. However, recent 
evidence indicates that seminal fluid is more than a passive carrier and is actually 
complex in composition, containing many factors, including chemokines, 
cytokines, and growth factors. This work has primarily stemmed from research on 
infertility, which seeks to understand the role that factors in semen may play in 
facilitating successful reproduction. These studies have revealed that seminal fluid 
is instrumental in driving the local immune changes within the female reproductive 
tract (FRT) that are integral to fertilization as well as embryo implantation. 
Although semen induces an initial local inflammatory response due to 
recognition of foreign paternal antigens by the female, there is an eventual decline 
in inflammation and a state of immune tolerance that prevents immune clearance 
of sperm and the ensuing embryo allograft [87]. The shift from inflammation to 
tolerance is orchestrated not only by factors contained in seminal fluid, but also by 
another major participant: the epithelial monolayer lining the FRT. Seminal fluid 
can act directly on the epithelium by altering the function of the epithelial barrier 
[29], and indirectly by inducing the secretion of factors that will, in turn, direct local 
immune responses. Together, semen-derived factors and epithelial-derived 
factors direct the biphasic immune response necessary for sperm clearance and, 
eventually, tolerance. 
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The same factors that are critical to fertilization may also affect the 
susceptibility of women to infection by STD pathogens, including the human 
immunodeficiency virus type 1 (HIV-1). Despite effective antiretroviral therapies, 
the HIV-1 epidemic continues to be a problem, with over 2.5 million new infections 
in 2011 [173, 174]. About half of the world’s HIV-1-infected individuals are women, 
the majority of whom acquired the infection through male-to-female sexual 
transmission	[2]. Females are twice as likely as men to become infected during 
intercourse, with a 1-in-2000 risk of a woman acquiring HIV-1 from her infected 
male partner, as compared to the 1-in-7000 risk for a male becoming infected by 
a HIV-1-infected female [2]. In order to better understand the factors that put 
women at risk for infection in the current epidemic, it will be essential to closely 
study the initial steps of HIV-1 transmission that occur within the FRT. 
For this purpose, we turned to an in vitro cell culture system that more 
accurately mimics the FRT. Previous semen-epithelium interaction studies have 
relied on traditional submerged cultures in which cells are grown in flat-bottom 
plates. Although the cells grow rapidly in this setting, the polarized aspect of the 
cell monolayer is not properly reproduced and only one interface (apical) is 
available to the external environment. More recent studies have relied on a 
transwell culture system [8, 148] in which cells are grown on semi-permeable 
transwell membrane inserts and monitored for confluence to ensure the 
development of fully intact monolayers. Transwell-based studies of cell lines 
derived from different regions of the FRT have identified differences in tight 
junction expression and phenotype unique to each region, which is consistent with 
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analyses of ex vivo tissues isolated from these areas [175]. Importantly, stimuli in 
the transwell system can be applied as they may be encountered in vivo; in our 
model, the apical chamber represents the FRT lumen where semen is deposited 
during intercourse, and the basolateral chamber represents the subepithelial 
space. 
This method of culture also permits us to monitor the dual functions of 
epithelial monolayer: the “fence” and the “gate” [176]. Tight junction strands, 
expressed in the apical region of the membrane, are responsible for connecting 
the neighboring cells to form the “fence” network, resulting in cell polarity and 
structure	 [176]. At the same time, tight junctions also function as a “gate” to 
regulate paracellular permeability, blocking larger entities, such as bacterial 
pathogens or cancer cells; maintaining osmotic balance; and regulating the 
passage of molecules and ions [176]. These functions have been well 
characterized in many tissues using measurements of electrical resistance and 
permeability, and have also been reviewed in the literature [157, 175-178]. 
Therefore, in our system, the transwell culture system provides an excellent 
platform for examining the effects of semen on the female epithelium at the level 
of both barrier integrity [29] and the polarized release of soluble factors. 
We hypothesized that epithelial cells grown in a transwell culture system 
would respond to semen by releasing factors in a polarized manner – a key aspect 
that cannot be studied in a submerged culture. In order to determine the identities 
of biologically active components released by the epithelium, we exposed epithelial 
monolayers to seminal fluid (SF) as they would be encountered in vivo during 
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coitus and analyzed the supernatants to determine how factors in SF contributed 
to the initial inflammatory response by the epithelium. The goal of these 
investigations was to study the early steps of heterosexual transmission in vitro 
using a quick, effective, and inexpensive assay that can be used to show changes 
in epithelial function and their potential effects of HIV-1 transmission. 
 
A1.3 Materials and Methods 
A1.3.1. Cell line maintenance 
Experiments were performed using cell lines derived from three regions of 
the human female reproductive tract: endocervical cells (End1/E6E7), ectocervical 
cells (Ect1/E6E7), and vaginal keratinocytes (VK2/E6E7) (ATCC, Manassas, VA). 
Prior to seeding, cells were grown and maintained in T150 tissue culture flasks 
(Grenier Bio One, Monroe, NC) at 37°C and 5% CO2. Ect1 cells were cultured 
using the Keratinocyte Serum-Free Medium (Gibco, Grand Island, NY), which 
included 50 μg/ml bovine pituitary extract (BPE), 0.1 ng/ml epithelial growth factor 
(EGF), and 50X penicillin/streptomycin solution. End1 and VK2 cells were cultured 
in the same Keratinocyte-SFM medium described above but with the addition of 
0.4 mM calcium chloride (EMD Millipore, Billerica, MA).  
A1.3.2. Transwell culture system 
Cell lines were cultured as confluent, polarized monolayers by seeding into 
the apical chamber of a 6.5 mm, 0.4 μm pore size, polyester (PET) transwell insert 
in a 24-well receiver plate (Corning, Corning, NY). All cell lines were seeded at a 
density of 1.5 x 105 cells per well in 200 μl of media in the apical chamber and 600 
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μl in the basolateral chamber. Time to confluence (determined by electrical 
resistance, as described below) was cell line-dependent and varied between 14 
and 21 days post-seeding. 
A1.3.3. Transepithelial electrical resistance 
Epithelial monolayer establishment was monitored by measuring 
transepithelial electrical resistance (TEER or TER), which is an indirect measure 
of tight junctions. Using an EVOM2 voltohmeter and STX2 chopstick electrode 
(World Precision Instruments, Sarasota, FL), daily resistance readings (ohms or 
Ω) were taken during the growth of the monolayers. Cell monolayers were 
determined to be fully developed once the TEER readings had plateaued for 2 to 
3 consecutive days. Empty wells containing media only (no cells) were used to 
establish background TEER levels. Due to differences in the expression of tight 
junctions, raw plateau TEER values (Ω) differed between cell lines: End1 cells, 
~250-300 Ω; Ect1 cells, ~220-250 Ω; and VK2 cells, ~220 Ω. These results are 
consistent with other studies using these cell lines [148, 175]. 
2A1.3.4. Seminal fluid 
Seminal fluid (SF) was purchased as 10 ml of pooled semen from a mixture 
of six healthy donors between 26 and 34 years of age (Lee Biosolutions, St. Louis, 
MO). Specimens were shipped overnight on dry ice and immediately divided into 
500 μl aliquots and frozen at -20°C upon arrival. In all descriptions, SF refers to 
whole semen containing sperm. 
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A1.3.5. Collection of conditioned media 
End1, Ect1, and VK2 monolayers in transwells were exposed apically to 
25% SF in duplicate for 4 h, and then apical and basolateral supernatants were 
collected and stored at -80°C. The monolayers were washed two times with HBSS 
and fresh media was added to both chambers. After an additional 20 h incubation, 
the apical and basolateral supernatants were again collected and stored at -80°C. 
For experiments involving HIV-1, the monolayers were exposed apically to HIV-1 
laboratory strain BaL (Zeptometrix, Buffalo, NY) in the absence or presence of 25% 
SF for 4 h, followed by the collection of apical and basolateral supernatants. All 
conditioned media samples were analyzed by Luminex analysis. 
A1.3.6. Luminex assay of conditioned media 
The 30-plex assay was performed as described by the manufacturer 
(Millipore, Billerica, MA). Briefly, each well of the 96-well filter plate was pre-
equilibrated using assay buffer prior to the addition of the conditioned media (apical 
or basolateral) samples. The cytokine standards and samples were diluted to 2X 
in assay buffer and added in duplicate to the designated well of the filter plate, then 
incubated with antibody-coupled beads with shaking for 1 h and without shaking 
for 1 h. Next, secondary antibody was added to the wells and incubated with 
shaking for 30 min and without shaking for 30 min. Unbound analytes were 
removed through the well filters using a vacuum manifold. After washing the wells, 
the samples were then analyzed on a Luminex200 xMap plate reader (Applied 
Biosystems, Carlsbad, CA, USA) [179, 180]. Each sample was assayed for 30 
different factors, including cytokines and chemokines, and graphed using Excel. 
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The benefit of using Luminex technology is the sensitivity of the assay and ability 
to detect cytokine proteins in small sample volumes. Semen samples were also 
analyzed using the 30-plex Luminex assay. 
A1.3.7. Statistical analyses 
p-Values were calculated for the difference between pairs of treatments 
conditions using a two-tailed Student’s t-test, and a value of less than 0.05 was 
set as the limit for statistical significance. p-Values are indicated on the figures 
and within the figure legends. 
 
A1.4 Results 
A1.4.1. Epithelial monolayer viability and monolayer integrity are 
unaffected by SF exposure 
Three well characterized cell lines were used to represent the distinct 
regions of the FRT. End1, Ect1, and VK2 cell lines express variable levels of tight 
junctions, which correlate with their respective functions in the regions from which 
they were derived [83, 175]. It is important to mention that each cell line has a 
transwell TEER reading at confluence that corresponds to the level of tight junction 
expression in vivo: VK2 < Ect1 < End1 [175]. VK2 cells (vaginal keratinocytes) 
were derived from cells that form an effective mechanical barrier that is up to 25 
squamous cell layers thick, but have low expression of tight junctions facilitating 
the continual sloughing of the lining. Ect1 cells (ectocervical cells) represent the 
transition zone, an area in which the thick squamous epithelium begins to thin and 
gains a columnar phenotype that expresses high levels of tight junctions. End1 
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cells (endocervical cells) form single, organized layers of columnar epithelium that 
express high levels of tight junctions [175]. Previous studies of a similar nature 
were performed by culturing these cell lines in flat-bottom plates rather than 
transwells [29, 84]. 
Several studies have reported decreased cellular viability in the presence 
of SF, resulting in limitations with respect to exposure time and usable 
concentration ranges [7, 84]. While dilution of semen to concentrations as low as 
0.1% can circumvent these limitations, these concentrations are too low to fully 
replicate the concentrations of semen that occur after deposition in the FRT. 
Studies of human and animal reproduction have revealed that once in the FRT, SF 
is diluted by mixing with vaginal secretions and spreading throughout the vaginal 
tract [114]. Although there is some disagreement about the actual degree of 
dilution that occurs, the general consensus is that semen is diluted to between 
25% and 10% of its original concentration [114]. With respect to semen retention 
in the FRT, observations on the absorption, spreading, and breakdown of SF that 
occurs within the FRT have determined that the majority of SF has been removed 
or exited the region by 4 h [114]. These factors are important to define in order to 
develop an in vitro approach that better mimics in vivo conditions and events. We 
speculated that past studies have not been able to achieve physiological 
concentrations due to the hypersensitivity of the cells to semen in submerged 
culture. Using this information to guide our experimental design, End1 monolayers 
were incubated apically with 25% or 10% SF for 4 h. In this time frame, SF 
exposure had no effect on cell viability (data not shown). Similar results were 
  
  
	
220 
observed when the experiment was repeated using Ect1 or VK2 monolayers (data 
not shown). With respect to the integrity of the monolayer, we have shown that the 
apical application of 25% SF to these cells in transwell cultures caused a rapid and 
significant increase in TEER [29], reinforcing the conclusion that cell line 
monolayers (i) remain viable after SF exposure and (ii) serve to effectively partition 
the semen in the upper chamber from the media in the lower chamber. 
A1.4.2. Seminal fluid has a proinflammatory profile and contains a 
multitude of immunomodulatory factors 
Before defining the response of the epithelial monolayer, the contents of the 
semen were profiled in order to determine what factors would be introduced into 
the apical transwell environment during SF exposure. Since SF is highly variable 
not only between donors, but even between ejaculates collected from the same 
individual on different days, pooled specimens from multiple donors were utilized 
in order to reduce the variability and obtain a more representative picture of semen 
factor content across an average population [120]. While SF was shown to be rich 
in a wide array of factors, the most prominent among the 30 factors analyzed were 
chemokines (Fig. A1.1). In agreement with other published studies, our analyses 
indicated that semen from the average healthy male is generally characterized as 
slightly pro-inflammatory, as detectible concentrations of inflammatory factors 
such as IL-12, IFN-α, IL-6, and IFN-γ were present (Fig. A1.1B) [6, 7]. In contrast, 
anti-inflammatory cytokines were almost undetectable, with the exception of IL-
1RA (177 pg/ml) (Fig. A1.1B). There were also high concentrations of chemokines 
and growth factors present, which have been widely discussed in literature for their 
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pivotal biological role in reproduction and embryogenesis	 [87, 114]. The most 
prominent chemokines in pooled SF were monocyte chemotactic protein 1 (MCP-
1) (5637.5 pg/ml) and interleukin 8 (IL-8) (3971.4 pg/ml) (Fig. A1.1C), while the 
most concentrated growth/signaling molecule was epithelial growth factor (EGF) 
(2867.1 pg/ml) (Fig. A1.1D). 
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Figure A1.1A 
 
MCP-1 5637.5 MIG 325 IL-2R 69.02 MIP-1β 14.24 GM-CSF 2.48 
IL-8 3971.40 IL-15 322.48 IL-6 58.08 MIP-1α 10.78 IL-10 2.18 
EGF 2867.1 IL-RA 177.71 G-CSF 30.67 IL-4 6.37 TNF-α 1.25 
HGF 437.40 VEGF 130.72 IFN-γ 26.12 IL-1β 5.94 IL-17 0.87 
IP-10 372.79 IL-12 107.49 IL-5 26.08 IL-13 5.62 IL-2 0.48 
IL-7 341.43 IFN-α 81.83 Rantes 15.96 Eotaxin 5.018 FGF-basic 0 
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Figure A1.1B 
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Figure A1.1C 
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Figure A1.1D 
 
 
 
Fig. A1.1. Concentrations of biological factors contained in pooled human 
seminal fluid. (A) Analytes detected by Luminex assay in 25% diluted SF were 
arranged from highest to lowest concentration (pg/ml). The table shows the exact 
concentrations detected (pg/ml). (B-D) The factors are arranged according to 
different biological activities: (B) pro-inflammatory and anti-inflammatory 
cytokines, (C) chemokines, and (D) growth/signaling factors. Analytes are 
arranged from highest-to-lowest concentration (pg/ml). 
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A1.4.3. Polarized release of epithelial factors during SF exposure 
After demonstrating that the content of SF was predominantly inflammatory, 
the next step was to characterize the influence of semen on the epithelium in the 
context of the vaginal lumen during intercourse. We have characterized the direct 
effects of SF on the epithelium at the level of barrier integrity (Appendix Chapter 
2), but here we were interested in measuring the indirect effects of exposure by 
identifying the secretion of factors from the epithelium as a response to semen. A 
previous study on the effects of seminal plasma on genital epithelial cells (GECs) 
in transwell inserts demonstrated that these cells unilaterally released cytokines 
exclusively into the apical chamber, while the same factors were undetectable in 
the basolateral chamber [8]. In our model, all three cell lines secreted factors at 
basal levels into both the apical and basolateral chambers of the mock-exposed 
wells, and levels of release were generally increased after exposure to SF (Fig. 
A1.2). Overall, the profile of factors secreted into both chambers by all three SF-
exposed, FRT-derived cell lines at both time points was predominately pro-
inflammatory (Table A1.1). The only anti-inflammatory factor released at a level 
greater than 5-fold above its basal level was IL-1RA. However, IL-1RA returned to 
mock-exposed levels by 24 h post-exposure (Table A1.1). Heat maps show fold 
changes in factor release into the apical (Fig. A1.3) and basolateral (Fig. A1.4) 
conditioned media from all three cell lines. 
When comparing the 4 and 24 h supernatants, it was apparent that there 
was a time-dependent aspect of the effects of SF on some factors. The basolateral  
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Figure A1.2 
 
 
 
Fig. A1.2. Immunomodulatory factor release from FRT epithelial cells is time-
, direction-, and cell line-dependent. Conditioned media samples were collected 
at 4 and 24 h post-exposure from cells exposed for 4 h to semen. The numbers of 
factors secreted out of the 30 analytes are plotted with respect to chamber of origin, 
time post-exposure, the absence (mock) or presence of SF, and the cell type. 
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Figure A1.3 
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Fig. A1.3. Relative changes in apical factor release are time-, direction-, and 
cell line-dependent. Changes in factor concentrations in the apical chambers are 
shown as a heat map of fold-change over mock of 30 analytes detected in 
conditioned media collected from the apical supernatants at 24 h after exposure to 
25% SF. 
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Figure A1.4 
 
 
 
Fig. A1.4. Relative changes in basolateral factor release are time-, direction-
, and cell line-dependent. Changes in factor concentrations in the basolateral 
chambers are shown as a heat map of fold-change over mock of 30 analytes 
detected in conditioned media collected from the basolateral supernatants at 4 and 
24 h after exposure to 25% SF. 
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Table A1.1 
Table A1.1. Factor release as a consequence of SF exposure. Fold change of 
each analyte in the conditioned media collected from the apical and basolateral 
chambers at both time points across all three cell lines after exposure to 25% SF. 
BD, below the assay limit of detection. 
 
 VK2 Ect1 End1 
 4h 24h 4h 24h 4h 24h 
IL-1β 
Apical 20.5 3.2 18.6 1.0 36.4 5.3 
Basolateral 3.3 1.8 2.0 BD BD 0.3 
IL-1RA 
 10.2 2.2 1.9 0.6 5.5 1.8 
 5.6 1.1 2.6 1.8 3.7 2.8 
IL-2 
 1.2 BD BD BD BD BD 
 BD BD BD BD BD BD 
IL-2R 
 5.7 3.8 1.8 2.4 4.7 1.7 
 3.7 1.2 25.0 1.2 1.0 1.3 
IL-4 
 14.7 4.0 11.9 BD 15.0 3.0 
 BD BD BD BD BD BD 
IL-5 
 23.0 4.3 12.9 0.6 29.4 2.7 
 0.6 BD 0.6 BD BD BD 
IL-6 
 25.7 9.9 35.1 15.2 23.8 11 
 5.0 5.1 14.5 24.3 9.7 5.1 
IL-7 
 130.6 12.9 110.2 2.7 416.6 36.5 
 25.1 2.7 44.0 BD 1.3 0.8 
IL-8 
 73.0 29.6 12.6 5.2 71.3 11.6 
 3.4 5.6 1.8 3.3 6.0 9.1 
IL-10 
 4.1 1.3 2.9 BD 4.1 1.2 
 BD BD BD BD BD BD 
IL-12 
 73.1 8.0 270.8 1.4 64.8 8.7 
 6.5 2.1 31.3 2.5 5.9 1.3 
IL-13  15.7 6.8 14.4 1.0 14.9 4.0 
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 BD BD BD BD BD BD 
IL-15 
 55.7 8.2 71.9 1.2 35.6 2.7 
 22.0 2.9 7.7 2.3 1.4 1.0 
IL-17 
 1.6 BD BD BD BD BD 
 BD BD BD BD BD BD 
FGF-
basic 
 1.4 1.2 BD BD 0.9 5.4 
 0.9 0.7 1.6 BD 1.7 1.3 
MIG 
 BD 15.6 1004.3 BD 1358.6 6.0 
 BD BD BD BD BD BD 
MCP-1 
 1182.6 16.4 97.6 2.1 930.4 7.2 
 7.4 3.3 5.9 1.3 6.5 1.8 
MIP-1α 
 22.3 3.4 27.6 0.5 18.8 6.7 
 1.0 0.7 1.4 1.0 1.4 BD 
MIP-1β 
 21.6 2.4 28.0 3.0 17.8 4.6 
 2.2 0.6 BD BD BD BD 
IFN-γ 
 72.6 15.5 40.5 1.6 74.9 16.7 
 3.6 1.3 5.9 BD BD BD 
IFN-α 
 22.0 5.1 13.3 1.3 11.7 1.7 
 2.1 2.2 2.4 1.5 1.7 0.7 
TNF-α 
 3.3 0.9 3.6 0.7 2.9 BD 
 BD BD BD BD BD BD 
EGF 
 4061.1 7.4 1445.8 12.5 3148.8 16.7 
 1.5 1.0 1.3 1.1 1.2 1.5 
G-CSF 
 25.6 10.8 70.7 1.3 73.2 6.2 
 BD 3.5 6.9 3.5 BD 1.0 
GM-CSF 
 4.8 7.3 1.5 4.5 5.6 9.1 
 BD 1.2 BD 2.3 BD 1.3 
HGF 
 256.1 13.7 155.3 1.9 264.7 13.7 
 2.1 1.1 2.1 2.1 BD BD 
VEGF 
 303.0 39.4 418.2 2.6 265.0 36.4 
 9.3 2.5 1.0 2.5 3.9 1.9 
IP-10 
 148.2 11.2 121.8 2.4 28.4 2.1 
 6.6 3.1 4.6 1.4 1.6 1.2 
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Eotaxin 
 3.6 0.1 1.7 BD 3.6 BD 
 BD BD BD BD BD BD 
RANTES 
 5.9 2.7 18.7 1.2 23.5 9.7 
 0.9 5.2 BD BD BD BD 
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compartment at 4 h included an overall increase in secretion activity that 
continued out to 24 h, which was also true for the apical compartment at 24 h (Fig. 
A1.2). When the fold change in factor secretion was compared between individual 
analytes, it was apparent that some were secreted at a maximum concentration 
early (4 h post-exposure) and decreased to nearly mock-exposed levels by 24 h. 
For example, IL-7 from VK2 and Ect1 cells peaked early (4 h post-exposure) at 25- 
and 44-fold above mock-exposed levels, respectively (Table A1.1). On the other 
hand, some factors continued to accumulate, such as VEGF, which increased 
nearly 40-fold by 24 h in the apical chamber of VK2 cells (Fig. A1.3 and Table 
A1.1), and IL-17, which increased 3.5-fold in the basolateral chamber (Fig. A1.4 
and Table A1.1). However, not all factors that were present in the conditioned 
media at 24 h were expressed at the early time point; IL-17 and RANTES were 
detected only in the 24 h apical and basolateral supernatants of VK2 cells (Table 
A1.1). 
In this experiment, polarized release of factors was also noted. While IL-6 
was consistently secreted by all three cells lines into both chambers at each time 
point (Figs. 3 and 4, and Table A1.1) some factors were exclusively released either 
into the apical or basolateral chamber. For example, IL-2R release by Ect1 cells at 
the 4 h time point was increased 25-fold in the basolateral chamber, but present 
at less than 2-fold in the apical chamber relative to mock (Table A1.1). In the same 
cells, IL-5 release was limited to the apical supernatant (~13-fold) and remained 
undetectable in the basolateral chamber (Table A1.1). The disparate concentration 
of IL-5 across the monolayer interface also provides evidence for efficient tight 
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junction interactions, proving that the seal regulating the paracellular space is tight 
enough to prevent factors secreted in great abundance in the apical chamber from 
diffusing into the bottom chamber. 
The integrity of the epithelial monolayer as a barrier to diffusion was also 
indicated by differences in concentrations between factors present in SF in the 
apical chamber and the same factors detected in the basolateral chamber. IFN-γ 
was present at low concentrations in SF (26.12 pg/ml) (Table A1.1). In contrast, 
VK2 cells subsequent to SF exposure released 72.5 pg/ml apically at the 4 h time 
point, which was still elevated to ~26 pg/ml at 24 h post-exposure despite the 
removal of SF; the same relationship was observed with IFN-γ in the End1 cells 
(Table A1.1). On the other hand, MCP-1, which was present in semen at very high 
concentrations – over 5500 pg/ml – was released into the basolateral chamber by 
all three cell lines at very low concentrations (~30 pg/ml or less) (Table A1.1). This 
is a key observation, indicating that factors in the basolateral chamber were 
released from the epithelial cells rather than diffusing out of the semen across the 
epithelial barrier. Further study will be required to determine whether significant 
correlations exist between the concentrations of factors found in seminal fluid and 
the concentrations released by the epithelium as a response. Establishing 
relationships between these variables will aid future investigations focused on the 
effects seminal factors on infertility and STD pathogen transmission within the 
FRT. 
The response of the epithelium to semen varied across the different regions 
of the FRT, as represented by the three FRT-derived cell lines. Cells from the 
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vaginal tract were the most active, secreting the widest range of factors in both the 
absence and presence of semen at both time points compared to the other two 
cell lines (Figs. 2-4 and Table A1.1). However, with respect to fold change, the 
ectocervical cells had the greatest response to SF at 4 and 24 h in the basolateral 
chamber, releasing high concentrations of IL-2R, IL-6, IL-7, and IL-12 (Fig. A1.4 
and Table A1.1). Endocervical cells were the least responsive to semen (Table 
A1.1), producing a few factors at 2-fold or more levels at either time point (including 
IL-8, IL-6, VEGF, and MCP-1). Some cytokines were exclusively expressed by one 
cell line. For example, FGF-basic, which was not detected in semen (Fig. A1.1), 
was not secreted by VK2 or Ect1 cells, but was increased 5.4-fold in the apical 
chamber of End1 cells at 24 h (Table A1.1). In summary, these analyses indicate 
that the epithelial response to SF, which continues through 24 h post-exposure 
even in the absence of SF, is directional, predominantly pro-inflammatory, and 
dependent on the identity of the epithelial cells. 
A1.4.4. Effects of HIV-1 BaL on epithelial cytokine release 
Previous studies have shown variable effects of HIV-1 on the epithelial 
barrier. Although epithelial cells may or may not host HIV-1 infection, they are still 
positioned to provide an innate immunological response to cell-free (or cell-
associated) virus. The release of factors by the epithelium will shape the local 
immune response and could possibly affect the early events of HIV-1 transmission. 
To examine this effect, Ect1 epithelial cell monolayers were exposed to HIV-1 
strain BaL (a strain which uses CCR5 as a co-receptor) for 4 h. Using the same 
30-plex assay, cytokine, chemokine, and growth factor output from the epithelium  
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Figure A1.5A 
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Figure A1.5B 
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Figure A1.5C 
 
 
Fig. A1.5. Release of factors as a response to apical exposure to HIV-1 BaL. 
(A) Ect1 conditioned media was collected at 4 h from the apical and basolateral 
chambers after exposure to HIV-1 in the absence of SF. Concentration changes 
are expressed as fold-change relative to mock-exposed wells. (B,C) Ect1 
conditioned media was collected at 24 h post-exposure from the (B) apical and (C) 
basolateral chambers after apical 4 h exposure to 25% SF in the absence or 
presence of HIV-1 BaL. Concentration changes are expressed as fold-change 
relative to mock-exposed wells. SF, semen only; SFV, uninfected pooled semen 
combined with HIV-1 BaL. 
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was measured after 4 and 24 h of incubation. The addition of apical virus to 
Ect1 cells most prominently induced high concentrations of RANTES in the apical 
chamber, with a 24-fold increase over mock-exposed monolayers at 4 h and a 
small increase in IL-6 (Fig. A1.5A). In contrast, the basolateral chamber, which did 
not contain any detectable RANTES, included a 10-fold increase in concentration 
of IL-2R over mock-exposed monolayers (Fig. A1.5A). By 24 h post-exposure, 
however, most of the factors (including RANTES) were found at concentrations 
less than 2-fold relative to mock-exposed levels (data not shown). These lower 
levels of soluble factors may be consistent with virus removal from the apical 
chamber at 4 h post-exposure. In summary, the release of these factors was both 
time- and direction-dependent. 
HIV-1 BaL was also added to uninfected semen in order to determine the 
combined effects of SF and virus. Factors released by Ect1 cells exposed apically 
to SF with virus (SFV) (Fig. A1.5B and C, blue bars) were similar to those released 
by Ect1 cells exposed to SF alone (Fig. A1.5B and C, red bars), and most analytes 
were increased to the same degree relative to mock-exposed cells across both 
profiles. However, there was a slight upregulation of IL-1RA (~2-fold) into the 
basolateral chamber in the presence of virus that had not been detected in the 
conditioned media from cells exposed to semen alone (Fig. A1.5C). Interestingly, 
there were fewer factors expressed in the SFV wells compared to the semen wells 
in the absence of virus (Fig. A1.5B and C, blue bars). For example, HGF was 
increased 2-fold in conditioned basolateral media from SFV-exposed cells, but was 
absent from the SF-only wells (Fig. A1.5C). Similarly, IL-2R, IL-7, and MIP-1β were 
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present in the apical supernatants from cells exposed to SF only, but were 
undetectable in conditioned media subsequent to the addition of virus (Fig. A1.5B). 
These results indicate that virus was capable of subtly modulating the cytokine 
output of the epithelium, and could potentially alter the local immune response as 
a consequence. Further study will be required to determine whether this profile is 
dependent on the viral strain or origin of the epithelial cells, and is consistent with 
effects of the virus in vivo. 
 
A1.5 Discussion 
The transwell tissue culture system is an effective means to model polarized 
tissues. Previous investigations have relied on the transwell system for the 
purpose of studying other tissues and organs, such as the kidney [181] and gut 
[182]. In our studies, this model system has been used to recapitulate the FRT in 
vitro, with the apical chamber representing the vaginal lumen and the basolateral 
chamber representing the subepithelial space. This experimental design has a 
distinct advantage over traditional submerged culture in that it maintains the 
topology of the FRT in an in vitro setting and offers a polarized environment in 
which (i) the epithelial monolayers can be exposed apically to semen, mimicking 
semen deposition in the FRT, and (ii) the cells can be provided with nutrients from 
the basolateral interface during apical exposure, thereby eliminating the toxic 
effects that have typically been associated with SF exposure in submerged culture 
studies. Since semen is not regarded as cytotoxic in vivo, the transwell model is a 
better representation of the FRT relative to submerged cell culture models. 
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This model also provides the opportunity to examine the polarized release 
of immunomodulatory factors in response to semen exposure. Previous studies of 
the effects of semen on the epithelium lining the FRT have relied on submerged 
cell culture as the preferred model system. This approach is expeditious and 
inexpensive, since the cells grow to confluence in a matter of 3 or 4 days, 
compared to a 20-day growth period required for cells cultured in a transwell insert. 
As demonstrated in our experiments, however, cell confluence after three days 
does not equate to the formation of tight intercellular connections, despite the 
presence of a detectable ZO-1 network (data not shown). The extra culture time is 
necessary for the assembly of tight junction-based connections between cells and 
the formation of a high resistance epithelial barrier. 
Experiments using the transwell culture model also revealed that the 
cervicovaginal monolayers are capable of releasing factors in a polarized manner 
in response to semen. This pattern of release varied with time, cell line identity, 
and direction of release. The profile of cytokine release at 4 and 24 h post-
exposure across the three cell lines was predominantly pro-inflammatory, with 
generally low or undetectable levels of anti-inflammatory factors. Several factors 
were predominant early, reaching maximal concentrations at 4 h and then tapering 
off to undetectable levels by 24 h. Other factors that were not secreted early were 
detectable by 24 h, suggesting the activation of a slower pathway of de novo 
protein production and their participation in later events in the process of 
fertilization. Specifically, RANTES was detected only in 24 h supernatants 
collected from the basolateral chamber of VK2 cells. RANTES is an important 
  
  
	
243 
chemotactic cytokine that recruits leukocytes, including T-lymphocytes, to the site 
of inflammation	 [119]. T cells play an important reproductive role at the site of 
implantation by secreting LIF and M-CSF that are important in maintaining 
pregnancy	 [183]. RANTES may also be involved in the process of inducing 
tolerance in the FRT by controlling inflammation, possibly through the recruitment 
of uterine natural killer cells (uNK) that play an essential role in angiogenesis to 
support fetal development	 [119, 184, 185]. Elevated RANTES at 24 h also 
suggested that, despite SF removal, the epithelium remained activated and 
capable of releasing soluble factors, including those that had not been present 
during semen incubation. The sustained effect correlates with post-coitus events 
in vivo, indicating that, despite the elimination of seminal fluid from the reproductive 
tract within ~4 h, the epithelium maintains a sustained response by releasing 
factors that continue to drive local effects in the FRT. 
We also observed differential release of cytokines between the apical 
(lumen) and basolateral (subepithelial) chambers. Of course, previous studies 
involving submerged epithelial cell cultures were not able to examine polarized 
factor release. This is meaningful, as our studies demonstrated that several 
analytes were limited in the direction of their release. For example, IL-4 was 
released strictly into the apical chamber at both early and late time post-exposure. 
Other factors that were expressed solely in the apical chamber included IL-13, 
MIG, MIP-1β, EGF, GM-CSF, and HGF; several of these factors have documented 
roles in promoting fertility [167, 186-188]. Several factors were released at higher 
concentrations in a basolateral direction compared to the apical chamber, including 
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G-CSF, which increased 3.5-fold in the basolateral chamber and only 1.3-fold in 
the apical chamber of Ect1 cells at 24 h. These results also indicate that factors 
may be released on both sides of the epithelium but at very different 
concentrations. A prominent example of this disparity is IL-8, which was increased 
at 24 h from Ect1 cells at 5.2-fold (6971 pg/ml) in the apical chamber but only 3.3-
fold (1376 pg/ml) in the basolateral chamber. The differing concentrations of 
factors detected in the apical and basolateral chamber are likely correlated with 
the different environments of the lumen and subepithelial space in the FRT. 
Quantification of analytes present in the lumen using cervicovaginal lavage (CVL) 
samples from young women demonstrated that the FRT releases similar 
concentrations of factors in vivo as the cell lines in our model. Specifically, CVLs 
from women with an immature cervical epithelium contained low concentrations of 
RANTES (2.55 pg/ml) that were comparable to concentrations released from Ect1 
(2.1 pg/ml) and End1 (1.5 pg/ml) mock-exposed apical supernatants at 24 h [189]. 
In addition, there were similar expression profiles for IL-6, IL-8, and MIP-1α, [189, 
190]. However, there are several variables associated with the CVL findings that 
must be considered, including donor variability, age, sexual maturity, and the fact 
that lavage samples include secretions from both the vagina and cervix. This latter 
fact confounds attempts to correlate our observation of region-dependent factor 
release with the CVL study findings [189, 190]. Based on these studies, however, 
it is evident that the lumen expresses an abundance of chemokines at basal levels, 
which likely maintain a constant influx of neutrophils into the FRT in order to 
remove waste products produced by bacterial flora and pathogens that are 
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regularly encountered in the non-sterile vaginal tract [87, 114]. Interestingly, SF 
stimulation resulted in the production of pro-inflammatory cytokines (IFN-γ, IL-6, 
and IL-12) in the apical chamber at 24 h, suggesting that the lumen mounts an 
immune response aimed at clearing foreign antigens (in this case, semen) through 
the recruitment of T cells and macrophages [28]. In contrast, the basolateral 
(subepithelial) space was initially pro-inflammatory, but more neutral by 24 h. This 
effect was particularly apparent in the VK2 monolayers, which released IL-12 (6-
fold), IL-6 (5-fold), IFN-γ (3-fold), IL-1β (3-fold), IFN-α (2-fold) at 4 h, but less IL-12 
(2-fold), the same amount of IL-6 and IFN-α, and undetectable IFN-γ and IL-1β by 
24 h. Additionally, IL-17, which was not expressed at 4 h, was increased 3.5-fold 
at the later time point. The shift in the release profile reflects the biphasic shift that 
occurs in vivo during the transition from inflammation to tolerance after semen 
deposition	[87]. Together, the inflammatory factors expressed in both chambers, 
combined with the low levels of anti-inflammatory cytokines expressed apically and 
the continued expression of chemokines (such as RANTES, IL-8, MCP-1, and 
IP10) are responsible for the recruitment and activation of immune cell populations 
trafficking through the subepithelial space and mediating the shift towards a 
tolerogenic environment that is important for sperm survival and embryo 
implantation during reproduction. 
Previous studies using transwell inserts have revealed some variations in 
the concentrations and patterns of factors released from epithelial cells. One 
particular study utilizing GECs showed that these cells released factors exclusively 
into the apical chamber [8]. In contrast, our experiments demonstrated that both 
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chambers were populated with factors secreted by the epithelium in the absence 
and presence of seminal fluid. A similar study using VK2, Ect1, and End1 cell lines 
in submerged cell culture determined that the Ect1 and End1 cervical cells were 
the most responsive at both resting state and upon exposure semen, while VK2 
cells were the least active at both basal level and post-exposure	 [84]. It was 
reasoned that the non-sterile nature of the vagina causes the vaginal epithelium to 
become less responsive and more tolerant to semen due to the constant exposure 
to foreign antigens. In contrast, the cervical cells were more responsive at the level 
of secretion due to the lack of stimulation received at an essentially sterile location 
within the FRT. In our system, however, we observed an inverse of this phenotype: 
the VK2 cells were the most responsive at both baseline and after stimulation with 
seminal fluid, while the End1 cells were the least responsive, expressing the fewest 
number of factors in both the absence or presence of seminal fluid. This has lead 
us to conclude that, because the vaginal environment is continually encountering 
antigens, it is more responsive in order to maintain a homeostatic balance between 
controlled inflammation and tolerance, as compared to the upper cervix, which is 
less frequently exposed to pathogens and therefore produces a less robust 
reaction to seminal fluid. One explanation for the differences between these 
studies is that cells in submerged culture may be subject to feedback loops that 
are activated by factors released uni-directionally. These loops, which may not be 
effective in polarized epithelial cultures, then serve to modify subsequent output. 
Without proper polarization, there may also be changes at the level of factor 
production within the cells due to the uni-directional nature of the cells’ interface 
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with the external environment, resulting in changes in analyte release. Differences 
between cells also likely contribute to the differences in results. In the GEC study, 
cells appeared to be much more active at a basal level, releasing 2000 pg/ml of 
IL-6 into the mock-exposed wells and over 3000 pg/ml after a 4 h exposure to 10% 
seminal plasma [8]. 
However, despite the differences in these studies, some consistent trends 
are apparent. In both our study and the GEC study, IL-6 release from the 
epithelium increased after semen exposure and TNF-α decreased at 24 h post-
exposure. In a comparison to the submerged culture experiments, increases in IL-
6, IL-8, GM-CSF, and MCP-1 were observed after semen exposure in both studies. 
Nonetheless, some differences in expression can also be expected due to 
experimental variables between studies. The submerged study exposed the cells 
to 10% seminal plasma (the soluble fraction of semen) for 12 h, while our 
experiments utilized 25% whole seminal fluid in a 4 h exposure in order to mimic 
post-coitus events in vivo. The longer exposure to semen in the other studies might 
contribute to differences in the measured concentrations of factors by inducing 
more robust and sustained response as a consequence. 
A previous study of the effects of HIV-1 on TEER demonstrated that the 
virus – regardless of strain, length of exposure, or concentration – decreased 
resistance via tight junction breakdown induced by gp120 interactions with the 
epithelial surface	[191]. In our experiments, we sought to examine alterations in 
cytokine output during incubation with virus. HIV-1 BaL exposure induced a very 
limited secretory response, with only 2-fold or greater expression of RANTES, IL-
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6, and IL-2R at 4 h post-exposure. Exposure to virus in the presence of seminal 
fluid (SFV) resulted in a slight modulation of the semen-induced profile of cytokine 
release relative to SF exposure alone. Although the secretion profiles were 
generally similar between 24 h SF- and SFV-exposed cells, factors that were 
released at higher levels from SF-exposed wells (IL-2R, IL-6, IL-7, EGF, MIP-1β, 
and VEGF) were released apically from SFV-exposed wells at concentrations less 
than 2-fold above controls. In contrast, releases of IL-15 and G-CSF were higher 
in the SFV-exposed apical media, but less than 2-fold in the SF wells. There was 
additional evidence of immunomodulation by the virus in the basolateral 
compartment, with decreases in HGF but upregulation of IL-1RA relative to cells 
exposed only to semen. These results suggest that epithelial exposure to HIV-1 
results in a delayed reduction in inflammatory and growth factors, but a concurrent 
upregulated secretion of anti-viral factors (IL-15) into the apical compartment. At 
the same time, there appeared to be little change in factor release within the 
subepithelial space, which was dominated by inflammatory factors (IL-6 and IL-12) 
and chemokines. The caveat to these results is that these effects were produced 
by combining cell-free HIV-1 with seminal fluid from healthy donors, which is likely 
not equivalent to semen from HIV-1-infected donors. Indeed, comparisons of 
semen from uninfected and HIV-1-infected donors have revealed significant 
differences in immunomodulatory factor content [6], suggesting differences in the 
effects of HIV-1-infected semen on the FRT epithelium. 
Our analyses indicated that semen is generally pro-inflammatory, which is 
in agreement with other reports [6-8]. However, published evidence indicates that 
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the factor content is variable across individuals and may be influenced by disease 
state, including infection by STD pathogens and infertility. It is therefore likely that 
the epithelial response will be shaped by the contents of semen. When compared 
to other studies, several factors were detected at similar levels in the pooled 
seminal fluid of our healthy cohort. IL-2, IL-7, IL-10, VEGF, EGF, G-CSF, and TNF-
α were present at similar concentrations ranges. The concentration of GM-CSF 
was similar to most reported values except for the GEC study. In comparison, IL-
6, IFN-γ, IFN-α, and MCP-1 were on the higher end of the reported range of values 
in our study, while RANTES was present in pooled semen at the low end of the 
published concentration range. While factors were fairly consistent among the 
healthy males, recent studies using HIV-1-infected semen indicated that content 
differed between uninfected males and also varied by the stage of infection. 
Additionally, semen content can vary relative to the concentrations in the 
peripheral blood [6]. These changes could be important in the context of HIV-1 
transmission within the FRT, and even with respect other sexually transmitted 
pathogens. The cytokines released by the epithelium in response to factors in 
semen during intercourse could shape the local immune response, thereby 
enhancing or hindering viral transmission. Immune cell recruitment, activation, and 
differentiation in response to epithelial stimulation by semen may be especially 
important as the type of cell and state of activation or differentiation could result in 
the influx of target cell populations with greater susceptibility to HIV-1 infection.  
The transwell culture system is an inexpensive alternative to more complex 
modeling methods. Current methods, such as the use of MatTek cell cultures 
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(MatTek Corp., Ashland, MA) or the culture of ex vivo cervical tissue chips 
procured during biopsies, represent important advances in modeling the FRT. 
These tissues allow for the full complexity of the reproductive tract to be 
maintained, including important cell populations not represented in submerged or 
transwell cultures, such as Langerhans cells or secretory epithelial cells. Although 
these systems are valuable for the experimental designs they can accomodate, 
they also have their own limitations. Because of the cost of the MatTek cultures, 
the pre-made culture systems are more suited to smaller, more focused validation 
of experimental results obtained in less specialized model systems. Similarly, 
experiments using biopsy-derived tissue chips are limited by tissue availability, 
donor variability, and the potential for contamination during extended 
maintenance. Additionally, the complexity of these models can make it difficult to 
determine minute changes in the epithelium or the contribution of each cell type to 
the observed effects. For studies such as those described herein, the transwell 
culture model provides a transition between simple, submerged cell culture and 
more complex in vitro and ex vivo tissue-based systems. 
These results provide evidence to support two major claims. First, semen is 
not an inert vehicle and is capable of directly affecting the FRT epithelium in a time-
, direction-, and tissue-dependent fashion. Interestingly, our experiments using the 
transwell model system have also demonstrated a secondary effect of semen in 
the FRT: increased epithelial barrier function (Appendix Chapter 2). Second, the 
FRT epithelium likely plays an important role in shaping the ensuing immune 
response to SF through cytokine secretion. The epithelial response has been 
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shown to be important in the context of reproduction, shaping a biphasic shift from 
inflammation to tolerance. The changes in the local immunological environment 
will likely impact events that take place in the FRT during HIV-1 transmission. In 
future studies, it will be necessary to evaluate the effects of these local cytokines 
and chemokines on subepithelial immune cell populations in order to investigate 
their effects on the overall risk of HIV-1 transmission. 
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Appendix Chapter 2 
 
Factors in human seminal fluid reduce epithelial permeability by increasing 
integrity of epithelial tight junctions 
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Ph.D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter will be submitted for publication: 
Keogan, S., Karl Siegert, Wigdahl B., and Krebs, F.C. Factors in human seminal fluid reduce 
epithelial permeability by increasing integrity of epithelial tight junctions. Manuscript in preparation, 
2016. 
 
These studies were supported by faculty development funds provided by the 
Department of Microbiology and Immunology, Drexel University College of 
Medicine and the Institute for Molecular Medicine and Infectious Disease. 
 
  
  
	
253 
A2.1 Abstract 
Factors in seminal fluid (SF) that have integral roles in reproductive biology 
may also alter the ability of HIV-1 to penetrate the cervicovaginal epithelium and 
infect target immune cells. We hypothesized that one consequence of SF exposure 
may be alterations in cervicovaginal epithelial tissue tight junction integrity, 
resulting in changes in epithelial barrier function with respect to HIV-1. To address 
this possibility, human cell lines derived from three different regions of the female 
reproductive tract – vagina, ectocervix, and endocervix - were cultured in a 
transwell cell culture system to form polarized epithelial monolayers. Changes in 
barrier integrity were measured over time by monitoring transepithelial electrical 
resistance (TEER). Apical exposure to SF caused a rapid and sustained increase 
in epithelial integrity across all cell lines, as well as a decrease in permeability. 
Further investigation revealed that a combination of calcium, lipids, and soluble 
proteins in seminal fluid were responsible for inducing these changes through a 
specific apical interaction with reproductive-derived cell lines. In the context of HIV-
1, the virus did not alter resistance, but preliminary data indicates that seminal fluid 
may decrease viral permeability as a consequence of the increases in tight junction 
expression. These results suggest that factors present in SF may initially protect 
the female reproductive tract from HIV-1 infection during sexual intercourse. 
Ongoing studies are investigating the mechanism(s) by which SF affects epithelial 
cell tight junction integrity as well as the changes in resistance induced in the 
presence of seminal fluid from HIV-1-infected men.	
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A2.2 Introduction 
Seminal fluid (SF) is often assumed to function as a simple, passive 
transport vehicle for the delivery of sperm into the female reproductive tract (FRT) 
during fertilization. However, studies have revealed that semen may be far more 
complex than initially assumed [42, 84]. The majority of what is understood about 
semen has been garnered from studies of human infertility and animal husbandry, 
which have established that the process of embryogenesis is largely governed by 
the molecules and cells contained in semen, including cytokines, hormones, 
enzymes, and growth factors. During reproduction, these are intended to modulate 
the FRT immune response to seminal fluid after it has been deposited in the 
vaginal tract, priming the uterus for successful fertilization and subsequent embryo 
implantation [87]. Changes in concentrations of immunomodulatory factors have 
been associated with adverse events, resulting in the clearance of seminal 
constituents by the female immune system and rejection of the embryo	[87, 114]. 
This function of semen, however, is not just important to fertility, but also potentially 
operative during transmission of sexually transmitted disease (STD) pathogens, 
such as the human immunodeficiency virus type 1 (HIV-1).  
Roughly half of the global HIV-1 infected population is comprised of women, 
who have been primarily exposed through male-to-female heterosexual 
transmission [2, 174]. Despite over 30 years of study, the mechanisms that 
underlie the sexual transmission of HIV-1 are incompletely understood. A better 
understanding of the events that occur during transmission is fundamental to 
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developing strategies that effectively reduce or eliminate the risk of acquiring HIV-
1. 
Like the early infertility studies, studies of HIV-1 transmission have 
traditionally overlooked the participation of semen, reducing it to a static medium 
that deposits virus into the vaginal environment. Many studies of HIV-1 
transmission – investigations of microbicide toxicity, female mucosal immunity, 
and local virus dissemination – have focused primarily on the female without 
consideration for the role of semen. Understanding the contribution of semen in 
the transmission of HIV-1 is gaining importance as researchers become aware of 
the potential active role it may play. These studies are critical in light of the recent 
demonstration that virus can persist in seminal fluid despite effective highly active 
antiretroviral therapy (HAART) [192].  
Knowledge of the physiology of the FRT is also very important in 
understanding its interaction with seminal fluid. During heterosexual intercourse, 
semen and pathogens first encounter the epithelial lining of the FRT, which forms 
a mechanical barrier [148]. The epithelium has an innate protective quality 
conferred by the presence of apical tight junction protein complexes that connect 
adjacent cells and create a watertight seal that regulates the passage of 
substances between the cells [170, 193]. The number of tight junctions, which is 
regulated, in part, by the levels of tight junction protein expression, establishes the 
strength of the epithelial layer. Within the FRT, the expression of tight junction 
proteins varies anatomically, from very low expression in the vagina to increased 
expression in the upper reproductive tract	[83]. Tight junctions serve as a barrier, 
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providing protection against STD pathogens such as HIV-1. If this barrier is 
disrupted, HIV-1 may be able to penetrate the subepithelium where it can access 
and infect susceptible CD4+ T-cell populations [98, 148]. 
SF is complex in composition and function, with studies indicating that 
semen has both inhibitory and enhancing effects on HIV-1 infection. More 
specifically, semen deposition in the female reproductive tract induces a pH 
change from acidic to neutral, a natural process that may prevent destruction of 
the virus and allow it to persist in the normally harsh, low pH vaginal environment. 
Conversely, semen has also been shown to harbor intrinsic anti-viral activity 
mediated primarily by other naturally occurring cationic peptides, suggesting that 
charge is important in antiviral activity [194]. Ultimately, the same conditions that 
regulate whether sperm are protected or cleared can also modulate transmission. 
If other factors found in SF are involved in either directly or indirectly modulating 
the integrity of the epithelial barrier, the first step in establishing an infection may 
potentially be driven by SF. For example, SF is rich in divalent metal cations, such 
as calcium and zinc [32, 161], which have been shown to play key roles in epithelial 
integrity at other mucosal sites, such as the gut, by increasing tight junction 
expression in order to regulate absorption. On the other hand, seminal fluid also 
contains IFN-γ, a factor that has been shown to increase gut permeability by 
inducing internalization of tight junction complexes [26]. Based on such studies, 
we were prompted to further investigate the effects of semen exposure on the 
epithelial lining of the FRT. Specifically, we sought to determine the effects of 
semen on epithelial integrity and identify factors in semen that may be mediating 
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these changes. The results of these studies will have clear relevance to a greater 
understanding of HIV-1 transmission within the FRT. 
 
 
A2.3 Materials and Methods 
A2.3.1 Cell Line maintenance  
Experiments were performed using cell lines derived from four regions of 
the human female reproductive tract: uterine epithelial cells (HEC-1-A), 
endocervical cells (End1/E6E7), ectocervical cells (Ect1/E6E7), and vaginal 
keratinocytes (VK2/E6E7) (ATCC, Manassas, VA). Prior to seeding, cells were 
grown and maintained in T150 tissue culture flasks (Grenier Bio One, Monroe, NC) 
and incubated at 37°C with 5% CO2. HEC-1-A cells were cultured in Dulbecco’s 
Modification of Eagle’s Medium (DMEM) 1X (Cellgro, Manassas, VA) 
supplemented with 10% deactivated fetal bovine serum (FBS) (Gemini Bio-
products, West Sacramento, CA), 0.05% sodium bicarbonate (Cellgro, Manassas, 
VA), 40 μg/ml of penicillin/streptomycin and kanamycin sulfate (Cellgro, 
Manassas, VA). Ect1 cells were cultured using the Keratinocyte Serum-Free 
Medium kit (Gibco, Grand Island, NY), which includes 50 μg/ml bovine pituitary 
extract (BPE) and 0.1 ng/ml epithelial growth factor (EGF) supplements, with 40 
μg/ml penicillin/streptomycin solution added. End1 and VK2 cells were cultured in 
the Keratinocyte-SFM supplemented with 0.4 mM calcium chloride (EMD Millipore, 
Billerica, MA).  
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P4-R5 MAGI cells (AIDS Reagent Program, Germantown, MD) are a non-
tight junction-expressing, HeLa-derived, cervical epithelial cell line that has been 
stably transformed to express β-galactosidase under the HIV-1 LTR promoter 
during HIV-1 infection. The cells were cultured in DMEM supplemented with 10% 
FBS, 7.5% (w/v) sodium bicarbonate, penicillin/streptomycin solution 50X, 5000 
μg/ml kanamycin sulfate, and 1 μg/ml puromycin (Sigma-Aldrich, St. Louis, MO). 
A2.3.2 Transwell culture system 
Cell lines were cultured into confluent, polarized monolayers by seeding into 
the apical chamber of a 6.5 mm, 0.4 μm pore, polyester (PET) transwell insert in a 
24-well receiver plate (Corning, Corning, NY). All cell lines were seeded at a 
density of 1.5 x 105 cells per well in 200 μl of media in the apical chamber and 600 
μl in the basolateral chamber. Cells required 14 to 21 days of maintenance for the 
development of monolayers with high resistance (see below). 
A2.3.3 Transepithelial electrical resistance 
Epithelial monolayer confluence was monitored by measuring 
transepithelial electrical resistance (TEER or TER), which is an indirect measure 
of tight junction formation between cells. Using an EVOM2 voltohmeter and STX2 
chopstick electrode (World Precision Instruments, Sarasota, FL), resistance was 
read once daily, in ohms, during the growth phase. Monolayers were determined 
to be fully confluent once the resistance readings plateaued for 2 or 3 consecutive 
days. 
A well containing media only was also measured at each time point to 
provide background resistance readings. Monolayer resistance was calculated by 
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subtracting the background value from the experimental reading and then 
expressing that value as a percentage of the average value for mock-exposed 
wells (monolayer exposed to media only). 
Due to the differential expression of tight junctions by each cell line, 
polarized monolayers plateaued at different resistance levels: HEC-1-A cells at 
~350 Ω; End1 cells at ~250-300 Ω; Ect1 cells at ~220-250 Ω; and VK2 cells at 
~220 Ω. These measurements were comparable to measurements recorded in 
other studies using these cell lines [148, 175]. 
A2.3.4 Seminal Fluid 
Seminal fluid (SF) was purchased as 10 ml of semen pooled from six 
healthy donors between 26 and 34 years of age (Lee Biosolutions, St. Louis, MO). 
Specimens were shipped overnight on dry ice, immediately divided into 500 μl 
aliquots, and frozen at -20°C upon arrival. In all of the experiments described, SF 
refers to whole, crude semen containing sperm. In experiments using seminal 
plasma (SP), semen was centrifuged for 15 min at 3000g. The liquid portion 
containing soluble factor was collected and referred to as “SP”. The resulting pellet, 
which contained sperm and other cellular components, was resuspended in an 
equivalent volume of PBS and labeled as the “sperm” fraction. SP and sperm 
fractions were diluted to the same 25% concentration as SF. 
A2.3.5 Permeability 
Cells in transwell inserts were exposed apically for 4 h to 25% SF diluted in 
culture media, then aspirated and washed apically and basolaterally three times 
with media. The apical chamber was loaded with 4 mg/ml of 70 kDa dextran-FITC 
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(Sigma-Aldrich, St. Louis, MO) diluted in keratinocyte-SFM media (which is phenol-
red free, thereby eliminating the background autofluorescence that is characteristic 
of phenol red-containing DMEM culture medium), while the basolateral chamber 
was filled with keratinocyte-SFM alone. A time course experiment (data not shown) 
determined that maximum dextran-FITC penetration into the basolateral chamber 
occurred by 30 min of incubation in the dark at 37°C. As an additional control, 
dextran-FITC was loaded into an empty, cell-free transwell insert in order to 
account for background diffusion through the porous membrane. After incubation, 
aliquots from the basolateral chamber were transferred in duplicate to an empty 
96-well plate with black, opaque walls and a clear bottom (BD, San Jose, CA). 
Media only controls were also added to several wells to serve as background. 
Migration of fluorescent molecules from the apical to the basolateral chamber was 
then measured using a Fluorskan fluorometer with filters set at 485 nm to 520 nm 
absorbance (Thermo Fisher Scientific, Waltham, MA). Relative permeability was 
calculated by subtracting the average media-only well reading, which represents 
autofluorescent background, from each of the experimental reading. The resulting 
numbers were then set relative to the empty well by dividing the experimental 
reading by the empty well and expressing the final value as percent permeability 
relative to an empty well. 
A2.3.6 Immunofluorescence 
Transwells were prepared for immunofluorescence by washing gently with 
HBSS to remove any residue (Cellgro, Manassas, VA). Cells in the transwells were 
then fixed by incubating in a 2% paraformaldehyde (PFA) (Alfa Aesar, Ward Hill, 
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MA) solution diluted in HBSS added to the apical chamber only. The monolayers 
were incubated for 10 min at room temperature (RT) in a dark laminar flow hood, 
followed by a second incubation with 4% PFA apically for 20 min at RT in the dark. 
After fixing, the cells were washed and permeabilized in a 0.5% solution of Triton 
X-100 (Sigma-Aldrich, St. Louis, MO) in both the apical and basolateral chambers 
of the transwells. The plates were incubated at RT in the dark for 1 h and then 
washed at least three times with HBSS, or no traces of detergent remained. For 
staining, the cells in transwells were incubated in a 50 μg/ml concentration of ZO-
1 antibody conjugated to Alexa Fluor 488 (Life Technologies, Grand Island, NY) 
diluted in a 2% donkey serum/HBSS solution (Jackson Laboratory, Bar Harbor, 
ME). Prior to the addition of antibody, transwell inserts were transferred from the 
receiver plate into a 6-well plate (BD Falcon, San Jose, CA) so that the inserts 
were sitting flat on the bottom of the culture well, thereby preventing antibody 
leakage through the membrane. During incubation, the plates were wrapped in foil 
and placed at 37°C for 2 h, and stored at 4°C overnight. The next day, the wells 
were washed and stained with a 1:100 concentration of 4’,6’-diamidino-2-
phenylindole (DAPI) (Life Technologies, Grand Island, NY) diluted in HBSS for 2 
min. The DAPI stain was removed by washing three times with HBSS, followed by 
a wash with sterile diH2O (Cellgro, Manassas, VA) to remove HBSS crystals. In 
order to visualize the cells, the membranes were carefully excised from the 
transwell inserts while they were still moist, placed onto slides (Thermo Fisher 
Scientific, Waltham, MA), and then sealed under coverslips (VWR, Radnor, PA). 
Staining was visualized using an Olympus 1X81 inverted fluorescence microscope 
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(Olympus America, Center Valley, PA) and images were captured with Slidebook 
5.0 Digital Microscopy software (Intelligent Imaging Innovations, Denver, CO). 
A2.3.7 Semen exposure and heat denaturation studies 
During acute exposure, cell lines cultured into confluent monolayers in the 
apical chamber of transwells were incubated with either 25% SF, 25% SP, or 25% 
sperm fraction diluted in either media or PBS (as indicated). Changes in TEER 
were measured every 5 min for the first half hour and then every 30 min for the 
remaining 4 h exposure. In a long-term exposure, additional TEER readings were 
taken daily out to six days, with media changes every other day. For heat 
denaturation studies, the semen was heat inactivated prior to the experiment in a 
water bath at either 55°C for 1 h or 65°C for 20 min (both are commonly used 
methods) and stored at -20°C. 
A2.3.8 Tight junction breakdown studies 
Confluent monolayers were incubated apically or basolaterally (as 
indicated) with either 4 mM EDTA (Cellgro, Manassas, VA), 4mM EGTA (Boston 
Bioproducts, Ashland, MA), 1.4 M of mannitol (Sigma-Aldrich, St. Louis, MO), or 
0.1% C31G, diluted in media as positive controls for tight junction break down. 
Changes in TEER were measured during the acute time course described 
previously. In the tight junction recovery studies, the monolayers were pre-
incubated with 4 mM EDTA or EGTA for 30 min, followed by a gentle wash with 
media, and then either new media or 25% SF was added. Additional readings were 
taken daily out to 72 h post-exposure. 
A2.3.9 Metal cation studies 
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Monolayers were exposed to physiological concentrations of metal ions 
naturally found in seminal fluid. Cells were incubated apically with either 1 mg/ml 
each of KCl (EMD Millipore, Billerica, MA), MgCl2 (VWR, Radnor, PA), ZnCl2 (EMD 
Millipore), CaCl2 (EMD Millipore), or a metal ion mixture of all four, and measured 
for changes in TEER up to 4 h. 
A2.3.10 TGF-β and pH resistance studies 
HEC-1-A and Ect1 monolayers were incubated apically with TGF-β at either 
70 ng/ml, representing the high end of the average physiological concentration of 
TGF-β present in seminal fluid from healthy males	 [70], or 2 ng/ml, a low 
concentration control, and measured for changes in TEER over the course of 4 h. 
In pH acid-activation studies, the cells were first assessed for changes in response 
to a 1 h incubation in a pH titration ranging from a pH of 8.2 to 4.0. The range of 
pH concentrations were achieved by adjusting the media with sodium hydroxide 
and hydrogen chloride (J.T. Baker, Center Valley, PA) in a drop-wise manner. 
Changes in TEER were measured over the 1 h time course and then cell viability 
was assayed as described below. Following the initial optimization experiment, 
HEC-1-A and Ect1 monolayers were exposed to SF in a transition model: 
transwells were pre-incubated for 1 h at pH 4, then 25% SF was added and TEER 
readings were recorded for 1 h. A 25% SF control well was also measured in which 
semen was added to the normal, neutral culture media (pH 7.2).  
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A2.3.11 Cytotoxicity assay 
Changes in cell viability after semen, virus, or low pH exposure were 
assessed spectrophotometrically to detect the cleavage of 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) by dehydrogenase enzymes in the 
mitochondria, a process that results in the production of purple formazan crystals 
[195]. After washing the transwells with HBSS, MTT powder (Sigma-Aldrich) 
dissolved in media at a concentration of 7.5 mg/ml was added to the apical 
chamber of each transwell and fresh media added to the basolateral chamber. The 
plates were incubated for 45 min to 1 h at 37°C and then aspirated. The formazan 
crystals trapped within the cells were solubilized in acidic isopropanol by shaking 
at room temperature for 20 min. The dissolved solution was then transferred to a 
clear, flat-bottomed 96-well plate (BD Falcon, San Jose, CA) and read on a 
multiskan colorimeteric plate reader (Thermo Scientific, Waltham, MA). The 
calculated absorbance is proportional to cellular viability and inversely proportional 
to any toxicity due to semen exposure [196].  
 
A2.3.12 TLR2 interaction studies 
Cell lines cultured into confluent monolayers in the apical chamber of 
transwells were measured for TEER then pre-incubated for 1 h in 20 µg/ml of Toll-
like receptor 2 (TLR2) monoclonal antibody diluted in media (Invivogen, San 
Diego, CA). Following pre-incubation, SF was added to the TLR2 antibody solution 
in the transwell at a concentration of 50% in order to give a final chamber 
concentration of 25% SF in the presence of 10 μg/ml of TLR2 antibody. TEER 
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measurements were taken as out to 24 h. As a control, wells containing 20 μg/ml 
TLR2 antibody only were also measured over the time course. In order to ensure 
that the monolayers expressed TLR2 when cultured in this model, peptidoglycan 
(PGN) (Sigma-Aldrich, St. Louis, MO), a bacteria-derived, known TLR2 agonist, 
was included as a positive control. PGN diluted to 10 µg/ml as a suspension in 
media was then added to the apical chamber of the transwells either alone or in 
the presence of the TLR2 antibody and TEER measurements were monitored over 
the 24 h time course. 
A2.3.13 HIV-1 permeability studies 
Monolayers of HEC-1-A, Ect1, and End1 cells cultured to confluence in 
transwells were exposed apically for 4 h to either HIV-1 laboratory strains BaL 
(Zeptometrix, Buffalo, NY) or HIV-1 IIIB (Advanced Biotechnologies Inc, Columbia, 
MD), in the presence or absence of 25% SF and changes in TEER were monitored. 
After 4 h, the basolateral chamber supernatant was removed and incubated with 
P4-R5 MAGI cells, which express CCR5 and CXCR4 co-receptors to allow 
infection, seeded at 1.5 x 104 cell/well in a 96-well flatbottom plate for 48 h. After 
incubation the cells were assayed for β-galactosidase production as a relative 
measure of HIV-1 infection using the Galacto-Star β-Galactosidase Reporter Gene 
Assay System for Mammalian Cells per the manufacturer’s protocol (Applied 
Biosystems, Bedford, MA).  
A2.3.14 Statistical analysis 
p-Values were calculated for the difference between pairs of treatment 
conditions using a two-tailed Student’s t-test and a value of less than 0.05 was 
  
  
	
266 
set as the limit for statistical significance. p-Values are indicated on the figures 
and within the figure legends. 
 
A2.4 Results 
A2.4.1 SF exposure causes rapid increases in epithelial monolayer 
TEER 
 Studies of the polarized release of immunomodulatory factors from FRT 
epithelial cell lines exposed to semen (Appendix Chapter 1) established the 
transwell culture system as a model for the human FRT epithelium. In this model, 
epithelial cells are cultured in the apical chamber of a transwell insert to form 
confluent monolayers with a high electrical resistance characteristic of cells 
interconnected by tight junctions. The model system emulates the topography of 
the FRT epithelium, where the apical chamber represents the cervicovaginal 
lumen and the basolateral chamber represents subepithelial tissue. Previous 
studies demonstrated the release of immunomodulatory factors from SF-exposed 
epithelial cells in a direction-, time-, and cell type-specific manner (Appendix 
Chapter 1). In experiments designed to examine any adverse effects of SF on 
monolayer permeability, a small but significant decrease in permeability was noted 
after SF exposure. The following experiments explore that observation in more 
detail. 
Previous studies have established that, once semen is deposited in the 
FRT, resident secretions dilute it to about 10-25% concentration, which then 
dissipates over the course of approximately 4 h [29]. Using these parameters, 
monolayers of HEC-1-A cells in transwell inserts were exposed apically to 25% or 
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10% SF for 4 h. SF exposure resulted in a time-dependent increase in resistance 
that persisted throughout the duration of exposure, reaching a peak of 237% at the 
highest SF concentration relative to mock-exposed cells transwells (Fig. A2.1A). 
Of particular note was the rapid speed at which the increase was initiated, which 
produced a significant and repeatable increase of 28% over mock untreated levels 
within 5 min of exposure. A dose-dependent response was also evident as the 
diluted 10% concentration of SF induced a similar rapid and sustained increase in 
TEER, but at a lower magnitude relative to the 25% SF (Fig. A2.1A). The scope of 
the dose-dependent effect was evaluated more closely in a SF titration spanning 
50% to 0.1%, which demonstrated that increases in resistance were clearly 
dependent on the concentration of SF (Fig. A2.1B). For the remainder of the study, 
a concentration of 25% SF was utilized, as this concentration best represents the 
high end of the physiologically relevant concentrations occurring in vivo [87, 114].  
A2.4.2 Changes in TEER persist during long-term incubation with SF 
To determine the extent to which SF could exert effects on tight junctions, 
daily TEER was monitored over a long-term, five-day time course. Continuous 
incubation of HEC-1-A monolayers in 25% SF for 18 h resulted in a steady increase 
that peaked at 158% at the 24 h time point and remained elevated out to 48 h, 
despite the removal of SF (Fig. A2.2A). TEER returned to mock, untreated levels 
by 72 h and was maintained at this level over the remainder of the five-day time 
course. Similar to the acute exposure studies, the long-term effects were also 
dose-dependent, since 10% SF exposure produced a similar trend at a lower level  
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Figure A2.1A 
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Figure A2.1B 
 
 
 
Figure A2.1 SF-induced increases in epithelial monolayer resistance are 
time-, concentration, and direction-dependent. (A) HEC-1-A monolayers were 
continuously exposed to SF for 4 h and changes in resistance were measured. (B) 
A titration curve of 50% to 0.1% SF dilution provided additional evidence that the 
degree of increase in resistance was dependent upon semen concentration. 
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Figure A2.2A 
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Figure A2.2B 
 
 
 
Figure A2.2 SF-induced non-permanent increases in resistance peaked at 
24 h and remained elevated out to 48 h during continuous exposure. (A) Long-
term incubation of HEC-1-A monolayers in either 25% or 10% SF resulted in a 
peak elevation at 24 h, after which point the resistance began to decrease. (B) 
HEC-1-A cells were pre-incubated with SF for 4 h to induce a maximal increase in 
resistance and then washed. After removal of SF, resistance decreased rapidly 
and continued a steady decline until reaching mock levels.  
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of resistance (Fig. A2.2B). These results suggest that, as semen is removed 
from the reproductive tract during the post-coital phase, the increased resistance 
across the epithelium is temporary and will return to mock levels within a short time 
period. Thus, the presence of SF is required in order to induce and maintain 
changes in resistance. 
A2.4.3 SF-induced changes in permeability and TEER are specific to 
tight junction expressing cells 
Changes in resistance are an indirect indication that semen is inducing 
changes at the level of tight junctions. To determine the specificity of the effect, 
P4-R5 MAGI (P4R5) cells (a HeLa-derived cell line) were cultured in transwells. 
Despite their epithelial and cervical lineage, these cells do not express tight 
junctions. After apical exposure of P4R5 cells to SF, the resistance of the cell 
monolayer remained at ~162 Ω, which is just above the average background level 
of 135 Ω (data not shown). Similarly, addition of SF to empty transwells (i.e. lacking 
cells) did not result in increased TEER over baseline values observed with media 
alone (data not shown). These observations indicated that the effects of SF were 
specific to tight junctions and excluded the possibility that seminal fluid was 
producing a false increase in resistance by physically occluding the membrane 
pores or filling the paracellular spaces.  
The effect of SF on the epithelial barrier was confirmed by measuring 
changes in paracellular permeability. A fluorescently tagged tracer molecule, 
dextran-FITC, was utilized to measure the migration from the apical to basolateral 
chamber, as previously described (Appendix Chapter 1). Although the HEC-1-A 
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monolayers are an effective barrier at a mock level when normalized to the 
permeability of an empty transwell, semen exposure further reduced dextran- FITC 
passage to 2.7% in a repeatable and significant manner (p=0.014) (Appendix 
Chapter 1 and Fig. A2.3). In the non-tight junction-forming P4R5 cells, however, 
the low level of resistance correlated with high levels of tracer permeability, both 
with and without SF exposure, again demonstrating the specificity of this effect and 
illustrating the reciprocal relationship between permeability and TEER. 
A2.4.4 Increased epithelial resistance is an exclusive activity of the 
seminal plasma fraction 
Initial experiments used whole pooled seminal fluid, which contains both the 
cellular and soluble fractions produced during ejaculation. However, many studies 
on reproduction exclusively utilize only seminal plasma, which is the soluble 
fraction of semen with the cellular portion removed by centrifugation. To determine 
if the two main fractions comprising semen have differential effects on TEER, the 
seminal fluid was separated into a seminal plasma (SP) fraction containing the 
soluble factors, and a sperm pellet containing the cellular components. HEC-1-A 
monolayers were exposed apically to either 25% SF, 25% SP, or 25% sperm 
fraction and then the changes in TEER were measured over the 4 h time course. 
Interestingly, SF and SP increased TEER to the same extent in a repeatable 
manner, with increases beginning as early as the 5 min time point and continuing 
throughout the experiment (Fig. A2.4). However, the sperm component had no 
effect on TEER and remained at mock level. This revealed that there was no  
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Figure A2.3 
 
 
 
Figure A2.3  Changes in resistance during SF exposure are inversely 
correlated with permeability. 4 h post-exposure, HEC-1A monolayers were 
incubated apically with dextran-FITC to measure paracellular migration. While 
healthy mock monolayers were relatively impermeable due to high basal 
expression of tight junctions, SF exposure further significantly decreased 
fluorescence. EDTA exposure, which breaks down tight junctions, increased 
permeability but was reduced back to near mock levels during simultaneous 
exposure with SF.  
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Figure A2.4 
 
 
 
Figure A2.4 Seminal plasma contains the active component of SF. Semen 
was fractionated to seminal plasma (SP) and a sperm pellet containing cellular 
matter. Incubation with SP produced an increase in resistance that was 
comparable to SF, while the sperm exposed cells remained at mock level.  
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division of activity across the two major fractions of semen and the activity 
was confined solely to the SP fraction. Although the majority of previous 
publications utilized seminal plasma, having ruled out any deleterious effects 
contributed by the sperm fraction, whole SF was used throughout the remainder 
of this study in order to maintain a physiologically intact model. 
A2.4.5 Changes in TEER are independent of the physical properties of 
semen 
Seminal fluid is complex in both composition and property, so in order to 
decipher whether the effects of semen on resistance were mediated by a specific 
factor or due to a physical characteristic of semen as a bodily fluid, a series of 
experiments investigating the contribution of various physiological properties were 
executed. 
SF is known to have mucus-like properties [32], so establish that the 
changes in resistance were not attributable to paracellular occlusion by the 
viscosity of semen, monolayers were incubated with 0.5% carrageenan, a similarly 
thick and viscous compound. Even with a high concentration of carrageenan, no 
changes in resistance were observed (Fig. A2.5A). Combined with previous data 
of P4R5 cells and empty wells, the contribution of semen viscosity to changes in 
resistance was ruled out. 
In relation to viscosity, SF also has serum-like properties, so in order to 
determine that the effects were specific to semen and not a non-specific response 
of the epithelium to all serous-type fluids (such as blood serum or saliva), the same 
experiments were repeated with FBS substituted for SF. FBS diluted to 25% in 
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either HEC-1-A media (which is supplemented with 10% FBS) or in serum-free 
DMEM, did not induce a change in resistance (Fig. A2.5B). This also demonstrates 
that SF does not combine with FBS present in growth medium to enhance these 
effects (Fig. A2.5C). Lastly, in order to determine if any other components or 
supplements in the media affected resistance, SF was diluted in PBS. PBS alone 
did not alter resistance and use of PBS as a dilution alternative to culture media 
also did not modify the characteristic semen increases in resistance (Fig. A2.5D). 
Together, these studies on the physical characteristics of semen indicate that 
increased resistance is specifically attributable to soluble factors in the plasma 
fraction. Therefore, the next step was to identify which factor(s) in SF were 
mediating this effect. 
A2.4.6 Different regions of the FRT differentially respond to SF  
The observations from these experiments indicate that seminal fluid 
contains a factor that specifically alters tight junctions. Up to this point, the studies 
have utilized HEC-1-A cells, which are a good model as they express high levels 
of tight junctions, are easy to culture, and are derived from the female reproductive 
tract. However, HEC-1-A cells are specifically uterine epithelial cells, which 
although relevant to the area of study, are not the cell type primarily exposed to 
seminal fluid during heterosexual intercourse, nor is this a region suspected to be 
involved in HIV-1 transmission. This posed the question as to whether the SF-
induced effects were specific to HEC-1-A cells or if it would persist using relevant 
reproductive cells. To address the contribution of tissue specificity in SF-mediated  
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Figure A2.5A 
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Figure A2.5B 
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Figure A2.5C 
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Figure A2.5D 
 
 
 
Figure A2.5 Changes in resistance are not due to physical properties of SF 
or outside experimental factors. A) A 25% solution of carrageenan mimicking 
SF viscosity excluded the possibility that SF induced an increase in resistance by 
physically occluding the paracellular spaces. B) A 25% FBS solution used as a 
substitute for semen proved that the effects on resistance were specific to SF and 
not a characteristic effect induced by all serum-based solutions. Similarly, any 
contribution to changes in resistance by C) media components were eliminated by 
dilution of SF in 25% serum-free DMEM or D) 25% PBS. 
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changes in TEER, the 4 h exposure experiments were repeated using three 
immortalized cell lines isolated from a single donor, representing the three main 
regions of the reproductive tract: VK2, vaginal keratinocytes, from the vagina; Ect1, 
ectocervical cells, from the lower cervix representing the transition zone; and End1, 
endocervical cells, from the upper cervix. All three cell lines have been 
characterized in literature previously, correlating tight junction expression in vitro 
with the physiology of the respective regions from which they are isolated in vivo 
[83, 175]. It has been shown that the vaginal tract has a low, disorganized pattern 
of tight junction expression, which supports the main function of this region as a 
mechanical barrier to insults, reaching upwards of 25 squamous cell layers thick 
in some areas [148, 191]. At the uppermost layers near the lumen, the vagina is 
characterized as being almost devoid of tight junction expression, which facilitates 
the continual sloughing of these layers and adds an additional aspect of protection	
[83]. When confluent VK2 monolayers cultured in transwells were exposed to 25% 
SF, there was a 24% increase in resistance over mock-untreated monolayers by 
4 h, which, although low due to mediocre tight junction expression, was 
nevertheless significant and repeatable (Fig. A2.6A). In contrast, Ect1 cells, which 
represent the portion of the reproductive tract in which the squamous epithelium 
transitions into a single-layer columnar epithelial phenotype, had a greater 
response to SF exposure, increasing significantly 171% relative to mock-untreated 
(Fig. A2.6B). The greater response of Ect1 cells is due to the higher expression of 
tight junctions characteristic of this cell type, resulting in an organized monolayer 
that, despite being only one cell layer thick, is relatively impermeable. Lastly, the 
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End1 cells, which are also a simple columnar epithelial cell type expressing high 
levels of tight junctions, demonstrated a rapid increase in TEER after 5 min of SF 
exposure, similar to HEC-1-A cells, and continued to increase significantly out to 
the 4 h time point, reaching 155% relative to mock (Fig. A2.6C). Overall, each cell 
line increased in resistance during semen exposure in a manner consistent with 
the degree of tight junction expression associated with each tissue (Fig. A2.6D). 
These results highlight the differences in regional expression of tight junctions and 
the contribution of these differences to the resistance response during SF 
exposure.  
In order to rule out any complications due to changes in viability, MTT 
assays of all three reproductive cell lines determined that there were no detrimental 
effects during SF exposure at the concentrations or time points used (data not 
shown).  
A2.4.7 SF-induced effects are specific to reproductive cell lines 
In order to determine if the effects of SF were specific to the four FRT cell 
lines utilized thus far or universal to all tight junction-expressing tissues, two non-
FRT cell lines were evaluated. Caco-2 cells, colon derived epithelial cells, express 
high levels of tight junctions that peak in confluence around 800-1000 Ω. When 
exposed apically to SF in for 4 h, the cells increased by only 3% relative to pre-
exposure readings (data not shown). The experiment was also repeated using the 
brain microvascular endothelial cell line hCMEC/D3 (BMECs) in place of epithelial 
cells, which are used to model the blood-brain barrier but express relatively low  
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Figure A2.6A 
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Figure A2.6B 
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Figure A2.6C 
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Figure A2.6D 
 
 
 
Figure A2.6 Cells derived from different regions of the FRT increase in 
resistance as a response to SF at varying degrees, dependent upon the 
characteristic tight junction expression associated with the tissues in vivo. 
(A) VK2, (B) Ect1, and (C) End1 monolayers incubated with SF for 4 h were 
measured for changes in resistance. Each cell line demonstrated significant 
increases in resistance by 4 h of SF exposure; End1 responded the most rapidly, 
with a significant increase by 5 min of exposure. D) Although each cell line was 
derived from a different region of the FRT, each responded to SF in a time-
dependent manner. 
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levels of tight junctions. Like the Caco-2 cells, the BMECs did not respond 
to SF, which was determined by both TEER and permeability to dextran-FITC (data 
not shown). Unexpectedly, these studies indicate that the effects of SF on 
resistance are not universal to all tight junction-expressing cells and that the semen 
factor responsible may be acting in a specific manner with FRT-derived epithelial 
cells. 
A2.4.8 EDTA abrogates SF-mediated changes in TEER 
To better understand the mechanism of the effects of SF on resistance, 
EDTA was introduced into the model as a positive control, as it is widely utilized 
and well characterized for its ability to break down tight junctions [197]. In the 4 h 
exposure transwell assay, EDTA produced a predictable, time-dependent and 
dose-dependent decrease in resistance (Fig. A2.7A). Interestingly, when the 
monolayers were exposed simultaneously to a mixture of 25% SF and 4mM EDTA, 
the effects of SF were abrogated (Fig. A2.7A) in a dose-dependent manner with 
decreasing concentrations of EDTA (Fig. A2.7B). The changes in resistance were 
also consistent with changes in permeability. As EDTA broke down tight junctions 
and reduced TEER, there was a significant 4% increase in dextran-FITC detection 
in the basolateral chamber as compared to mock monolayers (Fig. A2.3). In 
contrast, in the presence of SF, the effects of EDTA on permeability were restored 
back to nearly mock levels (3.1% and 3.5%, respectively) (Fig. A2.3). 
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Figure A2.7A 
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Figure A2.7B 
 
 
 
Figure A2.7 EDTA abrogates the effects of SF on resistance. (A) Transwells 
incubated in a combination of 4mM EDTA and 25% SF resulted in an abrogation 
of the effects of SF on resistance to nearly mock level. (B) The dampening effect 
of EDTA on SF was dose-dependent. 
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A2.4.9 SF restores TEER when epithelial tight junctions have been 
broken  
In order to bring these findings into a physiological context, it was necessary 
to determine if SF was able to increase TEER in a scenario in which the monolayer 
had already been compromised. Monolayers were pre-exposed for 30 min to 
EDTA, which resulted in a decrease in TEER down to 30% relative to mock 
transwells (Fig. A2.8A). After removal of EDTA, SF was added to the wells and 
changes in resistance were observed over the course of 5 h. By 90 min, resistance 
had recovered to mock level and further increased until the end time point, peaking 
at a 205% increase (Fig. A2.8A). In order to determine whether the natural 
recovery process of the tight junctions augmented the semen-induced restoration 
of TEER following removal of EDTA, HEC-1-A monolayers were pre-exposed to 
EDTA and then monitored for tight junction reformation in fresh media alone. By 1 
h the epithelial cells had already started to recover to 65%, and by 4 h, resistance 
had almost returned to mock level at 89% (Fig. A2.8B). This indicates that the 
changes induced by EDTA were not permanent, suggesting that in a scenario in 
which the FRT epithelium has been damaged at the level of tight junctions prior to 
intercourse, semen may be able to reverse the detrimental effects and speed tight 
junction resealing, potentially reducing transmission of STD pathogens, or 
preventing the loss of sperm during passage through the FRT in the context of 
reproduction [156]. 
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Figure A2.8A 
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Figure A2.8B 
 
 
 
Figure A2.8 SF restores tight junction resistance in compromised 
monolayers (A) Transwells were pre-incubated in EDTA or EGTA for 30 min to 
break down tight junctions. After EDTA and EGTA were replaced with SF. (B) 
Although monolayers will gradually reseal tight junctions on their own after 
EDTA/EGTA removal, the process is slow--barely reaching mock levels (85%) by 
5 h.  
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TEER is an indirect measure of tight junctions, therefore, in order to 
correlate changes in resistance with changes in tight junctions proteins, the 
monolayers were visualized by immunofluorescence staining for zonula occludin-
1 (ZO-1), a scaffolding protein that acts as an accessory to the transmembrane 
tight junction protein complexes of claudins and occludins at the cell surface [177]. 
Differences in healthy monolayers and semen-exposed monolayers were difficult  
to distinguish as both monolayers highly expressed ZO-1 (Fig. A2.9AB), 
which resonates with the subtle changes in permeability observed previously (Fig. 
A2.3). Visually, the changes between an intact, relatively impermeable mock 
monolayer (350 Ω) were indistinct compared to an even less permeable monolayer 
post-SF exposure (540 Ω). An analogous problem was encountered in a similar 
study in which slight changes in resistance were inconspicuous across intact 
epidermal keratinocyte monolayers after staining with occludin and ZO-1 during 
TLR2 stimulation [159]. Therefore, to gain a better contrast the EDTA-only 
exposed HEC-1-A monolayers were directly compared to the “recovery” 
monolayers that had been pre-incubated with EDTA followed by SF incubation. 
While mock exposed wells had a distinct pattern that is characteristic of ZO-1 
staining around the perimeter of cells	[159], just 30 min of EDTA exposure was 
enough to result in a profound absence of this network, manifesting as a punctate 
staining pattern (Fig. A2.9C). However, incubation of EDTA-pre-exposed 
monolayers in SF for 4 h resulted in a return of the ZO-1 network that was visually 
similar to mock monolayers (Fig. A2.9D).  
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Figure A2.9A 
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Figure A2.9B 
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Figure A2.9C 
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Figure A2.9D 
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Figure A2.9 Subtle changes in ZO-1 staining are not detectable visually 
among mock and semen exposed monolayers. HEC-1-A cells incubated 
apically with 25% SF were stained in transwells for ZO-1 protein expression using 
a FITC conjugated antibody. The high levels of resistance in mock monolayers (A), 
about 350 Ω, corresponded to a high degree of ZO-1 staining around the perimeter 
of the cells. Interestingly, SF-exposed monolayers (B) also demonstrated an 
impressive staining for the ZO-1 network that was virtually indistinguishable from 
the mock monolayers, despite their high resistance readings of over 500 Ω. In 
order to make a more striking contrast, the staining patterns of monolayers 
exposed to EDTA for 30 min (C) were compared to monolayers that had been pre-
incubated with EDTA for 30 min, followed by SF for 4 h (D) in order to assess the 
degree of recovery that occurred in the presence of SF. 60X magnification. Blue, 
DAPI/nucleus; green, FITC/ZO-1. White arrows highlight small blue dots that are 
examples of DAPI stain taken up by the acrosome of spermatozoa, which 
remained despite vigorous washing of the monolayers.  
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A2.4.10 Calcium in seminal fluid is partially responsible for increasing 
TEER 
EDTA is a non-specific chelator that induces the break down of tight 
junctions by removing metal cations from the environment. Since SF is capable of 
overcoming this effect, it was hypothesized that the factor responsible for 
increasing resistance may be one of the several metal cations contained in SF. 
Cells were exposed to physiological concentrations of MgCl2, CaCl2, KCl, and  
ZnCl2 [32] in order to determine if they contributed to the effects on TEER. Upon 
exposure, MgCl2, CaCl2, and KCl induced a partial increase in TEER—123%, 
119%, and 113%, respectively—as compared to the 160% increase induced by 
25% SF (Fig. A2.10A). However, not all metal ions were able to alter resistance, 
as the ZnCl2 exposed monolayers remained at mock level (data not shown).  
In order to determine the effect of removing cations from semen in a more 
specific manner, the same experiment was repeated, substituting EDTA for EGTA, 
which preferentially chelates calcium ions from the environment. EGTA acted 
similarly to EDTA, mediating a decrease in resistance comparable in magnitude 
and time (Fig. A2.10B, and Figures 8) and abrogating the effects of SF on TEER 
to a similar degree (Fig. A2.10B). These studies demonstrate the contribution of 
semen-derived metal ions to the observed increases on resistance, but specifically 
highlight the role of calcium, since EGTA chelation of predominantly calcium ions 
from the environment resulted in a dramatic decrease in resistance whereas the 
addition of calcium partially restored TEER relative to SF. Considering that seminal 
fluid is able to induce recovery of resistance in epithelial monolayers compromised  
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Figure A2.10A 
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Figure A2.10B 
 
 
Figure A2.10 Chelation of cations results in a reduction of TEER in 
semen exposed monolayers. (A) HEC-1-A monolayers incubated apically with 
physiological concentrations of CaCl2, KCl, and MgCl2 present in seminal fluid 
resulted in a partial increase in resistance relative to whole semen. (B) HEC-1-A 
monolayers incubated apically with EGTA, a preferential chelator of calcium, 
resulted in a time-dependent decrease in resistance similar in magnitude to EDTA.  
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with either EDTA or EGTA (Fig. A2.8 and 10B), the next step was to 
determine whether the post-damage-recovery mechanism had specificity 
regarding the type of damage present. Like EDTA and EGTA, mannitol is well 
characterized for its ability to break down tight junctions, but does so by an 
alternative mechanism in which an osmostic imbalance is produced, causing the 
cells in a monolayer to shrink and physically separate the tight junction strands 
[198]. In this scenario the mannitol mimics a monolayer compromised by a 
microabrasion. As expected, a 30min pre-exposure to mannitol decreased 
resistance in HEC-1-A cells in a time-dependent manner down to 54% relative to 
mock; however, simultaneous exposure with SF did not result in an increase in 
resistance above mock levels (data not shown). Of note, the slight recovery evident 
beginning at 30 min post-SF-replacement was not due to the effects of factors in 
semen, but was attributed to the natural recovery of the osmotic balance in the 
cells after receiving fresh media leading to tight junction resealing (data not 
shown). Furthermore, when HEC-1-A monolayers were incubated simultaneously 
with 25% SF and 0.1% C31G, a surfactant known to break up the cell membrane 
[199], seminal fluid was not able to overcome the damage caused by C31G, but it 
did however reduce the rate at which resistance dropped (data not shown). These 
findings suggest that the mechanism by which SF induces changes in resistance 
is attributable to pathways related specifically to tight junctions and therefore does 
not protect from all physical damaging agents. 
 
  
  
	
304 
A2.4.11 Heat denaturation of proteins contained in SF results in a 
partial decrease in TEER 
The increased resistance is in part mediated by calcium contained in semen 
(Fig. A2.10A), implicating the contribution of an additional unidentified factor that 
may be responsible for producing the remainder of the partial increase. SF is 
complex in composition and contains many constituents in addition to metal ions, 
including cytokines, chemokines, and growth factors. These soluble factors are 
located in the seminal plasma, which was shown to be the active fraction of SF 
(Fig. A2.4). To determine whether a soluble factor in the SP was contributing to 
the increased resistance, SF was heat inactivated to denature the proteins. 
Regardless of heat inactivation method used, denaturation resulted in a repeatable 
and significant partial reduction in TEER (Fig. A2.11A). This suggests that although 
the addition of calcium alone is able to induce a partial increase in resistance, a 
heat-sensitive, soluble SP-factor may be responsible for inducing the remainder of 
the observed increase. Using this information, the cells were simultaneously 
exposed to heat-inactivated SF in the presence of EGTA in order to both inactivate 
the soluble factors and remove the calcium component of SF. However, despite 
these steps, there was only a 2/3 reduction in resistance rather than full inhibition 
of the semen-induced increase, implicating an as yet unidentified third component 
contributing to this effect (Fig. A2.11B). 
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Figure A2.11A 
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Figure A2.11B 
 
 
 
Figure A2.11 Heat denaturation of proteins and chelation of multiple 
metal ions in SF results in a decrease in SF-induced effects on resistance. 
(A) Incubating HEC-1-A monolayers with heat denatured SF resulted in a partial 
increase in resistance relative to 25% SF. (B) Heat inactivated SF was combined 
with 4 mM EDTA, which removes cationic metal ions, resulted in an increase in 
resistance of only 1/3 that of the whole SF.  
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A2.4.12 SF from healthy donors is slightly pro-inflammatory in 
cytokine content 
 To determine the identity of the heat-labile soluble component, seminal fluid 
was screened for 30 protein analytes in a luminex assay. The purpose of 
identifying semen content was to lead to clues as to what factor or combination of 
factors may be responsible for augmenting TEER. Although the luminex 
methodology and results are described in detail in Appendix Chapter 1, what is 
important to note here is that SF contained very high concentrations of growth 
factors, chemokines, and pro-inflammatory cytokines. Based on that analysis and  
information contained in literature, lead factors were identified and evaluated 
individually at physiologically relevant semen concentrations for effects on TEER. 
One such factor was epithelial growth factor (EGF), which is present at a high 
concentration of 2867.1 pg/ml in 25% concentrated SF and has been shown to be 
involved in tight junction formation [200]. However, when HEC-1-A transwells were 
incubated with 2 ng/ml of EGF, there were no changes in resistance (data not 
shown). Similarly, when prostaglandin E2 (PGE2), another concentrated semen 
growth factor, was evaluated at the physiological concentration of 16,000 pg/ml, 
there were also no effects on resistance (data not shown).  
Searching the literature for information on prominent reproductive factors 
contained in seminal fluid, one protein often discussed is transforming growth 
factor-β (TGF-β). Although this factor was not included in the 30-plex luminex 
screen, it is present in seminal fluid at the highest concentration of anywhere else 
in the human body—other than breast milk—and likely plays a key role in 
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protecting the fetus from clearance by suppressing the local maternal immune 
response in the FRT [70]. Of particular relevance are cancer studies on epithelial-
to-mesenchymal transition (EMT), which indicate that TGF-β may have 
concentration-dependent effects on tight junctions	 [201, 202]. Based on this 
information, it was possible that the high concentrations of TGF-β present in 
seminal fluid were contributing to the increased resistance. To address this, HEC-
1-A and End1 monolayers were exposed in transwells to either a low or high 
(physiological) concentration of TGF-β for 4 h (data not shown). However, in this 
model, TGF-β did not have any effects on the epithelium when evaluated for 
changes in resistance, permeability, or cell viability, suggesting that this factor is 
not responsible for the rapid, increased resistance observed during short-term SF 
exposure (data not shown). Additional experiments will be required to determine 
whether TGF-β is able to overcome tight junction compromise in epithelial cells as 
opposed to playing a role in increases in resistance on already intact monolayers.  
Using the transwell model, it is possible to replicate events that naturally 
occur during intercourse that may contribute to changes in resistance. TGF-β is 
expressed in the latent form in seminal fluid and requires activation; one possible 
mechanism of activation may be acid-activation within the FRT [70]. The vaginal 
tract maintains a low pH of 4. However, when alkaline semen at pH 7.2 [174] is 
introduced to the acidic environment of the vagina, there is a neutralization process 
that occurs, resulting in a pH transition. It is important to determine whether TGF-
β activation in semen could affect the magnitude of SF-induced effects on 
resistance. To study the contribution of pH and TGF-β activation on tight junctions  
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Figure A2.12A 
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Figure A2.12B 
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Figure A2.12C 
 
 
 
Figure A2.12 Changes in pH do not alter resistance or affect cell 
viability but the pH transition may slightly increase the magnitude of SF-
induced effects on resistance. HEC-1-A monolayers were incubated in media 
pH concentrations ranging from alkaline, pH 8.2, to acidic, pH 4.0, for 1 h. (A) No 
changes in resistance were induced when cells were cultured with high or low pH. 
(B) pH did not have a detrimental effect on cell viability at the time points observed. 
(C) Ect1 monolayers were cultured for 1 h in media titrated to pH 4 in order to 
replicate the acidic environment of the vagina. SF was then added to the apical 
chamber, mimicking the pH transition phase of intercourse in which alkaline SF is 
deposited into the vagina, inducing a neutralization of pH in the local environment. 
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in a realistic configuration, a model of the pH transition that occurs during 
intercourse was developed. Culture of HEC-1-A and Ect1 monolayers in a range 
of acidic, neutral, and alkaline media conditions for 1 h alone was not enough to 
induce changes in resistance (Fig. A2.12A) or cell viability, with only a 13% 
decrease at the most alkaline pH of 8.2 (Fig. A2.12B, Ect1 data not shown). Once 
it was established that the cells could survive culture in low pH, Ect1 monolayers 
were pre-incubated for 1 h in pH 4 media in order to replicate the acidic 
environment of the vagina, followed by the addition of semen to induce a pH 
transition. Interestingly, the peak of SF-induced resistance after 4 h was slightly 
higher in monolayers cultured at a low pH when compared to SF exposure in 
neutral pH culture medium (219% and 180%, respectively) (Fig. A2.12C); further 
study will be required to determine if this difference is significant. Using this model, 
it was possible to determine that although pH alone does not affect resistance, 
there is some indication that factors, perhaps TGF-β, in seminal fluid may further 
alter activity once in vivo and modify tight junction expression. 
A2.4.12 SF interacts with apically expressed surface molecules to 
induce changes in TEER 
During the pursuit to identify the unknown soluble semen factor, it was 
hypothesized that there may be an interaction between the unknown factor and a 
receptor on the surface of epithelial cells which initiates tight junction regulating 
pathways. The preliminary data regarding tissue specificity indicates that a specific 
receptor may be involved since non-FRT tight junction expressing cells did not 
respond to semen. To determine if the effects of SF were mediated through a 
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surface receptor or through other methods of tight junction regulation, the transwell 
cell cultures were incubated with 25% SF in the basolateral chamber. Many factors 
have surface specificity in the context of TEER and transwells, such as bone 
morphogenetic proteins (BMPs), which interact with BMP receptors (BMPRs) 
located exclusively on the basolateral surface of the polarized epithelium to 
increase TEER [203]. As a control, monolayers were incubated basolaterally with 
4 mM EDTA or EGTA, which resulted in a decrease in resistance similar to the rate 
and magnitude of apically exposed cells (Fig. A2.13A, EGTA data not shown). 
However, when 25% SF was incubated in the basolateral chamber, no significant 
changes in resistance were observed in either HEC-1-A or Ect1 cells (Fig. A2.13B, 
Ect1 data not shown). Interestingly, apical SF was unable to overcome the effects 
of basolateral EDTA during simultaneous exposure. This particular observation 
may have an important implication in the context of male-to-female STD pathogen 
transmission in circumstances where the FRT is vulnerable due to existing damage 
prior to SF exposure, possibly from an existing infection or inflammation associated 
with menstruation [204] (Fig. A2.13C). In summary, the data here suggest that SF 
interacts in a specific manner with an apically expressed surface receptor in order 
to induce changes in resistance.  
A2.4.13 TLR2 and semen interaction 
Previous literature has shown that VK2, Ect1, End1, and HEC-1-A cells 
express functional Toll-like receptor 2 (TLR2) receptors on the surface [159]	[205]. 
TLR2 is a pattern recognition receptor that recognizes a variety of structural 
features, including bacterial- and viral-derived molecules, which results in the  
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Figure A2.13A 
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Figure A2.13B 
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Figure A2.13C 
 
 
 
 
Figure A2.13 SF mediates and increase in TEER in a surface-specific 
manner. HEC-1-A transwells were incubated in the basolateral chamber with 
either (A) 4mM EDTA, a control to ensure that the monolayers are capable of 
responding to exposure from the basal surface, (B) 25% SF, or (C) simultaneous 
exposure to 25% SF in the apical well and 4mM EGTA in the basolateral well, in 
order to determine if subepithelial-sourced decreases in resistance can abrogate 
the effects of SF upon deposition. Although EDTA produced a time-dependent 
decrease in resistance almost identical to apical EDTA, SF did not affect 
resistance, with TEER remaining around mock level. Incubation with EGTA (C) in 
the subepithelial space overcomes the effects that SF mediates during apical 
exposure, resulting in a rapid and sustained decrease in resistance.  
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activation of innate immunity [206]. Most recently, gut studies of Salmonella 
typhimurium have demonstrated that the bacterially derived curli amyloid fibrils 
induce changes in resistance via interaction with TLR2 on T84 gut cells [206]. This 
is especially relevant in light of the recent discovery of SEVI (Semen-derived 
enhancer of virus infection) in seminal fluid, a conglomeration of PAP-derived 
peptide fragments naturally present in semen that aggregate to form cationic 
amyloid fibrils [142]. Studies suggest that this fibril may be involved in increasing 
HIV-1 transmission via electrostatic interactions with the virus, neutralizing virion-
host cell surface charge repulsions and thus facilitating infection [142, 143]. 
Denaturation of SEVI may alter conformation and neutralize the enhancing activity 
[143]. Based on this information, we hypothesized that the unidentified heat-labile 
factor present in SF may induce changes in resistance via TLR2 interaction. HEC-
1-A, Ect1, and VK2 monolayers pre-incubated with an anti-TLR2 blocking antibody 
were exposed to SF and monitored for changes in TEER. The results revealed that 
a TLR2-semen interaction was not involved, as blocking of the receptor did not 
dampen the SF-mediated increase in TEER (Fig. A2.14, Ect1 and VK2 data not 
shown). The ability of the cells to respond to TLR2 stimulation was confirmed by 
incubation with a positive-control, peptidoglycan (PGN), which produced a rapid 
increase in resistance that persisted out to the later time points, but was abrogated 
in the presence of the TLR2 antibody (data not shown). While further study will be 
necessary to eliminate a possible role for TLR2 interactions at time points beyond  
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Figure A2.14 
 
 
 
Figure A2.14 SF does not mediate changes in resistance through an 
interaction with TLR2. Pre-incubation of HEC-1-A monolayers with a neutralizing 
antibody 1 h prior to 25% SF exposure did not alter the effects of SF on resistance 
even out to 24 h of continuous exposure. Antibody alone did not affect normal 
resistance readings. 
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4 h, the factors involved in the initial rapid, increase in resistance observed 
within 5 min out to 4 h of SF exposure remain elusive. 
A2.4.14 SF-induced effects on resistance may protect against sexual 
transmission of pathogens 
In addition to reproductive implications, the changes induced by SF are also 
important when considered in the context of disease transmission. The decrease 
in permeability following SF incubation may have a secondary effect of protecting 
against sexual HIV-1 transmission by decreasing paracellular passage of the virus. 
Previous studies have indicated that HIV-1 alone has a detrimental effect on 
TEER, with exposure resulting in a consistent decrease in resistance across 
genital epithelial cells regardless of incubation time, concentration of virus, or strain 
of virus used [191]. Furthermore, the proposed mechanism of decrease was 
attributed to a gp120 interaction with the epithelial cell surface, resulting in a rapid 
breakdown of tight junctions [191]. However, this study on HIV-1 transmission was 
performed in the absence of seminal fluid, which itself will contribute to effects by 
modulating the local resistance and immune responses and may possibly interfere 
with the proposed virus-epithelial interaction. To study the effect of transmission 
across the epithelium in the context of seminal fluid, HEC-1-A, End1, and Ect1 
monolayers were incubated apically with either HIV-1 BaL only or HIV-1 BaL mixed 
with SF. During incubation no effects on resistance were observed on TEER in the 
virus-only control out to 4 h, nor was there a change in the degree of increase 
induced by SF in the presence of the virus (Fig. A2.15A-C). The stability of  
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Figure A2.15A 
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Figure A2.15B 
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Figure A2.15C 
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Figure A2.15D 
 
 
 
Figure A2.15 HIV-1 BaL does not induce changes in resistance or 
viability in reproductive monolayers. (A) HEC-1-A, (B) End1, and (C) Ect1 
monolayers were incubated apically for 4 h with HIV-1 BaL and then assessed for 
changes in TEER either with virus alone, or virus in the presence of 25% SF. HIV-
1 BaL alone did not induce a change in resistance. (D) In order to rule out any 
external effects as a result of decreased viability in the presence of virus, the 
monolayers were assessed via MTT assay. No detrimental effects induced by HIV-
1 BaL were observed at the concentrations or time points utilized (End1 pictured 
here, HEC-1-A and Ect1 data not shown).  
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resistance was also consistent with the viability assay, demonstrating that 
the virus did not induce cell death in these experiments (Fig. A2.15D). To 
determine whether increased resistance corresponded to a decrease in viral 
penetration into the basolateral chamber, the media from the basolateral chamber 
of each transwell was incubated with P4R5 cells. In this model, if even a single 
virus migrated across the epithelium (which would be undetectable by p24 assay) 
the virus could amplify through multiple rounds of infection in the P4R5 cells 
resulting in a proportional β-galactosidase (β-gal) output. Wells in which the virus 
had been co-incubated with SF resulted in a 50% reduction in β-gal output relative 
to wells that had virus only (Fig. A2.16). Further study will be required to determine 
if this effect is significant, along with follow-up using a more precise method for 
quantifying virus migration across the epithelium. The preliminary studies 
presented here implicate a protective role for semen from healthy donors by 
decreasing permeability, thereby potentially reducing HIV-1 transmission. 
 
A2.5 Discussion 
Recent studies have only begun to shift the view of seminal fluid as a carrier 
of sperm to an active immunological participant in the FRT, implicating the active 
role it may play in both reproduction and STI susceptibility. The studies presented 
here reveal that in addition to the previously documented immunological effects, 
SF also mediates direct changes on the epithelium at the level of tight junctions, 
the initial step that drives subsequent local environmental processes. Physiological 
parameters based on previous work were utilized in order to develop a model of 
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heterosexual intercourse and study these changes in a relevant and accurate 
context. Our initial observations indicate that semen induces an increase in 
resistance in the epithelial monolayer that is both dose- and time-dependent. 
Although, the concentration of SF that ultimately occurs in the FRT is debatable, 
we found that regardless of degree of dilution, these effects persisted across 
concentrations ranging from 50% to as low as 0.1%. However, the most interesting 
observation was that the increase in resistance that SF induced occurred very 
rapidly, with significantly elevated TEER evident by 5 min of exposure, suggesting 
that this process is likely independent of tight junction protein production. At longer 
time points, though, it is possible that protein production is a contributing factor in 
order to sustain the continued increase in resistance that eventually peaks beyond 
4 h.  
It is interesting to note that the changes that SF induces are not permanent, 
as removal of semen in a manner that corresponds to the time frame of clearance 
from the FRT during coitus resulted in a gradual decline in resistance, eventually 
resuming back mock level after 4 h and remaining stable. Previously published 
studies indicate that after semen deposition in the reproductive tract, SF is no 
longer present in large quantities in the vagina due to clearance by several 
processes including phagocytosis by neutrophils and macrophages; absorption; 
leakage out of the tract; and the upward migration towards the uterus [28]. It is 
important to highlight that although the monolayer resumes tight junction 
expression to “mock level” this does not imply that the monolayer is vulnerable in 
this state. The permeability studies and staining demonstrate that the monolayers  
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Figure A2.16 
 
 
 
Figure A2.16 SF reduces monolayer permeability to HIV-1. HEC-1-A 
monolayers were incubated apically with HIV-1 IIIB, a CXCR4 co-receptor 
utilizing virus that infects more efficiently than HIV-1 BaL. In the presence of 25% 
SF the level of β-gal was decreased relative to monolayers infected with virus 
only. 
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form a relatively impermeable barrier even at baseline levels, which is an 
innate protective function characteristic of the epithelium lining the FRT. These 
studies also established that changes in resistance correlated inversely with 
changes in the monolayer’s ability to regulate paracellular passage, proving that 
increased resistance resulted in a corresponding decrease in permeability. This 
relationship was corroborated by the staining pattern of the ZO-1 protein network, 
verifying that the tight junctions remain intact during SF exposure and are 
responsible for the elevated resistance. Studies of tight junctions have 
demonstrated that they are a dynamic system of strands, in a constant motion of 
opening and closing [177, 181, 207]. To make these rapid changes possible there 
are vesicles containing tight junction complexes located just beneath the cell 
surface that are at the ready for upregulation and surface expression [97, 207]. 
The process of vesicle fusion is governed by several pathways, one of which is 
calcium-mediated [97]. In addition to vesicle trafficking, calcium signaling 
pathways have been shown to be a part of tight junction formation and regulation 
[177]. Calcium signaling is one of the few processes that functions quickly enough 
to produce the rapid increase in TEER observed at the 5 min time point. In general, 
when calcium is introduced into the extracellular environment signaling may be 
activated through the calcium sensing receptor (CSR), a G-protein coupled 
receptor (GPCR), resulting in the release of intracellular calcium stores from the 
ER which combines with DAG to activate protein kinase C (PKC) and thus increase 
vesicle fusion at the cell surface, upregulating tight junctions [97, 158]. The rapid 
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exocytosis of vesicles containing entire junctional complexes at the cell surface 
may explain the ability for resistance to increase minutes after SF deposition [158]. 
Eventually, though, the calcium stores would either be depleted or the gradient 
across the membrane would re-equilibrate, thus it is likely that a second pathway 
is also activated, which would be responsible for upregulating tight junction protein 
production in order to sustain the elevated resistance during the later phases after 
4 h and peaking around 24 h.  
Our studies indicate that calcium is only one aspect responsible for the 
increased TEER, as the addition of extracellular calcium at the concentration 
present in SF only partially increased resistance relative to seminal fluid. A second 
possible factor may be a heat-labile protein in the seminal plasma, since heat 
denaturation of SF resulted in a partial decrease in semen-induced effects. Soluble 
factors were pursued as possible leads in the identification this unknown 
contributor. However, proteins detected by the Luminex assay at high 
concentrations that have been known to alter tight junctions were ruled out, such 
as TGF-β, EGF, and PGE2. Additional data supports the hypothesis that this 
unidentified protein is acting through a specific protein-epithelial surface receptor 
interaction, as evidenced by basolateral exposure studies and the lack of effects 
in non-FRT, tight junction-expressing cell lines. Although TLR2, a surface receptor 
implicated in tight junction modulation via bacterial studies, was ruled out, further 
study will be required to identify both the semen factor and apical receptor involved 
in these processes.  
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The preliminary evidence presented here suggests that a third factor may 
also be involved. Mixing heat denatured SF with EDTA, a process that inactivates 
the proteins and chelates cationic metal ions in semen, did not completely abolish 
the increase in TEER, maintaining a 1/3 increase in resistance. Exclusionary 
experiments ruled out any contribution of physical characteristics of SF, such as 
viscosity, spermatozoa, pH, or serum effects. A previous study of SF in the 
reproductive tract has proposed that the changes in resistance may be induced by 
lipids, which are found in semen as part of both the spermatozoa membrane and 
in the seminal plasma fraction [156, 208]. Diacylglycerol, which is involved in the 
tight junction regulating signaling cascade induced by extracellular calcium, is an 
example of one lipid found in semen that may increase surface tight junction 
expression by activation of protein kinase C (PKC) and subsequent upregulation 
of ZO-1 [162, 208]. Another possibility is regulation of tight junctions by lipid-
derived hormones, such as testosterone. Studies of prostate epithelium have 
indicated that low serum testosterone levels may result in decreased tight junction 
expression leading to prostatic hypertrophy; in the context of healthy SF, 
testosterone may contribute to the persistent increase in resistance observed 
despite heat-denaturation and cation removal	[209]. 
Identifying the key changes mediated by SF in the FRT is important 
because these changes have application to many reproductive and sexual 
transmission studies. From a reproductive standpoint, SF-induced increases in 
resistance may facilitate fertilization via closing of the tight junctions between the 
cells lining the reproductive tract, which would: (i) prevent the spermatozoa from 
  
  
	
330 
getting trapped in the paracellular spaces, (ii) prevent clearance by immunological 
factors in the FRT, and (iii) provide a smooth passage across the epithelial surface 
towards the egg [156]. However, in the context of disease studies, the same factors 
that alter the environment during fertility may affect the likelihood of a female 
becoming infected	 [172]. Preliminary studies have determined that the 
concentrations of cytokines present in SF from infected males are dysregulated, 
varying with factors such as stage of disease and treatment intervention [8, 10, 
94]. A thorough analysis of semen content from the infected population in future 
studies will be a challenge as the variability of these factors from one male to 
another is likely to be high, depending on overall health, current HIV disease 
status, age, drug use, etc. Interestingly, virus alone may alter tight junction 
expression. Previous studies have observed decreases in resistance using 
multiple concentrations and strains of HIV-1 in the absence of semen [191]. This 
is in contradiction to the results presented here, in which virus did not affect 
resistance either alone or in combination with SF. Although the difference in 
observations may be attributable to differences in experimental conditions, such 
as the types of cell lines used, what is important to consider is that the composition 
of seminal fluid from an infected male forming the environment surrounding the 
virus will be different from the healthy males studied here and likely impact both 
resistance and permeability. In regards to the other two factors involved, calcium 
and lipids, studies have shown that HIV-infected males also suffer from both low 
testosterone [210] and calcium deficiency, which may be attributed to infection 
and/or ART	[211]. With the compounding changes in testosterone, calcium, and 
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cytokines, the protective effect on resistance mediated by semen from healthy men 
may be absent or reduced in the case of an infected male.  
In conclusion, we identified a possible protective role for semen in the FRT 
in the context of HIV-1 transmission. Exposure to SF resulted in a rapid and 
sustained increase in resistance that also produced a concurrent decrease in 
permeability. Our investigations suggest that these changes may be induced by a 
combination of semen-derived calcium, a soluble protein component, and a lipid 
portion that mediate an increase in resistance through a specific interaction with 
the apical interface of the reproductive epithelium. Further study will be required to 
identify the specific semen protein factor in healthy seminal fluid responsible for 
initiating these changes. Establishing the epithelial events that take place after 
semen deposition will prompt future studies to focus on examining whether these 
factors or events are dysregulated during exposure to HIV-1 infected seminal fluid. 
Changes in the profile of factors constituting SF in the MRT of an infected male 
may alter the effects of semen on tight junctions observed here, thereby enhancing 
passive permeability of the epithelium to virus, resulting in direct access to target 
immune cell population located in the subepithelial space. The loss of the 
protective effect induced by semen in the FRT may be the unaccounted aspect of 
transmission that has been overlooked thus far, providing one explanation as to 
how a disease with an estimated low-risk of transmission per sex act could lead to 
the world epidemic present among heterosexual women today. 
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